[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 4750
1. Cheung YW, Spevack DM: Single left ventricle and pheochromocytoma. Congenit Heart Dis; 2008 Sep-Oct;3(5):355-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Single left ventricle and pheochromocytoma.
  • We report a patient born with a Holmes heart who was later diagnosed with pheochromocytoma in her teenage years.
  • [MeSH-major] Adrenal Gland Neoplasms / complications. Heart Defects, Congenital / complications. Heart Ventricles / abnormalities. Pheochromocytoma / complications


2. Martínez Lesquereux L, Puñal JA, Paredes Cotoré JP, Parada González P, Beiras Sarasquete C, Gamborino Caramés E, Ladra González MJ, Beiras Torrado A: [Laparoscopic adrenalectomy: presentation of 43 cases]. Cir Esp; 2010 Mar;87(3):159-64
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Adrenalectomía laparoscópica: presentación de 43 casos.
  • Indications for adrenalectomy included hyperaldosteronism (19), non-functioning adenoma (8), phaeochromocytoma (6), Cushing's syndrome (6), metastasis (3) and adrenal primary tumour (1).
  • CONCLUSION: Laparoscopic adrenalectomy is a safe and effective method in the treatment of adrenal masses and it can be performed with minimal risk and morbidity.
  • [MeSH-major] Adrenal Gland Diseases / surgery. Adrenalectomy / methods

  • MedlinePlus Health Information. consumer health - Adrenal Gland Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 AEC. Published by Elsevier Espana. All rights reserved.
  • (PMID = 19896122.001).
  • [ISSN] 0009-739X
  • [Journal-full-title] Cirugía española
  • [ISO-abbreviation] Cir Esp
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


3. Mohaupt MG, von Vigier RO: [Urinary hormone analysis]. Ther Umsch; 2006 Sep;63(9):559-64
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Occasionally, these determinations need to be complemented by plasma- or serum hormone analysis.
  • Diseases to be investigated by steroid hormone analysis are excess production of a typical or atypical mineralocorticoid active steroid hormones, the hormonal activity of adrenal or ovarian tumors, acne of unknown origin, hirsutism, a PCO-, an adrenogenital or a suspected Cushing syndrome.
  • Biogenic amines should be determined in suspected secondary or refractory arterial hypertension, in case of pheochromocytoma- or paraganglioma-associated symptoms or if a serotonin-producing tumor is suspected.
  • In children genetically determined diseases are the primary background to perform an analysis.
  • [MeSH-major] Endocrine System Diseases / diagnosis. Endocrine System Diseases / urine. Hormones / urine. Urinalysis / methods

  • MedlinePlus Health Information. consumer health - Endocrine Diseases.
  • MedlinePlus Health Information. consumer health - Hormones.
  • MedlinePlus Health Information. consumer health - Urinalysis.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17048168.001).
  • [ISSN] 0040-5930
  • [Journal-full-title] Therapeutische Umschau. Revue thérapeutique
  • [ISO-abbreviation] Ther Umsch
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Hormones
  • [Number-of-references] 11
  •  go-up   go-down


Advertisement
4. Hashiba T, Maruno M, Fujimoto Y, Suzuki T, Wada K, Isaka T, Izumoto S, Yoshimine T: Skull metastasis from papillary thyroid carcinoma accompanied by neurofibromatosis type 1 and pheochromocytoma: report of a case. Brain Tumor Pathol; 2006 Oct;23(2):97-100
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Skull metastasis from papillary thyroid carcinoma accompanied by neurofibromatosis type 1 and pheochromocytoma: report of a case.
  • In her medical history, she was diagnosed with neurofibromatosis type 1 (NF1) at age 28 years, and she underwent thyroidectomy for PTC at age 52 years and adrenectomy for pheochromocytoma (PC) at age 58 years.
  • Head computed tomography (CT) showed an expansive, osteolytic, and solid tumor extending from the dura mater into the subcutis, destroying part of the frontal bone.
  • Head magnetic resonance imaging (MRI) revealed that the tumor was chiefly extradural but partially invaded the dura mater.
  • Cerebral angiography showed that the tumor was fed from a branch of the external carotid artery.
  • She underwent surgery, and histological examination revealed that the skull tumor was a metastasis from PTC, indicating that skull metastasis occurred 23 years after curative surgery for PTC.
  • [MeSH-major] Carcinoma, Papillary / secondary. Neurofibromatosis 1 / pathology. Pheochromocytoma / secondary. Skull Neoplasms / secondary. Thyroid Neoplasms / pathology


5. Sood SK, Balasubramanian SP, Harrison BJ: Percutaneous biopsy of adrenal and extra-adrenal retroperitoneal lesions: beware of catecholamine secreting tumours! Surgeon; 2007 Oct;5(5):279-81
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Percutaneous biopsy of adrenal and extra-adrenal retroperitoneal lesions: beware of catecholamine secreting tumours!
  • An increasing number of these patients are discovered to have incidental adrenal or retroperitoneal tumours.
  • Approximately 5% of all incidentally detected adrenal lesions are phaeochromocytomas and 25% of phaeochromocytomas are discovered during imaging studies for unrelated disorders.
  • 10% of phaeochromocytomas are extra-adrenal.
  • METHODS: Retrospective case notes review of three patients with adrenal/retroperitoneal lesions who had percutaneous biopsy before biochemical testing and tertiary referral.
  • FINDINGS: Adrenal/retroperitoneal lesions are still being biopsied without prior biochemical testing.
  • One patient with phaeochromocytoma had a critical event.
  • The others were found to have a phaeochromocytoma and a ganglioneuroma.
  • CONCLUSIONS: The possibility of a catecholamine secreting tumour should be considered in adrenal and extra-adrenal retroperitoneal lesions.
  • If a biopsy is planned, rarely required in adrenal lesions, phaeochromocytoma must be excluded by biochemical testing prior to the biopsy to avoid potential life threatening complications.
  • [MeSH-major] Adrenal Gland Neoplasms / pathology. Ganglioneuroma / pathology. Pheochromocytoma / pathology. Retroperitoneal Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - Pheochromocytoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17958227.001).
  • [ISSN] 1479-666X
  • [Journal-full-title] The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland
  • [ISO-abbreviation] Surgeon
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Scotland
  • [Chemical-registry-number] 0 / Catecholamines
  •  go-up   go-down


6. Kim DS, Kim JY, Han YS: Alzheimer's disease drug discovery from herbs: neuroprotectivity from beta-amyloid (1-42) insult. J Altern Complement Med; 2007 Apr;13(3):333-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Alzheimer's disease drug discovery from herbs: neuroprotectivity from beta-amyloid (1-42) insult.
  • DESIGN: Twenty-seven (27) herbs were selected, extracted with aqueous methanol (90%) and chloroform, and the extracts were evaluated for their ability to protect PC12 rat pheochromocytoma and primary neuronal cells from betaA(1-42) insult using both 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide reduction assay and lactate dehydrogenase efflux assay.
  • Several extracts showed cytotoxicity at high concentration (approximately 150 microg/mL), whereas other extracts did not at all protect cells from betaA(1-42) insult.
  • CONCLUSION: Selective herbs may be potentially important resources to discover drug candidates against the onset of Alzheimer's disease.
  • [MeSH-major] Alzheimer Disease / physiopathology. Amyloid beta-Peptides / toxicity. Neurons / drug effects. Neuroprotective Agents / pharmacology. Plant Extracts / pharmacology

  • MedlinePlus Health Information. consumer health - Alzheimer's Disease.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Altern Complement Med. 2007 Apr;13(3):345-6 [17480134.001]
  • [CommentIn] J Altern Complement Med. 2007 Apr;13(3):347-8 [17480135.001]
  • [CommentIn] J Altern Complement Med. 2007 Apr;13(3):341-4 [17480133.001]
  • (PMID = 17480132.001).
  • [ISSN] 1075-5535
  • [Journal-full-title] Journal of alternative and complementary medicine (New York, N.Y.)
  • [ISO-abbreviation] J Altern Complement Med
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Amyloid beta-Peptides; 0 / Neuroprotective Agents; 0 / Plant Extracts
  •  go-up   go-down


7. Kavakebi P, Hausott B, Tomasino A, Ingorokva S, Klimaschewski L: The N-end rule ubiquitin-conjugating enzyme, HR6B, is up-regulated by nerve growth factor and required for neurite outgrowth. Mol Cell Neurosci; 2005 Aug;29(4):559-68
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The N-end rule ubiquitin-conjugating enzyme, HR6B, is up-regulated by nerve growth factor and required for neurite outgrowth.
  • The search for enzymes responsible for increased utilization of ubiquitin revealed the ubiquitin-conjugating enzyme, HR6B (yeast UBC2/RAD6), increased on mRNA and protein level in rat pheochromocytoma (PC12) cells after treatment with nerve growth factor (NGF).

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • Saccharomyces Genome Database. Saccharomyces Genome Database .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15946855.001).
  • [ISSN] 1044-7431
  • [Journal-full-title] Molecular and cellular neurosciences
  • [ISO-abbreviation] Mol. Cell. Neurosci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Dipeptides; 0 / RNA, Messenger; 0 / RNA, Small Interfering; 9061-61-4 / Nerve Growth Factor; EC 6.3.2.- / Ube2b protein, rat; EC 6.3.2.19 / UBR1 protein, human; EC 6.3.2.19 / Ubiquitin-Conjugating Enzymes; EC 6.3.2.19 / Ubiquitin-Protein Ligases
  •  go-up   go-down


8. Chavez-Rodriguez J, Pasieka JL: Adrenal lesions assessed in the era of laparoscopic adrenalectomy: a modern day series. Am J Surg; 2005 May;189(5):581-5; discussion 585-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adrenal lesions assessed in the era of laparoscopic adrenalectomy: a modern day series.
  • METHODS: Retrospective analysis of patients with adrenal lesions referred from 1992 to 2004.
  • Before the introduction of LA, 13% had primary hyperaldosteronism (PA), 23% had pheochromocytoma (Pheo), 20% had Cushing's syndrome (CS), and 7% had adrenal cortical cancer (ACC).
  • [MeSH-major] Adrenal Gland Neoplasms / surgery. Adrenalectomy / methods. Laparoscopy
  • [MeSH-minor] Cushing Syndrome / surgery. Female. Humans. Hyperaldosteronism / surgery. Male. Pheochromocytoma / surgery. Retrospective Studies. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15862500.001).
  • [ISSN] 0002-9610
  • [Journal-full-title] American journal of surgery
  • [ISO-abbreviation] Am. J. Surg.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


9. Kasahara T, Nishiyama T, Takahashi K: Laparoscopic adrenalectomy for pheochromocytoma: evaluation of experience and strategy at a single institute. BJU Int; 2009 Jan;103(2):218-22
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopic adrenalectomy for pheochromocytoma: evaluation of experience and strategy at a single institute.
  • OBJECTIVE: To assess the utility, safety and feasibility of laparoscopic adrenalectomy (LA) for pheochromocytoma.
  • PATIENTS AND METHODS: Between 1997 and 2007, 23 patients with pheochromocytoma underwent LA at our institution.
  • In the first cases of LA, we used an abdominal wall-lifting device with low pneumoperitoneal pressure and initial ligation of the adrenal vein.
  • In subsequent cases, we adopted similar methods to those we perform for other benign adrenal tumours, including a 'regular' pneumoperitoneal pressure, and disconnection of the adrenal vein as the last step of tumour dissection.
  • RESULTS: Rates of hypertension crisis (systolic blood pressure (sBP) of >200 mmHg) and sudden hypotension subsequent to ligation of the adrenal vein (sBP of <80 mmHg) were 17% and 48% in the LA group, and 44% and 72% in the OA group, respectively.
  • CONCLUSION: Laparoscopic removal of pheochromocytoma can be safely and feasibly accomplished by surgical approaches similar to those used for other pathological conditions of the adrenal gland.
  • [MeSH-major] Adrenal Gland Neoplasms / surgery. Adrenalectomy / methods. Laparoscopy. Pheochromocytoma / surgery


10. Ogola HJ, Kamiike T, Hashimoto N, Ashida H, Ishikawa T, Shibata H, Sawa Y: Molecular characterization of a novel peroxidase from the cyanobacterium Anabaena sp. strain PCC 7120. Appl Environ Microbiol; 2009 Dec;75(23):7509-18
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Molecular characterization of a novel peroxidase from the cyanobacterium Anabaena sp. strain PCC 7120.
  • The open reading frame alr1585 of Anabaena sp. strain PCC 7120 encodes a heme-dependent peroxidase (Anabaena peroxidase [AnaPX]) belonging to the novel DyP-type peroxidase family (EC 1.11.1.X).
  • The purified enzyme was a 53-kDa tetrameric protein with a pI of 3.68, a low pH optima (pH 4.0), and an optimum reaction temperature of 35 degrees C.
  • [MeSH-minor] Amino Acid Sequence. Anthraquinones / metabolism. Cloning, Molecular. Coenzymes / analysis. Enzyme Stability. Escherichia coli / genetics. Gene Expression. Heme / analysis. Hydrogen Peroxide / metabolism. Hydrogen-Ion Concentration. Isoelectric Point. Kinetics. Molecular Sequence Data. Molecular Weight. Phylogeny. Sequence Alignment. Substrate Specificity. Temperature

  • Hazardous Substances Data Bank. HYDROGEN PEROXIDE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Appl Biochem Biotechnol. 2002 Jul-Dec;102-103(1-6):109-18 [12396115.001]
  • [Cites] Appl Environ Microbiol. 2000 Aug;66(8):3357-62 [10919791.001]
  • [Cites] Biotechnol Lett. 2003 May;25(9):709-13 [12882171.001]
  • [Cites] J Biol Inorg Chem. 2003 Sep;8(7):751-60 [12884090.001]
  • [Cites] Curr Opin Microbiol. 2003 Dec;6(6):557-63 [14662350.001]
  • [Cites] Folia Microbiol (Praha). 2003;48(6):771-4 [15058190.001]
  • [Cites] Appl Microbiol Biotechnol. 2004 Aug;65(3):287-94 [14767623.001]
  • [Cites] Biochim Biophys Acta. 1969 Jul 30;184(2):420-31 [4309260.001]
  • [Cites] Nature. 1970 Aug 15;227(5259):680-5 [5432063.001]
  • [Cites] Anal Biochem. 1987 Feb 15;161(1):1-15 [3578775.001]
  • [Cites] J Biol Chem. 1988 May 25;263(15):7029-36 [2835361.001]
  • [Cites] Nature. 1992 Mar 5;356(6364):83-5 [1538787.001]
  • [Cites] J Mol Biol. 1992 Jul 20;226(2):507-33 [1640463.001]
  • [Cites] J Biol Chem. 1993 Oct 25;268(30):22292-8 [8226738.001]
  • [Cites] Appl Environ Microbiol. 1994 Nov;60(11):4216-8 [7527628.001]
  • [Cites] J Biol Chem. 1995 Jun 9;270(23):13740-7 [7775429.001]
  • [Cites] J Biol Chem. 1996 May 10;271(19):11126-33 [8626657.001]
  • [Cites] Appl Environ Microbiol. 1999 Mar;65(3):1029-35 [10049859.001]
  • [Cites] Appl Environ Microbiol. 2005 Apr;71(4):1775-84 [15812000.001]
  • [Cites] Appl Environ Microbiol. 2005 Nov;71(11):6711-8 [16269701.001]
  • [Cites] Bioresour Technol. 2001 May;77(3):247-55 [11272011.001]
  • [Cites] Eur J Biochem. 2001 Aug;268(15):4169-76 [11488909.001]
  • [Cites] DNA Res. 2001 Oct 31;8(5):205-13; 227-53 [11759840.001]
  • [Cites] Appl Microbiol Biotechnol. 2002 Sep;59(6):672-8 [12226723.001]
  • [Cites] J Biol Chem. 2006 May 19;281(20):13972-8 [16551627.001]
  • [Cites] Chemosphere. 2007 Sep;69(2):338-45 [17524451.001]
  • [Cites] Proteins. 2007 Nov 1;69(2):223-33 [17654545.001]
  • [Cites] Proteins. 2007 Nov 1;69(2):234-43 [17654547.001]
  • [Cites] J Biol Chem. 2007 Dec 14;282(50):36652-8 [17928290.001]
  • [Cites] Appl Microbiol Biotechnol. 2008 Jan;77(5):1139-44 [18034237.001]
  • [Cites] Appl Microbiol Biotechnol. 2008 Jan;77(6):1241-50 [18038130.001]
  • [Cites] J Biosci Bioeng. 2009 Feb;107(2):113-5 [19217546.001]
  • [Cites] Cell Mol Life Sci. 2009 Apr;66(8):1387-403 [19099183.001]
  • [Cites] Biodegradation. 2009 Jun;20(3):433-40 [19009358.001]
  • [Cites] Appl Environ Microbiol. 2000 Apr;66(4):1754-8 [10742277.001]
  • [Cites] Appl Microbiol Biotechnol. 2003 May;61(3):220-5 [12698279.001]
  • (PMID = 19801472.001).
  • [ISSN] 1098-5336
  • [Journal-full-title] Applied and environmental microbiology
  • [ISO-abbreviation] Appl. Environ. Microbiol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anthraquinones; 0 / Bacterial Proteins; 0 / Coenzymes; 42VZT0U6YR / Heme; BBX060AN9V / Hydrogen Peroxide; EC 1.11.1.7 / Peroxidase
  • [Other-IDs] NLM/ PMC2786418
  •  go-up   go-down


11. Ay B, Wallace D, Mantilla CB, Prakash YS: Differential inhibition of neuronal Na+-Ca2+ exchange versus store-operated Ca2+ channels by volatile anesthetics in pheochromocytoma (PC12) cells. Anesthesiology; 2005 Jul;103(1):93-101
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Differential inhibition of neuronal Na+-Ca2+ exchange versus store-operated Ca2+ channels by volatile anesthetics in pheochromocytoma (PC12) cells.
  • The authors hypothesized that volatile anesthetic inhibition of neuronal activity is mediated by inhibition of Ca2+ influx via two major mechanisms: plasma membrane Na+-Ca2+ exchange (NCX) and the novel mechanism of Ca2+ influx triggered by endoplasmic reticulum Ca2+ depletion (store-operated Ca2+ channels [SOCCs]).
  • METHODS: Differentiated rat pheochromocytoma cells loaded with the Ca2+ indicator fura-2 were Na+-loaded with 0 Ca2+, 145 mm Na+ Tyrode's and 5 microm cyclopiazonic acid plus 10 microm ryanodine (functionally isolating plasma membrane).
  • The protocol was repeated in the presence of volatile anesthetics (0.5-1.5 minimum alveolar concentration [MAC] halothane, isoflurane, or sevoflurane) or other drugs to characterize NCX.
  • CONCLUSIONS: These data indicate that volatile anesthetics, especially halothane and isoflurane, interfere with neuronal [Ca2+]i regulation by inhibiting NCX but not SOCC-mediated Ca2+ influx (except high concentrations of halothane).

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CALCIUM, ELEMENTAL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15983461.001).
  • [ISSN] 0003-3022
  • [Journal-full-title] Anesthesiology
  • [ISO-abbreviation] Anesthesiology
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anesthetics, Inhalation; 0 / Calcium Channels; 0 / Sodium-Calcium Exchanger; SY7Q814VUP / Calcium
  •  go-up   go-down


12. Simon DP, Vadakkadath Meethal S, Wilson AC, Gallego MJ, Weinecke SL, Bruce E, Lyons PF, Haasl RJ, Bowen RL, Atwood CS: Activin receptor signaling regulates prostatic epithelial cell adhesion and viability. Neoplasia; 2009 Apr;11(4):365-76
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Using prostatic cancer cell (PCC) lines as a model of cancer cell proliferation, we have identified the fetal serum component activin A and its signaling through the activin receptor type II (ActRII), as necessary, although not sufficient, for PCC proliferation.
  • Activin A induced Smad2 phosphorylation and PCC proliferation, but only in the presence of fetal bovine serum (FBS).
  • Conversely, activin A antibodies and inhibin A suppressed FBS-induced PCC proliferation confirming activin A as one of multiple serum components required for PCC proliferation.
  • Basic fibroblast growth factor was subsequently shown to synergize activin A-induced PCC proliferation.
  • Inhibition of ActRII signaling using a blocking antibody or antisense-P decreased mature ActRII expression, Smad2 phosphorylation, and the apparent viability of PCCs and neuroblastoma cells grown in FBS.
  • Suppression of ActRII signaling in PCC and neuroblastoma cells did not induce apoptosis as indicated by the ratio of active/inactive caspase 3 but did correlate with increased cell detachment and ADAM-15 expression, a disintegrin whose expression is strongly correlated with prostatic metastasis.
  • These findings indicate that ActRII signaling is required for PCC and neuroblastoma cell viability, with ActRII mediating cell fate via the regulation of cell adhesion.
  • [MeSH-minor] ADAM Proteins / metabolism. Cell Adhesion / physiology. Cell Line, Tumor. Cell Survival / physiology. Humans. Immunoblotting. Male. Membrane Proteins / metabolism. Neuroblastoma / metabolism

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Endocrinol Metab. 1998 Mar;83(3):969-75 [9506758.001]
  • [Cites] J Clin Endocrinol Metab. 1998 Apr;83(4):1194-200 [9543140.001]
  • [Cites] Prostate. 1998 May 15;35(3):212-20 [9582090.001]
  • [Cites] J Natl Cancer Inst. 1998 Jun 17;90(12):911-5 [9637140.001]
  • [Cites] Urol Res. 1998;26(4):259-64 [9759999.001]
  • [Cites] Ann Med. 1998 Aug;30(4):357-68 [9783834.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15333-8 [9860969.001]
  • [Cites] Mol Endocrinol. 1999 Jan;13(1):15-23 [9892009.001]
  • [Cites] J Urol. 1999 Mar;161(3):970-6 [10022736.001]
  • [Cites] Int J Oncol. 1999 Jun;14(6):1185-95 [10339677.001]
  • [Cites] J Cell Physiol. 1999 Jul;180(1):53-60 [10362017.001]
  • [Cites] Gynecol Oncol. 1999 Jul;74(1):93-7 [10385557.001]
  • [Cites] J Endocrinol. 2004 Oct;183(1):69-78 [15525575.001]
  • [Cites] Oncol Rep. 2005 Jan;13(1):81-8 [15583806.001]
  • [Cites] Oncogene. 2004 Dec 16;23(58):9326-35 [15531927.001]
  • [Cites] Cell Mol Life Sci. 2005 Feb;62(3):257-70 [15723162.001]
  • [Cites] J Pathol. 2005 Jun;206(2):205-13 [15818594.001]
  • [Cites] Endocr Rev. 2005 May;26(3):361-79 [15867098.001]
  • [Cites] JAMA. 2005 Jul 13;294(2):238-44 [16014598.001]
  • [Cites] Dev Dyn. 2005 Aug;233(4):1560-70 [15968639.001]
  • [Cites] Life Sci. 2005 Oct 14;77(22):2752-9 [15978633.001]
  • [Cites] Am J Pathol. 2005 Nov;167(5):1405-10 [16251424.001]
  • [Cites] Ann Urol (Paris). 2005 Oct;39 Suppl 3:S46-50 [16302710.001]
  • [Cites] Mol Cancer Res. 2006 Apr;4(4):235-46 [16603637.001]
  • [Cites] Neoplasia. 2006 Apr;8(4):319-29 [16756724.001]
  • [Cites] Prostate Cancer Prostatic Dis. 2006;9(2):185-9 [16550207.001]
  • [Cites] Nat Methods. 2006 Aug;3(8):637-46 [16862139.001]
  • [Cites] Nat Med. 2006 Aug;12(8):925-32 [16892036.001]
  • [Cites] Clin Exp Metastasis. 2006;23(2):117-22 [16841234.001]
  • [Cites] J Pathol. 2007 Jan;211(2):173-80 [17200939.001]
  • [Cites] Nat Rev Cancer. 2007 Apr;7(4):246-55 [17384580.001]
  • [Cites] Anticancer Res. 2007 Mar-Apr;27(2):793-9 [17465204.001]
  • [Cites] Biochimie. 2008 Feb;90(2):369-79 [17920749.001]
  • [Cites] Cancer Res. 2008 Feb 15;68(4):1092-9 [18281484.001]
  • [Cites] FASEB J. 2008 Mar;22(3):641-53 [17905725.001]
  • [Cites] Endocrinology. 1999 Nov;140(11):5303-9 [10537161.001]
  • [Cites] J Pathol. 1999 Dec;189(4):564-9 [10629559.001]
  • [Cites] Br J Cancer. 2000 Jan;82(1):112-7 [10638976.001]
  • [Cites] J Urol. 2000 Feb;163(2):623-9 [10647698.001]
  • [Cites] J Biol Chem. 2000 Feb 4;275(5):3206-12 [10652306.001]
  • [Cites] Prostate. 2000 Oct 1;45(2):158-66 [11027415.001]
  • [Cites] Trends Endocrinol Metab. 2000 Oct;11(8):309-14 [10996525.001]
  • [Cites] J Urol. 2001 Jun;165(6 Pt 1):2121-5 [11371939.001]
  • [Cites] J Biol Chem. 2001 Jun 8;276(23):20688-94 [11274206.001]
  • [Cites] Gut. 2001 Sep;49(3):409-17 [11511564.001]
  • [Cites] Dev Biol. 2001 Sep 1;237(1):145-58 [11518512.001]
  • [Cites] Endocr Rev. 2001 Dec;22(6):836-58 [11739336.001]
  • [Cites] Mol Cell. 2001 Dec;8(6):1277-89 [11779503.001]
  • [Cites] Exp Biol Med (Maywood). 2002 Feb;227(2):75-87 [11815670.001]
  • [Cites] J Clin Invest. 2002 Apr;109(7):857-62 [11927611.001]
  • [Cites] Prostate. 2002 May 1;51(2):133-40 [11948968.001]
  • [Cites] J Steroid Biochem Mol Biol. 2002 Jul;81(3):191-201 [12163131.001]
  • [Cites] J Biol Chem. 2002 Sep 13;277(37):33683-9 [12091380.001]
  • [Cites] Exp Biol Med (Maywood). 2002 Oct;227(9):724-52 [12324653.001]
  • [Cites] Int J Oncol. 2003 Jan;22(1):75-80 [12469187.001]
  • [Cites] Differentiation. 2002 Dec;70(9-10):473-85 [12492490.001]
  • [Cites] Differentiation. 2002 Dec;70(9-10):506-21 [12492493.001]
  • [Cites] Endocr Relat Cancer. 2003 Jun;10(2):209-16 [12790784.001]
  • [Cites] Cancer Res. 2003 Sep 15;63(18):5754-60 [14522896.001]
  • [Cites] Nat Med. 2004 Jan;10(1):33-9 [14702632.001]
  • [Cites] J Cell Biochem. 2004 Mar 1;91(4):662-70 [14991758.001]
  • [Cites] J Biol Chem. 2004 May 7;279(19):20539-45 [14871891.001]
  • [Cites] Growth Factors. 2004 Jun;22(2):105-10 [15253386.001]
  • [Cites] Gerontology. 2004 Sep-Oct;50(5):265-90 [15331856.001]
  • [Cites] Prostate. 2004 Dec 1;61(4):332-53 [15389811.001]
  • [Cites] Natl Cancer Inst Monogr. 1978 Dec;(49):17-21 [571045.001]
  • [Cites] Invest Urol. 1979 Jul;17(1):16-23 [447482.001]
  • [Cites] Prog Clin Biol Res. 1980;37:115-32 [7384082.001]
  • [Cites] Cancer Res. 1983 Apr;43(4):1809-18 [6831420.001]
  • [Cites] Prostate. 1989;15(4):355-65 [2594585.001]
  • [Cites] Prostate. 1990;16(1):71-80 [1689483.001]
  • [Cites] Prostate. 1990;16(3):209-18 [2330326.001]
  • [Cites] Cancer Res. 1991 Jun 1;51(11):2780-5 [2032218.001]
  • [Cites] J Clin Endocrinol Metab. 1991 Aug;73(2):401-7 [1713219.001]
  • [Cites] Br J Urol. 1991 Sep;68(3):258-62 [1913066.001]
  • [Cites] Cancer Res. 1992 Feb 1;52(3):571-7 [1732045.001]
  • [Cites] Endocrinology. 1992 May;130(5):2955-63 [1374018.001]
  • [Cites] Nature. 1992 Nov 26;360(6402):313-9 [1448148.001]
  • [Cites] J Cell Biochem Suppl. 1992;16H:99-105 [1289680.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Feb 1;91(3):1074-8 [8302834.001]
  • [Cites] J Urol. 1994 Dec;152(6 Pt 1):2120-4 [7525998.001]
  • [Cites] Steroids. 1994 Jul;59(7):412-20 [7974525.001]
  • [Cites] J Biol Chem. 1995 Mar 17;270(11):6308-13 [7890768.001]
  • [Cites] World J Urol. 1995;13(5):297-305 [8581001.001]
  • [Cites] Endocr Res. 1995 Nov;21(4):815-24 [8582331.001]
  • [Cites] J Clin Endocrinol Metab. 1996 Jun;81(6):2125-30 [8964839.001]
  • [Cites] J Endocrinol. 1996 Apr;149(1):93-9 [8676059.001]
  • [Cites] Endocrinology. 1996 Dec;137(12):5230-5 [8940339.001]
  • [Cites] Endocrinology. 1996 Dec;137(12):5476-83 [8940374.001]
  • [Cites] Cancer Res. 1997 May 1;57(9):1807-13 [9135026.001]
  • [Cites] Biochem Biophys Res Commun. 1997 May 19;234(2):362-5 [9177276.001]
  • [Cites] Prostate. 1997 Jun 1;31(4):223-33 [9180932.001]
  • [Cites] Am J Pathol. 1997 Aug;151(2):353-9 [9250149.001]
  • [Cites] J Endocrinol. 1997 Sep;154(3):535-45 [9379131.001]
  • [Cites] J Clin Endocrinol Metab. 1997 Nov;82(11):3851-8 [9360551.001]
  • [Cites] Br J Cancer. 1997;76(9):1115-8 [9365156.001]
  • [Cites] Prostate. 1998 Jan 1;34(1):34-43 [9428386.001]
  • [Cites] Science. 1998 Jan 23;279(5350):563-6 [9438850.001]
  • [Cites] J Cell Biochem. 1998 Mar 1;68(3):328-38 [9518259.001]
  • (PMID = 19308291.001).
  • [ISSN] 1476-5586
  • [Journal-full-title] Neoplasia (New York, N.Y.)
  • [ISO-abbreviation] Neoplasia
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Canada
  • [Chemical-registry-number] 0 / Membrane Proteins; 0 / activin A; 104625-48-1 / Activins; EC 2.7.11.30 / Activin Receptors, Type II; EC 2.7.11.30 / activin receptor type II-A; EC 3.4.24.- / ADAM Proteins; EC 3.4.24.- / ADAM15 protein, human
  • [Other-IDs] NLM/ PMC2657882
  •  go-up   go-down


13. Lee EW, Grant JD, Loh CT, Kee ST: Bronchial and pulmonary arterial and venous interventions. Semin Respir Crit Care Med; 2008 Aug;29(4):395-404
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • With advancement of interventional techniques and increasing complexity of patients, the involvement of interventional radiologists in the pulmonary critical care (PCC) setting has increased in recent years.
  • In this article, we discuss management of these critically ill patients using four pulmonary and bronchial vascular interventional procedures: bronchial artery embolization in the setting of hemoptysis; pulmonary artery embolization in the setting of the treatment of AVM; thrombectomy and thrombolysis of the pulmonary arteries for the treatment of pulmonary embolism; and catheter-directed stent placement in the treatment of superior vena cava syndrome.
  • [MeSH-major] Arteriovenous Malformations / therapy. Bronchial Arteries. Embolization, Therapeutic / methods. Hemoptysis / therapy. Pulmonary Artery. Pulmonary Embolism / therapy. Radiography, Interventional. Superior Vena Cava Syndrome / therapy. Thrombectomy / methods

  • MedlinePlus Health Information. consumer health - Arteriovenous Malformations.
  • MedlinePlus Health Information. consumer health - Pulmonary Embolism.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18651357.001).
  • [ISSN] 1069-3424
  • [Journal-full-title] Seminars in respiratory and critical care medicine
  • [ISO-abbreviation] Semin Respir Crit Care Med
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 78
  •  go-up   go-down


14. Zhu JT, Choi RC, Chu GK, Cheung AW, Gao QT, Li J, Jiang ZY, Dong TT, Tsim KW: Flavonoids possess neuroprotective effects on cultured pheochromocytoma PC12 cells: a comparison of different flavonoids in activating estrogenic effect and in preventing beta-amyloid-induced cell death. J Agric Food Chem; 2007 Mar 21;55(6):2438-45
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Flavonoids possess neuroprotective effects on cultured pheochromocytoma PC12 cells: a comparison of different flavonoids in activating estrogenic effect and in preventing beta-amyloid-induced cell death.
  • Flavonoids, a group of compounds mainly derived from vegetables, share a resemblance, chemically, to estrogen, and indeed, some have been used as estrogen substitutes.
  • Identification of these flavonoids could be very useful in finding potential drugs, or food supplements, for treating Alzheimer's disease.
  • [MeSH-minor] Animals. Breast Neoplasms. Cell Line, Tumor. Humans. PC12 Cells. Rats. Reactive Oxygen Species. Response Elements / drug effects. Response Elements / genetics

  • Genetic Alliance. consumer health - Pheochromocytoma.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17323972.001).
  • [ISSN] 0021-8561
  • [Journal-full-title] Journal of agricultural and food chemistry
  • [ISO-abbreviation] J. Agric. Food Chem.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Amyloid beta-Peptides; 0 / Estrogens; 0 / Flavonoids; 0 / Neuroprotective Agents; 0 / Reactive Oxygen Species
  •  go-up   go-down


15. Dossena L, Curti B, Vanoni MA: Activation and coupling of the glutaminase and synthase reaction of glutamate synthase is mediated by E1013 of the ferredoxin-dependent enzyme, belonging to loop 4 of the synthase domain. Biochemistry; 2007 Apr 17;46(15):4473-85
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PCC 6803 ferredoxin-dependent glutamate synthase, FdGltS) may play a key role in activating glutamine binding and hydrolysis and ammonia transfer to the synthase site in this amidotransferase, in response to the ligation and redox state of the synthase site.
  • The E1013D variant showed coupling between glutamine hydrolysis at the glutaminase site and 2-oxoglutarate-dependent L-glutamate synthesis at the synthase site, but a sigmoid dependence of initial velocity on L-glutamine concentration.
  • The sigmoid dependence of the initial velocity of the glutamate synthase reaction of the E1013D mutant on glutamine concentration provides evidence for a participation of glutamine in the activation of glutamate synthase during the catalytic cycle.
  • [MeSH-minor] Amino Acid Sequence. Ammonia / metabolism. Catalysis. Catalytic Domain / genetics. Enzyme Activation / genetics. Hydrogen-Ion Concentration. Kinetics. Models, Biological. Models, Molecular. Molecular Structure. Mutagenesis, Site-Directed. Mutation. Oxidation-Reduction. Protein Structure, Tertiary. Synechocystis / enzymology

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. GLUTAMIC ACID HYDROCHLORIDE .
  • Hazardous Substances Data Bank. Ammonia .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17373776.001).
  • [ISSN] 0006-2960
  • [Journal-full-title] Biochemistry
  • [ISO-abbreviation] Biochemistry
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 3KX376GY7L / Glutamic Acid; 7664-41-7 / Ammonia; EC 1.4.- / Amino Acid Oxidoreductases; EC 1.4.7.1 / glutamate synthase (ferredoxin)
  •  go-up   go-down


16. Giménez N, Barahona M, Casasa A, Domingo A, Gavagnach M, Martí C: [Introduction of Aedes albopictus in Spain: a new challenge for public health]. Gac Sanit; 2007 Jan-Feb;21(1):25-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Llegada de Aedes albopictus a España, un nuevo reto para la salud pública.
  • INTRODUCTION: A spectacular increase was noticed in the number of consultations for insect bites at the Sant Cugat Primary Care Center (Barcelona, Spain).
  • OBJECTIVE: To analyze consultations for insect bites in this center (1998-2004).
  • CONCLUSIONS: Primary care alerted the town council of the significant increase in consultations for insect bites.

  • MedlinePlus Health Information. consumer health - Insect Bites and Stings.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17306183.001).
  • [ISSN] 0213-9111
  • [Journal-full-title] Gaceta sanitaria
  • [ISO-abbreviation] Gac Sanit
  • [Language] SPA
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


17. Elenkova A, Matrozova J, Zacharieva S, Kirilov G, Kalinov K: Adiponectin - A possible factor in the pathogenesis of carbohydrate metabolism disturbances in patients with pheochromocytoma. Cytokine; 2010 Jun;50(3):306-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adiponectin - A possible factor in the pathogenesis of carbohydrate metabolism disturbances in patients with pheochromocytoma.
  • Glucose metabolism disturbances are relatively common feature in pheochromocytoma patients.
  • Decreased insulin secretion due to the inhibitory effect of supraphysiological plasma catecholamine concentrations was considered to be the main cause for pheochromocytoma-associated diabetes mellitus.
  • OBJECTIVE: The aim of the present study was to evaluate the relationship between adiponectin levels and insulin sensitivity in patients with endocrine hypertension due to pheochromocytoma comparing them to these in patients with essential hypertension and healthy subjects.
  • DESIGN AND METHODS: Three groups of subjects were enrolled in the study: 26 patients with pheochromocytoma, 30 normal-weight patients with essential hypertension and 31 healthy subjects.
  • RESULTS: Serum adiponectin concentrations were significantly lower in patients with pheochromocytoma compared to these in normal-weight hypertensive patients and healthy controls.
  • Postoperative adiponectin levels were significantly higher then preoperative despite of the increased BMI in pheochromocytoma patients.
  • There was a significant negative correlation between adiponectin serum concentrations and preprandial glucose, insulin levels and HOMA as a marker of insulin sensitivity.
  • CONCLUSIONS: Hypoadiponectinemia in pheochromocytoma patients may represent a possible pathogenic factor for the development of carbohydrate metabolism disturbances in these patients.
  • [MeSH-major] Adiponectin / metabolism. Adrenal Gland Neoplasms / metabolism. Carbohydrate Metabolism. Pheochromocytoma / metabolism
  • [MeSH-minor] Adult. Body Weight. Case-Control Studies. Female. Humans. Hypertension / complications. Male. Middle Aged. Postoperative Care. Preoperative Care

  • Genetic Alliance. consumer health - Pheochromocytoma.
  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - Pheochromocytoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Ltd. All rights reserved.
  • (PMID = 20385503.001).
  • [ISSN] 1096-0023
  • [Journal-full-title] Cytokine
  • [ISO-abbreviation] Cytokine
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Adiponectin
  •  go-up   go-down


18. Watanabe S, Kobayashi T, Saito M, Sato M, Nimura-Matsune K, Chibazakura T, Taketani S, Nakamoto H, Yoshikawa H: Studies on the role of HtpG in the tetrapyrrole biosynthesis pathway of the cyanobacterium Synechococcus elongatus PCC 7942. Biochem Biophys Res Commun; 2007 Jan 5;352(1):36-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Studies on the role of HtpG in the tetrapyrrole biosynthesis pathway of the cyanobacterium Synechococcus elongatus PCC 7942.
  • In cyanobacterium Synechococcus elongatus PCC 7942, we observed that htpG-overexpression caused remarkable growth inhibition.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17107658.001).
  • [ISSN] 0006-291X
  • [Journal-full-title] Biochemical and biophysical research communications
  • [ISO-abbreviation] Biochem. Biophys. Res. Commun.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Bacterial Proteins; 0 / HSP90 Heat-Shock Proteins; 0 / Tetrapyrroles; 134548-76-8 / HtpG protein, bacteria; EC 4.1.1.37 / Uroporphyrinogen Decarboxylase
  •  go-up   go-down


19. Ghzili H, Grumolato L, Thouënnon E, Tanguy Y, Turquier V, Vaudry H, Anouar Y: Role of PACAP in the physiology and pathology of the sympathoadrenal system. Front Neuroendocrinol; 2008 Jan;29(1):128-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Sympathetic neurons and chromaffin cells derive from common sympathoadrenal precursors which arise from the neural crest.
  • PACAP also acts as a neurotransmitter to stimulate catecholamine and neuropeptide biosynthesis and release from sympathetic neurons and chromaffin cells, during development and in adulthood.
  • In addition, PACAP and its receptors have been described in neuroblastoma and pheochromocytoma, and the neuropeptide regulates the differentiation and activity of sympathoadrenal-derived tumoral cell lines, suggestive of an important role in the pathophysiology of the sympathoadrenal lineage.
  • [MeSH-major] Adrenal Gland Neoplasms / pathology. Adrenal Glands / physiology. Neuroblastoma / pathology. Pheochromocytoma / pathology. Pituitary Adenylate Cyclase-Activating Polypeptide / physiology. Sympathetic Nervous System / physiology
  • [MeSH-minor] Animals. Cell Differentiation. Chromaffin Cells / metabolism. Chromaffin Cells / physiology. Gene Expression Regulation, Neoplastic. Humans

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - Neuroblastoma.
  • MedlinePlus Health Information. consumer health - Pheochromocytoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18048093.001).
  • [ISSN] 1095-6808
  • [Journal-full-title] Frontiers in neuroendocrinology
  • [ISO-abbreviation] Front Neuroendocrinol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Pituitary Adenylate Cyclase-Activating Polypeptide
  • [Number-of-references] 175
  •  go-up   go-down


20. Kim HS, Yumkham S, Kim SH, Yea K, Shin YC, Ryu SH, Suh PG: Secretin induces neurite outgrowth of PC12 through cAMP-mitogen-activated protein kinase pathway. Exp Mol Med; 2006 Feb 28;38(1):85-93
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Here, we report that secretin induces the generation of neurite outgrowth in pheochromocytoma PC12 cells.
  • [MeSH-minor] Animals. Cell Culture Techniques. Cell Differentiation / drug effects. Cyclic AMP / analysis. Cyclic AMP / metabolism. Enzyme-Linked Immunosorbent Assay. Fluorescein-5-isothiocyanate. Fluorescent Dyes. Immunoblotting. Immunohistochemistry. Microscopy, Confocal. Neurons / cytology. Neurons / drug effects. PC12 Cells. Rats. Reverse Transcriptase Polymerase Chain Reaction

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16520556.001).
  • [ISSN] 1226-3613
  • [Journal-full-title] Experimental & molecular medicine
  • [ISO-abbreviation] Exp. Mol. Med.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Korea (South)
  • [Chemical-registry-number] 0 / Fluorescent Dyes; 1393-25-5 / Secretin; E0399OZS9N / Cyclic AMP; EC 2.7.11.24 / Mitogen-Activated Protein Kinases; I223NX31W9 / Fluorescein-5-isothiocyanate
  •  go-up   go-down


21. Ma W, Wei L, Wang Q: The response of electron transport mediated by active NADPH dehydrogenase complexes to heat stress in the cyanobacterium Synechocystis 6803. Sci China C Life Sci; 2008 Dec;51(12):1082-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this study, the rate of electron transport (ETR) driven by photosystem I (PSI) and photosystem II (PSII) during heat stress in the wild-type Synechocystis sp. strain PCC 6803 (WT) and its ndh gene inactivation mutants DeltandhB (M55) and DeltandhD1/ndhD2 (D1/D2) was simultaneously assessed by using the novel Dual-PAM-100 measuring system.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19093081.001).
  • [ISSN] 1006-9305
  • [Journal-full-title] Science in China. Series C, Life sciences
  • [ISO-abbreviation] Sci. China, C, Life Sci.
  • [Language] ENG
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Bacterial Proteins; 1406-65-1 / Chlorophyll; EC 1.6.99.1 / NADPH Dehydrogenase
  •  go-up   go-down


22. Stolbach AI, Hoffman RS, Nelson LS: Mechanical ventilation was associated with acidemia in a case series of salicylate-poisoned patients. Acad Emerg Med; 2008 Sep;15(9):866-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: The authors electronically searched a poison control center (PCC) database (2001-2007) for patients with salicylate poisoning, defined as a serum concentration > 50 mg/dL, who had MV listed as a therapy.
  • Eleven patients met the inclusion criteria of having both salicylate concentrations > 50 mg/dL and required MV; only 7 of them had post-MV data available.
  • RESULTS: In all seven patients with post-MV blood gas data, the post-MV pH was < 7.4.
  • Two of the seven patients in the study group died following intubation (two patients died within 3 hours [serum salicylate concentrations, 85 and 79 mg/dL, respectively]).
  • Another patient sustained severe neurologic injury (serum salicylate concentration, 84 mg/dL).


23. Okuno E, Kakinohana M, Miyata Y, Sugahara K: [Anesthetic management for off-pump coronary artery bypass grafting in a patient with a pheochromocytoma and followed by the resection of the pheochromocytoma]. Masui; 2007 Feb;56(2):190-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Anesthetic management for off-pump coronary artery bypass grafting in a patient with a pheochromocytoma and followed by the resection of the pheochromocytoma].
  • We successfully treated a 61-year-old woman with a pheochromocytoma and angina.
  • After 3 months, pheochromocytoma was resected.
  • We believe that it is very important to control blood pressure and to determine which operation, CABG or the pheochromocytoma resection, should be performed first, in these cases.
  • [MeSH-major] Adrenal Gland Neoplasms / complications. Adrenal Gland Neoplasms / surgery. Anesthesia, Epidural. Anesthesia, Inhalation. Anesthesia, Intravenous. Angina Pectoris / complications. Angina Pectoris / surgery. Coronary Artery Bypass, Off-Pump. Pheochromocytoma / complications. Pheochromocytoma / surgery


24. Sakai H, Oguma K, Katayama H, Ohgaki S: Effects of low or medium-pressure UV irradiation on the release of intracellular microcystin. Water Res; 2007 Aug;41(15):3458-64
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A pure culture of Microcystis aeruginosa PCC 7806 was exposed to monochromatic low-pressure or polychromatic medium-pressure UV lamps.
  • Irradiated pure culture suspension was subsequently incubated for 14 days under white light fluorescent lamps.
  • During incubation, profiles of the number of cells, intracellular and extracellular microcystin concentration were determined.
  • First, because UV exposure can inhibit increases in the number of cells for about 6 days, it inhibited the increase of microcystin concentrations in water.
  • Second, intracellular microcystin was gradually released into the surrounding water through a gradual reduction in the number of cells, preventing a rapid increase of microcystin concentration in water.
  • Microcystin concentration in water was not significantly higher in UV-irradiated samples than non-UV-irradiated sample.
  • This contributed to reduce increases in microcystin concentrations in water.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17548104.001).
  • [ISSN] 0043-1354
  • [Journal-full-title] Water research
  • [ISO-abbreviation] Water Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Microcystins; 0 / Water Pollutants, Chemical; 77238-39-2 / microcystin
  •  go-up   go-down


25. Stewart MF, Croft J, Reed P, New JP: Acute intermittent porphyria and phaeochromocytoma: shared features. J Clin Pathol; 2007 Aug;60(8):935-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acute intermittent porphyria and phaeochromocytoma: shared features.
  • [MeSH-major] Adrenal Gland Neoplasms / diagnosis. Pheochromocytoma / diagnosis. Porphyria, Acute Intermittent / diagnosis
  • [MeSH-minor] Adult. Catecholamines / urine. Diagnosis, Differential. Female. Humans. Hypertension / complications


26. Al-Gharabli SI: Determination of Glucose Concentration in Aqueous Solution Using ATR-WT-IR Technique. Sensors (Basel); 2009;9(8):6254-60
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Determination of Glucose Concentration in Aqueous Solution Using ATR-WT-IR Technique.
  • Fourier transformation infrared (FT-IR) spectroscopy has been used to measure glucose concentrations in different matrices.
  • One thousand interferograms, divided into training- and testing-sets, have been recorded from four glucose concentrations using an ATR-IR unit.
  • The Pearson's Correlation Coefficient (PCC) obtained by judging the predicted- against the real-concentrations was 0.9954, with a mean square error of 8.4e-005.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Comb Chem High Throughput Screen. 2007 Aug;10(7):560-70 [17979639.001]
  • [Cites] J Biomed Opt. 2007 Mar-Apr;12(2):024005 [17477720.001]
  • [Cites] Horm Res. 2002;57 Suppl 1:81-4 [11979031.001]
  • [Cites] Diabet Med. 2009 Mar;26(3):197-210 [19317813.001]
  • [Cites] Curr Opin Clin Nutr Metab Care. 2008 Sep;11(5):607-12 [18685457.001]
  • [Cites] Anal Bioanal Chem. 2007 Nov;389(6):2019-28 [17874084.001]
  • (PMID = 22454583.001).
  • [ISSN] 1424-8220
  • [Journal-full-title] Sensors (Basel, Switzerland)
  • [ISO-abbreviation] Sensors (Basel)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Other-IDs] NLM/ PMC3312442
  • [Keywords] NOTNLM ; ATR (major topic) / biosensors (major topic) / diabetes (major topic) / glucose monitoring (major topic) / infrared (major topic) / neural network (major topic) / noninvasive sensing (major topic) / wavelet (major topic)
  •  go-up   go-down


27. Fraser LA, Kiaii B, Shaban J, Islam A, Diamantouros P, Jones PM, Tweedie E, Varghese R, Van Uum S: Cardiac pheochromocytoma presenting during pregnancy. BMJ Case Rep; 2010;2010
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cardiac pheochromocytoma presenting during pregnancy.
  • A 25-year-old woman presented at 12 weeks gestation, with symptoms and laboratory investigations consistent with pheochromocytoma.
  • Imaging modalities available during pregnancy were limited and MRI scan of the abdomen and the neck failed to localise the tumour.
  • Postpartum imaging, including 131-metaiodobenzylguanidine and octreotide scans, cardiac CT, cardiac MRI and cardiac catheterisation, allowed accurate localisation of the tumour and helped plan for successful surgical removal.
  • [MeSH-major] Heart Neoplasms / diagnosis. Pheochromocytoma / diagnosis. Pregnancy Complications, Neoplastic / diagnosis
  • [MeSH-minor] 3-Iodobenzylguanidine. Adult. Cardiac Catheterization. Female. Humans. Infant, Newborn. Magnetic Resonance Imaging. Octreotide. Pregnancy. Puerperal Disorders / diagnosis. Puerperal Disorders / surgery. Tomography, X-Ray Computed


28. Ilias I, Pacak K: A clinical overview of pheochromocytomas/paragangliomas and carcinoid tumors. Nucl Med Biol; 2008 Aug;35 Suppl 1:S27-34
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A clinical overview of pheochromocytomas/paragangliomas and carcinoid tumors.
  • Pheochromocytomas/paragangliomas are rare tumors; most are sporadic.
  • Biochemical proof of disease is better with measurement of plasma metanephrines and less cumbersome than determinations in urine; its implementation is expanding.
  • Anatomical imaging with computed tomography or magnetic resonance imaging should be followed by functional (nuclear medicine) imaging: chromaffin tumor-specific methods are preferred.
  • Treatment is surgical; for nonoperable disease other options are available.
  • For most carcinoids, functional imaging is better than other modalities in localizing primary tumors.
  • [MeSH-major] Carcinoid Tumor / diagnosis. Paraganglioma / diagnosis. Pheochromocytoma / diagnosis

  • MedlinePlus Health Information. consumer health - Carcinoid Tumors.
  • MedlinePlus Health Information. consumer health - Pheochromocytoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nucl Med Commun. 2006 Jan;27(1):31-6 [16340721.001]
  • [Cites] Anticancer Res. 2006 Mar-Apr;26(2B):1599-604 [16619578.001]
  • [Cites] Curr Probl Surg. 2006 Jun;43(6):383-450 [16781906.001]
  • [Cites] Am Fam Physician. 2006 Aug 1;74(3):429-34 [16913162.001]
  • [Cites] Lancet Oncol. 2006 Sep;7(9):728-34 [16945767.001]
  • [Cites] Ann N Y Acad Sci. 2006 Aug;1073:21-9 [17102068.001]
  • [Cites] Ann N Y Acad Sci. 2006 Aug;1073:59-78 [17102073.001]
  • [Cites] Ann N Y Acad Sci. 2006 Aug;1073:104-11 [17102077.001]
  • [Cites] Ann N Y Acad Sci. 2006 Aug;1073:263-9 [17102094.001]
  • [Cites] Ann N Y Acad Sci. 2006 Aug;1073:332-47 [17102103.001]
  • [Cites] Ann N Y Acad Sci. 2006 Aug;1073:374-82 [17102106.001]
  • [Cites] Best Pract Res Clin Endocrinol Metab. 2007 Mar;21(1):15-31 [17382263.001]
  • [Cites] Best Pract Res Clin Endocrinol Metab. 2007 Mar;21(1):33-41 [17382264.001]
  • [Cites] Best Pract Res Clin Endocrinol Metab. 2007 Mar;21(1):43-68 [17382265.001]
  • [Cites] Best Pract Res Clin Endocrinol Metab. 2007 Mar;21(1):87-109 [17382267.001]
  • [Cites] Eur J Endocrinol. 2007 Apr;156(4):483-7 [17389464.001]
  • [Cites] J Intern Med. 2005 Jan;257(1):60-8 [15606377.001]
  • [Cites] Oncologist. 2005 Feb;10(2):123-31 [15709214.001]
  • [Cites] World J Surg. 2004 Nov;28(11):1157-62 [15490060.001]
  • [Cites] J Clin Endocrinol Metab. 2005 Apr;90(4):2110-6 [15644401.001]
  • [Cites] J Clin Endocrinol Metab. 2005 Aug;90(8):4955-62 [15914534.001]
  • [Cites] J Nucl Med. 2007 Apr;48(4):508-18 [17401086.001]
  • [Cites] J Clin Endocrinol Metab. 2007 Apr;92(4):1217-25 [17284633.001]
  • [Cites] J Clin Oncol. 2007 Jun 1;25(16):2262-9 [17538171.001]
  • [Cites] Hematol Oncol Clin North Am. 2007 Jun;21(3):409-32; vii [17548032.001]
  • [Cites] Hematol Oncol Clin North Am. 2007 Jun;21(3):433-55; vii-viii [17548033.001]
  • [Cites] Hematol Oncol Clin North Am. 2007 Jun;21(3):509-25; ix [17548037.001]
  • [Cites] Hematol Oncol Clin North Am. 2007 Jun;21(3):545-60; ix-x [17548039.001]
  • [Cites] Hematol Oncol Clin North Am. 2007 Jun;21(3):561-73; x [17548040.001]
  • [Cites] J Hypertens. 2007 Jul;25(7):1427-31 [17563565.001]
  • [Cites] Endocr Relat Cancer. 2007 Sep;14(3):569-85 [17914089.001]
  • [Cites] J Clin Endocrinol Metab. 2007 Nov;92(11):4069-79 [17989126.001]
  • [Cites] Eur J Cancer. 2007 Dec;43(18):2651-7 [17825550.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):72-9 [17874094.001]
  • [Cites] J Clin Oncol. 2008 Mar 20;26(9):1489-95 [18349401.001]
  • [Cites] J Nucl Med. 2008 Apr;49(4):573-86 [18344441.001]
  • [Cites] Cancer. 2008 Jun;112(11):2447-55 [18383518.001]
  • [Cites] Ann N Y Acad Sci. 2006 Aug;1073:405-16 [17102109.001]
  • [Cites] Ann N Y Acad Sci. 2006 Aug;1073:417-28 [17102110.001]
  • [Cites] Ann N Y Acad Sci. 2006 Aug;1073:444-8 [17102113.001]
  • [Cites] Ann N Y Acad Sci. 2006 Aug;1073:449-64 [17102114.001]
  • [Cites] Ann N Y Acad Sci. 2006 Aug;1073:465-90 [17102115.001]
  • [Cites] Ann N Y Acad Sci. 2006 Aug;1073:491-7 [17102116.001]
  • [Cites] Ann N Y Acad Sci. 2006 Aug;1073:505-11 [17102118.001]
  • [Cites] Orphanet J Rare Dis. 2006;1:49 [17156452.001]
  • [Cites] Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):92-102 [17237836.001]
  • [Cites] Otolaryngol Head Neck Surg. 2000 Mar;122(3):358-62 [10699810.001]
  • [Cites] Arch Intern Med. 2000 Oct 23;160(19):2957-63 [11041903.001]
  • [Cites] J Clin Endocrinol Metab. 2001 Feb;86(2):685-93 [11158032.001]
  • [Cites] Radiology. 2002 Feb;222(2):507-12 [11818620.001]
  • [Cites] JAMA. 2002 Mar 20;287(11):1427-34 [11903030.001]
  • [Cites] N Engl J Med. 2002 May 9;346(19):1459-66 [12000816.001]
  • [Cites] Ann N Y Acad Sci. 2002 Sep;970:159-69 [12381551.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2002 Dec;29(12):1571-80 [12458390.001]
  • [Cites] J Clin Endocrinol Metab. 2003 Feb;88(2):553-8 [12574179.001]
  • [Cites] J Clin Endocrinol Metab. 2003 Jun;88(6):2656-66 [12788870.001]
  • [Cites] Cancer. 2003 Jul 15;98(2):239-48 [12872341.001]
  • [Cites] Endocr Rev. 2003 Aug;24(4):539-53 [12920154.001]
  • [Cites] J Clin Endocrinol Metab. 2003 Sep;88(9):4083-7 [12970267.001]
  • [Cites] Cancer Res. 2003 Sep 1;63(17):5615-21 [14500403.001]
  • [Cites] J Clin Endocrinol Metab. 2003 Nov;88(11):5150-7 [14602742.001]
  • [Cites] J Nucl Med. 2003 Nov;44(11):1767-74 [14602858.001]
  • [Cites] Surgery. 2003 Dec;134(6):956-62; discussion 962-3 [14668728.001]
  • [Cites] Front Horm Res. 2004;31:61-75 [14674305.001]
  • [Cites] Front Horm Res. 2004;31:76-106 [14674306.001]
  • [Cites] Acta Oncol. 2003;42(7):672-92 [14690153.001]
  • [Cites] Radiology. 2004 Feb;230(2):423-8 [14752186.001]
  • [Cites] J Clin Endocrinol Metab. 2004 Feb;89(2):479-91 [14764749.001]
  • [Cites] Endocr Relat Cancer. 2004 Mar;11(1):1-18 [15027882.001]
  • [Cites] Laryngoscope. 2004 Mar;114(3):434-40 [15091215.001]
  • [Cites] AJNR Am J Neuroradiol. 2004 May;25(5):863-70 [15140737.001]
  • [Cites] Cancer. 2004 Nov 1;101(9):1987-93 [15455358.001]
  • [Cites] J Clin Endocrinol Metab. 1992 May;74(5):1082-9 [1349024.001]
  • [Cites] J Nucl Med. 1992 Jun;33(6):1125-31 [1597727.001]
  • [Cites] AJNR Am J Neuroradiol. 1997 Jun-Jul;18(6):1073-80 [9194434.001]
  • [Cites] J Endocrinol Invest. 1997 Dec;20(11):648-58 [9492103.001]
  • [Cites] J Urol. 1999 Feb;161(2):395-8 [9915410.001]
  • [Cites] J Clin Endocrinol Metab. 1999 Feb;84(2):775-80 [10022452.001]
  • [Cites] Radiology. 1999 Jul;212(1):35-41 [10405717.001]
  • [Cites] Endocr Relat Cancer. 2005 Dec;12(4):683-99 [16322317.001]
  • (PMID = 18707631.001).
  • [ISSN] 0969-8051
  • [Journal-full-title] Nuclear medicine and biology
  • [ISO-abbreviation] Nucl. Med. Biol.
  • [Language] eng
  • [Grant] United States / Intramural NIH HHS / / Z01 HD008735-07
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural; Review
  • [Publication-country] England
  • [Number-of-references] 94
  • [Other-IDs] NLM/ NIHMS53044; NLM/ PMC2597413
  •  go-up   go-down


29. Wang Q: Retraction statement. Effect of inhalational anesthetics on cytotoxicity and intracellular calcium differently in rat pheochromocytoma cells (PC12). J Huazhong Univ Sci Technolog Med Sci; 2008 Jun;28(3):372
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Retraction statement. Effect of inhalational anesthetics on cytotoxicity and intracellular calcium differently in rat pheochromocytoma cells (PC12).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [RetractionOf] Wang Q, Li K, Yao S. J Huazhong Univ Sci Technolog Med Sci. 2008 Feb;28(1):104-9 [18278471.001]
  • (PMID = 18807653.001).
  • [ISSN] 1672-0733
  • [Journal-full-title] Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban
  • [ISO-abbreviation] J. Huazhong Univ. Sci. Technol. Med. Sci.
  • [Language] eng
  • [Publication-type] Retraction of Publication
  • [Publication-country] China
  •  go-up   go-down


30. Goh YS, Tong KL: Phaeochromocytoma the great mimicker: a case report. Ann Acad Med Singapore; 2008 Jan;37(1):79-81
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Phaeochromocytoma the great mimicker: a case report.
  • [MeSH-major] Pheochromocytoma / diagnosis
  • [MeSH-minor] Acute Coronary Syndrome / diagnosis. Adult. Diagnosis, Differential. Humans. Male

  • MedlinePlus Health Information. consumer health - Pheochromocytoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18265905.001).
  • [ISSN] 0304-4602
  • [Journal-full-title] Annals of the Academy of Medicine, Singapore
  • [ISO-abbreviation] Ann. Acad. Med. Singap.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] Singapore
  •  go-up   go-down


31. Bessell-Browne R, O'Malley ME: CT of pheochromocytoma and paraganglioma: risk of adverse events with i.v. administration of nonionic contrast material. AJR Am J Roentgenol; 2007 Apr;188(4):970-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] CT of pheochromocytoma and paraganglioma: risk of adverse events with i.v. administration of nonionic contrast material.
  • OBJECTIVE: When pheochromocytoma or paraganglioma is suspected, many institutions perform only unenhanced CT because of a perceived risk of inducing a hypertensive crisis with i.v. administration of contrast material.
  • The purpose of this study was to review our experience with the use of nonionic i.v. contrast material for CT of patients with pheochromocytoma or paraganglioma.
  • MATERIALS AND METHODS: A retrospective review of radiology records identified 25 patients (17 women, eight men; mean age, 43 years; age range, 27-70 years) with 40 pathologically proven pheochromocytomas or paragangliomas who received nonionic i.v. contrast material for CT.
  • There were 16 adrenal pheochromocytomas, 12 abdominal paragangliomas, five neck paragangliomas, and seven metastatic lesions.
  • Medical records were reviewed to determine whether the tumors were sporadic or associated with a syndrome, incidentally detected, or biochemically active; and whether patients were taking alpha-blocking medication at the time of CT.
  • RESULTS: Nineteen patients had 23 sporadic tumors, and six patients had 17 tumors associated with a syndrome.
  • In 12 (48%) of the 25 patients the diagnosis was clinically unsuspected at the time of CT.
  • CONCLUSION: I.v. administration of nonionic contrast material for CT is a safe practice for patients with pheochromocytoma and related tumors even without alpha-blocking medication.
  • [MeSH-major] Contrast Media / administration & dosage. Contrast Media / adverse effects. Paraganglioma / radiography. Pheochromocytoma / radiography. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Pheochromocytoma.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Pheochromocytoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17377032.001).
  • [ISSN] 1546-3141
  • [Journal-full-title] AJR. American journal of roentgenology
  • [ISO-abbreviation] AJR Am J Roentgenol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media
  •  go-up   go-down


32. Ruiz M, Bettache A, Janicki A, Vinella D, Zhang CC, Latifi A: The alr2505 (osiS) gene from Anabaena sp. strain PCC7120 encodes a cysteine desulfurase induced by oxidative stress. FEBS J; 2010 Sep;277(18):3715-25
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The genome of the filamentous diazotrophic cyanobacterium Anabaena PCC 7120 contains four open reading frames potentially encoding NifS-like proteins.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Journal compilation © 2010 FEBS. No claim to original French government works.
  • (PMID = 20681987.001).
  • [ISSN] 1742-4658
  • [Journal-full-title] The FEBS journal
  • [ISO-abbreviation] FEBS J.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Bacterial Proteins; 0 / Ferredoxins; 0 / Recombinant Proteins; 0 / apoferredoxin; 0 / nifS protein, Bacteria; EC 4.4.- / Carbon-Sulfur Lyases; EC 4.4.1.- / cysteine desulfurase
  •  go-up   go-down


33. Aráoz R, Guérineau V, Rippka R, Palibroda N, Herdman M, Laprevote O, von Döhren H, de Marsac NT, Erhard M: MALDI-TOF-MS detection of the low molecular weight neurotoxins anatoxin-a and homoanatoxin-a on lyophilized and fresh filaments of axenic Oscillatoria strains. Toxicon; 2008 Jun 1;51(7):1308-15
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The masses obtained from the analysis of lyophilized filaments of the ANTX-producer Oscillatoria sp. strain PCC 9240 (m/z 166.15) and of fresh filaments of the HANTX-producers Oscillatoria sp. strains PCC 6506 (m/z 180.1375), PCC 9029 (m/z 180.1334) and PCC 10111 (m/z 180.13996) corresponded to the protonated molecular ions of ANTX and HANTX, respectively.
  • Therefore, the application of MALDI-TOF-MS for the detection of cyanobacterial anatoxins in clonal and axenic strains of the cyanobacterial culture collections worldwide may help to assess ANTX/HANTX incidence among cyanobacteria.
  • [MeSH-major] Anabaena. Bacterial Toxins / analysis. Bicyclo Compounds, Heterocyclic / analysis. Neurotoxins / analysis. Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization / methods. Tropanes / analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18420244.001).
  • [ISSN] 0041-0101
  • [Journal-full-title] Toxicon : official journal of the International Society on Toxinology
  • [ISO-abbreviation] Toxicon
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Bacterial Toxins; 0 / Bicyclo Compounds, Heterocyclic; 0 / Neurotoxins; 0 / Tropanes; 0 / homoanatoxin-a; 80023A73NK / anatoxin a
  •  go-up   go-down


34. Baran R, Bowen BP, Bouskill NJ, Brodie EL, Yannone SM, Northen TR: Metabolite identification in Synechococcus sp. PCC 7002 using untargeted stable isotope assisted metabolite profiling. Anal Chem; 2010 Nov 1;82(21):9034-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metabolite identification in Synechococcus sp. PCC 7002 using untargeted stable isotope assisted metabolite profiling.
  • Untargeted metabolite profiling has the potential to identify numerous novel metabolites; however, de novo identification of metabolites from spectral features remains a challenge.
  • PCC 7002 was performed using normal phase liquid chromatography coupled to mass spectrometry (LC-MS).
  • Analysis of acquired MS/MS spectra against spectral database records led to the identification of a number of metabolites absent not only from the reconstructed draft metabolic network of Synechococcus sp.
  • PCC 7002 but not included in databases of metabolism (MetaCyc or KEGG).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20945921.001).
  • [ISSN] 1520-6882
  • [Journal-full-title] Analytical chemistry
  • [ISO-abbreviation] Anal. Chem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  •  go-up   go-down


35. Ippolito G, Palazzo FF, Sebag F, Thakur A, Cherenko M, Henry JF: Safety of laparoscopic adrenalectomy in patients with large pheochromocytomas: a single institution review. World J Surg; 2008 May;32(5):840-4; discussion 845-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Safety of laparoscopic adrenalectomy in patients with large pheochromocytomas: a single institution review.
  • BACKGROUND: Laparoscopic adrenalectomy is the procedure of choice for small adrenal tumors, but some concerns have been voiced when this approach is adopted for larger tumors and pheochromocytomas.
  • The aim of this study was to examine the results of the laparoscopic resection of large pheochromocytomas.
  • METHODS: A retrospective review of adrenalectomies performed for adrenal pheochromocytomas>6 cm in diameter.
  • From this series we identified 18 procedures for pheochromocytomas with an average diameter on imaging of 78.2 mm (range 60-130 mm).
  • Histologically, four of the adrenal tumors displayed evidence of vascular invasion.
  • CONCLUSIONS: Laparoscopic adrenalectomy appears to be a safe and effective approach for large pheochromocytomas when no preoperative or intraoperative evidence of local invasion is present.
  • [MeSH-major] Adrenal Gland Neoplasms / surgery. Adrenalectomy. Laparoscopy. Pheochromocytoma / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Cohort Studies. Female. Humans. Male. Middle Aged. Neoplasm Invasiveness. Retrospective Studies. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - Pheochromocytoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Urology. 2001 Nov;58(5):677-81 [11711335.001]
  • [Cites] World J Surg. 1990 May-Jun;14(3):325-9 [1973322.001]
  • [Cites] World J Surg. 2000 Nov;24(11):1342-6 [11038204.001]
  • [Cites] Arch Intern Med. 1977 Aug;137(8):1073-5 [879946.001]
  • [Cites] Surgery. 2006 Oct;140(4):553-9; discussion 559-60 [17011902.001]
  • [Cites] Eur Urol. 2004 Feb;45(2):226-32 [14734011.001]
  • [Cites] N Engl J Med. 1979 Sep 27;301(13):682-6 [481462.001]
  • [Cites] World J Surg. 1996 Sep;20(7):923-6; discussion 927 [8678972.001]
  • [Cites] Br J Surg. 1999 May;86(5):656-60 [10361189.001]
  • [Cites] World J Surg. 1996 Sep;20(7):762-8; discussion 768 [8678948.001]
  • [Cites] Ann Surg. 1997 Sep;226(3):238-46; discussion 246-7 [9339930.001]
  • [Cites] Surgery. 1984 Dec;96(6):1061-6 [6505959.001]
  • [Cites] Surgery. 2004 Dec;136(6):1129-37 [15657566.001]
  • [Cites] Ann Surg. 1999 Jun;229(6):755-64; discussion 764-6 [10363888.001]
  • [Cites] N Engl J Med. 1992 Oct 1;327(14):1033 [1387700.001]
  • [Cites] Ann Surg. 2005 Jun;241(6):919-26; discussion 926-8 [15912041.001]
  • [Cites] Endocr Rev. 2003 Aug;24(4):539-53 [12920154.001]
  • [Cites] J Clin Invest. 1964 Jan;43:94-102 [14105236.001]
  • [Cites] World J Surg. 2006 May;30(5):893-8 [16680605.001]
  • [Cites] Clin Endocrinol (Oxf). 2004 Jul;61(1):102-8 [15212651.001]
  • [Cites] Am J Surg Pathol. 2002 May;26(5):551-66 [11979086.001]
  • [Cites] World J Surg. 2004 Nov;28(11):1176-9 [15490056.001]
  • [Cites] Arch Surg. 1974 Apr;108(4):450-4 [4815920.001]
  • [Cites] Ann Surg. 1997 May;225(5):495-501; discussion 501-2 [9193177.001]
  • [Cites] Ann Chir. 2002 Sep;127(7):512-9 [12404845.001]
  • (PMID = 18064512.001).
  • [ISSN] 0364-2313
  • [Journal-full-title] World journal of surgery
  • [ISO-abbreviation] World J Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


36. Bembo SA, Elimian A, Waltzer W, Carlson HE: Pheochromocytoma in a pregnant woman with a history of intracerebral aneurysms. Am J Med Sci; 2005 Jun;329(6):317-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pheochromocytoma in a pregnant woman with a history of intracerebral aneurysms.
  • Pheochromocytoma in pregnancy is rare; if unrecognized, potentially fatal hypertensive crises may occur.
  • We report a case of a 35-year-old woman with a history of two intracerebral aneurysms who presented at 26 weeks' gestation with tachycardia, hypertension, and pulmonary edema.
  • Laboratory data revealed elevated 24-hour urinary catecholamine and metanephrine levels, and abdominal sonography showed a 10-cm right adrenal mass.
  • Postpartum abdominal computed tomography scanning confirmed a 10-cm right adrenal mass.
  • A benign pheochromocytoma was removed without incident.
  • This case illustrates the importance of early diagnosis and management of pheochromocytoma in pregnancy and is also an example of the rare association of pheochromocytoma with intracerebral aneurysms.
  • [MeSH-major] Adrenal Gland Neoplasms / diagnosis. Pheochromocytoma / diagnosis. Pregnancy Complications, Neoplastic / diagnosis


37. Bassili M, Birman E, Schor NF, Saragovi HU: Differential roles of Trk and p75 neurotrophin receptors in tumorigenesis and chemoresistance ex vivo and in vivo. Cancer Chemother Pharmacol; 2010 May;65(6):1047-56
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The neurotrophin receptors TrkA (NGF receptor) and TrkC (NT-3 receptor) have been shown to be important in staging disease and predicting progression and drug response for various neoplasias such as neuroblastoma, medulloblastoma and prostate cancer.
  • To determine the effect of each neurotrophin receptor or co-receptor expression in tumorigenesis, we examined PC12 pheochromocytomas.
  • Thus, unique neurotrophin receptor tumor profiles may determine tumor aggressiveness and chemoresistance.
  • This work may help to develop tailored therapies for specific tumor phenotypes by combining traditional chemotherapy with neurotrophin receptor modulators.

  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19701634.001).
  • [ISSN] 1432-0843
  • [Journal-full-title] Cancer chemotherapy and pharmacology
  • [ISO-abbreviation] Cancer Chemother. Pharmacol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA082642; United States / NINDS NIH HHS / NS / R01 NS038569; United States / NCI NIH HHS / CA / CA82642; United States / NINDS NIH HHS / NS / R01-NS38569
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Receptor, Nerve Growth Factor; 80168379AG / Doxorubicin; EC 2.7.10.1 / Receptor, trkA; Q20Q21Q62J / Cisplatin
  • [Other-IDs] NLM/ NIHMS658162; NLM/ PMC4315186
  •  go-up   go-down


38. Waetzig V, Loose K, Haeusgen W, Herdegen T: c-Jun N-terminal kinases mediate Fas-induced neurite regeneration in PC12 cells. Biochem Pharmacol; 2008 Dec 1;76(11):1476-84
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In response to injury, peripheral neuronal cells initiate complex signalling cascades to promote survival and regeneration.
  • In the present study, we used a model of experimental injury in the rat pheochromocytoma cell line PC12 to investigate receptor signals that lead to neurite outgrowth.


39. Ruiz-Tovar J, Pérez de Oteyza J, Alonso Hernández N, Díez Tabernilla M, Rojo Blanco R, Collado Guirao MV, García Villanueva A: [Laparoscopic adrenalectomy]. Cir Esp; 2007 Sep;82(3):161-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: In the last few years, laparoscopic adrenalectomy has become widely used in the management of adrenal disease.
  • RESULTS: Surgery was indicated for Cushing's syndrome in 46% of the patients, aldosteronoma in 25%, incidentaloma in 21% and pheochromocytoma in 8%.
  • The mean size of the gland was 4 cm.
  • Disease control was achieved in 96% of the patients after a mean follow-up of 49 months.
  • CONCLUSIONS: Laparoscopic adrenalectomy should be considered the procedure of choice for the surgical management of benign adrenal disease.
  • [MeSH-minor] Female. Humans. Hyperaldosteronism / surgery. Male. Middle Aged. Pheochromocytoma / surgery. Pituitary ACTH Hypersecretion / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17916287.001).
  • [ISSN] 0009-739X
  • [Journal-full-title] Cirugía española
  • [ISO-abbreviation] Cir Esp
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


40. Aráoz R, Nghiêm HO, Rippka R, Palibroda N, de Marsac NT, Herdman M: Neurotoxins in axenic oscillatorian cyanobacteria: coexistence of anatoxin-a and homoanatoxin-a determined by ligand-binding assay and GC/MS. Microbiology; 2005 Apr;151(Pt 4):1263-73
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Two neurotoxic alkaloids, anatoxin-a and its homologue homoanatoxin-a, were purified from the filamentous cyanobacteria Oscillatoria sp. strain 193 (PCC 9240) and Oscillatoria formosa NIVA CYA-92 (PCC 10111), respectively, and characterized by mass spectrometry.
  • Inhibition was concentration dependent, with a K(i) of 5.4+/-1.1x10(-8) M for anatoxin-a and 7.4+/-0.9x10(-8) M for homoanatoxin-a.
  • GC/MS revealed that Oscillatoria sp. strains PCC 6407, PCC 6412 and PCC 9107 synthesized exclusively anatoxin-a, whereas both anatoxin-a and homoanatoxin-a were produced by strain PCC 9029.
  • Oscillatoria sp. strain PCC 6506, an isolate co-identic with strain PCC 9029, also produced both neurotoxins, but their respective presence depended upon growth conditions.
  • [MeSH-minor] Animals. Bicyclo Compounds, Heterocyclic. Binding, Competitive. Bungarotoxins / metabolism. Electric Organ / metabolism. Gas Chromatography-Mass Spectrometry. In Vitro Techniques. Microcystins. Radioligand Assay. Receptors, Nicotinic / metabolism. Torpedo. Tropanes

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15817793.001).
  • [ISSN] 1350-0872
  • [Journal-full-title] Microbiology (Reading, England)
  • [ISO-abbreviation] Microbiology (Reading, Engl.)
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Bacterial Toxins; 0 / Bicyclo Compounds, Heterocyclic; 0 / Bungarotoxins; 0 / Marine Toxins; 0 / Microcystins; 0 / Neurotoxins; 0 / Receptors, Nicotinic; 0 / Tropanes; 0 / cyanobacterial toxin; 0 / homoanatoxin-a; 80023A73NK / anatoxin a
  •  go-up   go-down


41. Zou Q, Wu CW, Stein EA, Zang Y, Yang Y: Static and dynamic characteristics of cerebral blood flow during the resting state. Neuroimage; 2009 Nov 15;48(3):515-24
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Consistent with previous PET results, static CBF measured by ASL was significantly higher in the posterior cingulate cortex (PCC), thalamus, insula/superior temporal gyrus (STG) and medial prefrontal cortex (MPFC) than the average CBF of the brain.
  • The high static and dynamic activities in the PCC, MPFC, insula/STG and thalamus suggest that these regions play a vital role in maintaining and facilitating fundamental brain functions.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Hum Brain Mapp. 2009 Aug;30(8):2356-66 [19172655.001]
  • [Cites] J Cereb Blood Flow Metab. 1992 May;12(3):491-9 [1569142.001]
  • [Cites] Neuroimage. 2008 Nov 15;43(3):528-39 [18786642.001]
  • [Cites] Neuroimage. 2008 Mar 1;40(1):110-20 [18191584.001]
  • [Cites] Neurosci Lett. 2007 Aug 23;423(3):189-93 [17709202.001]
  • [Cites] Neuroimage. 2004 May;22(1):394-400 [15110032.001]
  • [Cites] Brain Res Bull. 2001 Feb;54(3):287-98 [11287133.001]
  • [Cites] Nat Rev Neurosci. 2007 Sep;8(9):700-11 [17704812.001]
  • [Cites] Eur Radiol. 1996;6(4):518-22 [8798035.001]
  • [Cites] Hum Brain Mapp. 2005 Sep;26(1):15-29 [15852468.001]
  • [Cites] J Cereb Blood Flow Metab. 1997 Mar;17(3):301-8 [9119903.001]
  • [Cites] Neuroimage. 2005 Jan 1;24(1):207-15 [15588612.001]
  • [Cites] Neuroimage. 2009 Apr 15;45(3):694-701 [19280693.001]
  • [Cites] Magn Reson Med. 1998 Jan;39(1):61-7 [9438438.001]
  • [Cites] Cereb Cortex. 2009 Mar;19(3):524-36 [18567609.001]
  • [Cites] Neuroimage. 2009 Feb 1;44(3):893-905 [18976716.001]
  • [Cites] IEEE Trans Med Imaging. 2004 Feb;23(2):137-52 [14964560.001]
  • [Cites] J Neurosci. 2006 Jan 4;26(1):63-72 [16399673.001]
  • [Cites] Magn Reson Med. 1998 May;39(5):702-8 [9581600.001]
  • [Cites] Schizophr Bull. 2010 Jul;36(4):713-22 [18990709.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4637-42 [15070770.001]
  • [Cites] Hum Brain Mapp. 2009 May;30(5):1502-10 [18649351.001]
  • [Cites] Neuroimage. 1997 Feb;5(2):83-96 [9345540.001]
  • [Cites] PLoS Biol. 2008 Jul 1;6(7):e159 [18597554.001]
  • [Cites] Schizophr Bull. 2007 Jul;33(4):1004-12 [17556752.001]
  • [Cites] Arch Gen Psychiatry. 2009 Apr;66(4):431-41 [19349313.001]
  • [Cites] Am J Physiol. 1995 Feb;268(2 Pt 2):H569-75 [7864181.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9673-8 [15976020.001]
  • [Cites] NMR Biomed. 1997 Jun-Aug;10(4-5):165-70 [9430343.001]
  • [Cites] Science. 2006 Nov 24;314(5803):1249-50 [17124311.001]
  • [Cites] Neuroimage. 2008 Apr 15;40(3):1064-76 [18272400.001]
  • [Cites] Neuroimage. 2008 Aug 1;42(1):296-305 [18514545.001]
  • [Cites] Magn Reson Med. 1992 Jan;23(1):37-45 [1734182.001]
  • [Cites] Neurology. 1998 Mar;50(3):633-41 [9521248.001]
  • [Cites] J Neurophysiol. 2009 Jun;101(6):3270-83 [19339462.001]
  • [Cites] Neuroimage. 2008 May 1;40(4):1595-605 [18314354.001]
  • [Cites] Neuroimage. 2006 Feb 15;29(4):1359-67 [16260155.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):676-82 [11209064.001]
  • [Cites] Neuroreport. 2006 Jan 23;17(1):19-22 [16361943.001]
  • [Cites] Blood. 2006 Jul 1;108(1):379-81 [16537809.001]
  • [Cites] J Cogn Neurosci. 1997 Fall;9(5):648-63 [23965122.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):253-8 [12506194.001]
  • [Cites] Neuroimage. 2002 Mar;15(3):488-500 [11848692.001]
  • [Cites] Radiology. 2005 Mar;234(3):851-9 [15734937.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):10046-51 [16788060.001]
  • [Cites] Nature. 2001 Jul 12;412(6843):150-7 [11449264.001]
  • [Cites] Magn Reson Med. 2000 Sep;44(3):450-6 [10975898.001]
  • [Cites] J Neurosci Methods. 2008 Jun 30;171(2):349-55 [18486233.001]
  • [Cites] Comput Biomed Res. 1996 Jun;29(3):162-73 [8812068.001]
  • [Cites] Magn Reson Med. 2000 Sep;44(3):373-8 [10975887.001]
  • [Cites] J Neurosci Methods. 2008 Jul 15;172(1):137-41 [18501969.001]
  • [Cites] Brain Dev. 2007 Mar;29(2):83-91 [16919409.001]
  • [Cites] Neuroimage. 2007 Apr 1;35(2):488-500 [17254803.001]
  • [Cites] Neuroreport. 2006 Jul 17;17(10):1033-6 [16791098.001]
  • [Cites] Curr Opin Neurol. 2008 Aug;21(4):424-30 [18607202.001]
  • [Cites] Philos Trans R Soc Lond B Biol Sci. 2005 May 29;360(1457):1001-13 [16087444.001]
  • [Cites] Magn Reson Med. 1995 Oct;34(4):537-41 [8524021.001]
  • (PMID = 19607928.001).
  • [ISSN] 1095-9572
  • [Journal-full-title] NeuroImage
  • [ISO-abbreviation] Neuroimage
  • [Language] eng
  • [Grant] United States / Intramural NIH HHS / / Z01 DA000469-04; United States / Intramural NIH HHS / / Z99 DA999999
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Spin Labels
  • [Other-IDs] NLM/ NIHMS136586; NLM/ PMC2739419
  •  go-up   go-down


42. Rakototiana AF, Ramorasata AC, Rakoto-Ratsimba HN, Hunald FA, Rajaobelison T, Rantomalala HY: [Pheochromocytoma revealed by stroke in a child]. Arch Pediatr; 2008 Oct;15(10):1531-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Pheochromocytoma revealed by stroke in a child].
  • Pheochromocytoma is uncommon in children.
  • We report herein a case in a 6-year-old boy whose pheochromocytoma was revealed by cerebral ischemia as a consequence of acute-cardiac failure.
  • Abdominal ultrasonography and computed tomography located the tumor on the left adrenal gland.
  • Diagnosis and treatment of pheochromocytoma in children are discussed.
  • [MeSH-major] Adrenal Gland Neoplasms / diagnosis. Brain Ischemia / etiology. Pheochromocytoma / diagnosis. Stroke / etiology


43. Soon JL, Gibson FA, Janas S, Pillai R: Advantages of sutureless aortic valve in a patient with unsuspected pheochromocytoma. Innovations (Phila); 2010 Jul-Aug;5(4):306-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Advantages of sutureless aortic valve in a patient with unsuspected pheochromocytoma.
  • The early suspicion of a pheochromocytoma and immediate aggressive pharmacologic intervention are discussed.
  • The management of an undiagnosed pheochromocytoma presenting during general anesthesia is reviewed.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22437464.001).
  • [ISSN] 1559-0879
  • [Journal-full-title] Innovations (Philadelphia, Pa.)
  • [ISO-abbreviation] Innovations (Phila)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


44. Jiang H, Rao KS, Yee VC, Kraus JP: Characterization of four variant forms of human propionyl-CoA carboxylase expressed in Escherichia coli. J Biol Chem; 2005 Jul 29;280(30):27719-27
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Propionyl-CoA carboxylase (PCC) is a biotin-dependent mitochondrial enzyme that catalyzes the conversion of propionyl-CoA to D-methylmalonyl-CoA.
  • PCC consists of two heterologous subunits, alpha PCC and beta PCC, which are encoded by the nuclear PCCA and PCCB genes, respectively.
  • Deficiency of PCC results in a metabolic disorder, propionic acidemia, which is sufficiently severe to cause neonatal death.
  • We have purified three PCCs containing pathogenic mutations in the beta subunit (R165W, E168K, and R410W) and one PCCB polymorphism (A497V) to homogeneity to elucidate the potential structural and functional effects of these substitutions.
  • The three mutant PCCs had half the catalytic efficiency of wild-type PCC as judged by the kcat/Km ratios.
  • However, the variant PCCs were less thermostable than the wild-type.
  • Our biochemical data and the structural analysis using a beta PCC homology model indicate that the pathogenic nature of these mutations is more likely to be due to a lack of assembly rather than disruption of catalysis.
  • The strong favorable effect of the co-expressed chaperone proteins on PCC folding, assembly, and activity suggest that propionic acidemia may be amenable to chaperone therapy.

  • Hazardous Substances Data Bank. BIOTIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15890657.001).
  • [ISSN] 0021-9258
  • [Journal-full-title] The Journal of biological chemistry
  • [ISO-abbreviation] J. Biol. Chem.
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / P01HD08315
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Acyl Coenzyme A; 0 / Recombinant Proteins; 1264-45-5 / methylmalonyl-coenzyme A; 317-66-8 / propionyl-coenzyme A; 6SO6U10H04 / Biotin; EC 4.1.1.41 / Methylmalonyl-CoA Decarboxylase
  •  go-up   go-down


45. Espinosa J, Castells MA, Laichoubi KB, Contreras A: Mutations at pipX suppress lethality of PII-deficient mutants of Synechococcus elongatus PCC 7942. J Bacteriol; 2009 Aug;191(15):4863-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mutations at pipX suppress lethality of PII-deficient mutants of Synechococcus elongatus PCC 7942.
  • In Synechococcus elongatus PCC 7942, where P(II) forms complexes with the NtcA coactivator PipX, attempts to engineer P(II)-deficient strains failed in a wild-type background but were successful in pipX null mutants.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Photosynth Res. 2005;83(2):135-50 [16143848.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Jul 12;102(28):9907-12 [15985552.001]
  • [Cites] J Biol Chem. 2005 Oct 14;280(41):34684-90 [16109709.001]
  • [Cites] J Biol Chem. 2006 Mar 3;281(9):5726-33 [16377628.001]
  • [Cites] Mol Microbiol. 2006 Jul;61(2):497-510 [16762025.001]
  • [Cites] Mol Microbiol. 2006 Jul;61(2):457-69 [16796668.001]
  • [Cites] Plant Cell Physiol. 2006 Aug;47(8):1182-6 [16854940.001]
  • [Cites] J Biol Chem. 2006 Nov 17;281(46):34909-17 [17001076.001]
  • [Cites] Microbiology. 2007 Mar;153(Pt 3):711-8 [17322191.001]
  • [Cites] Annu Rev Microbiol. 2007;61:349-77 [17506680.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Nov 6;104(45):17644-9 [17959776.001]
  • [Cites] J Biol Chem. 2007 Nov 16;282(46):33641-8 [17875643.001]
  • [Cites] Mol Microbiol. 2007 Dec;66(6):1523-35 [18028310.001]
  • [Cites] Trends Microbiol. 2008 Feb;16(2):65-72 [18182294.001]
  • [Cites] Microbiology. 2008 Oct;154(Pt 10):3002-15 [18832306.001]
  • [Cites] J Bacteriol. 2009 Apr;191(7):2353-61 [19181812.001]
  • [Cites] Arch Microbiol. 2006 Feb;184(6):378-86 [16311758.001]
  • [Cites] FEBS Lett. 1999 Dec 17;463(3):216-20 [10606724.001]
  • [Cites] Eur J Biochem. 2000 Jan;267(2):591-600 [10632730.001]
  • [Cites] J Bacteriol. 2000 Oct;182(19):5615-9 [10986271.001]
  • [Cites] J Bacteriol. 2001 Jan;183(2):411-25 [11133933.001]
  • [Cites] Mol Microbiol. 2001 Aug;41(4):937-47 [11532155.001]
  • [Cites] J Biol Chem. 2001 Oct 12;276(41):38320-8 [11479309.001]
  • [Cites] FEBS Lett. 2002 Feb 13;512(1-3):71-4 [11852054.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4251-5 [11917135.001]
  • [Cites] Mol Microbiol. 2002 Jul;45(2):351-63 [12123449.001]
  • [Cites] J Bacteriol. 2003 Apr;185(8):2582-91 [12670983.001]
  • [Cites] FEBS Lett. 2003 May 22;543(1-3):42-6 [12753902.001]
  • [Cites] J Bacteriol. 2004 Jun;186(11):3346-54 [15150219.001]
  • [Cites] Mol Microbiol. 2004 Jun;52(5):1303-14 [15165234.001]
  • [Cites] FEMS Microbiol Rev. 2004 Jun;28(3):319-33 [15449606.001]
  • [Cites] FEBS Lett. 2004 Oct 8;576(1-2):261-5 [15474048.001]
  • [Cites] J Bacteriol. 1984 Apr;158(1):36-42 [6425267.001]
  • [Cites] J Bacteriol. 1990 May;172(5):2313-9 [2110139.001]
  • [Cites] Mol Microbiol. 1992 Jul;6(13):1853-9 [1630321.001]
  • [Cites] J Bacteriol. 1995 Apr;177(8):2033-40 [7721695.001]
  • [Cites] J Bacteriol. 1998 Mar;180(5):1166-73 [9495755.001]
  • [Cites] J Bacteriol. 1998 Jun;180(12):3260-4 [9620984.001]
  • [Cites] Microbiology. 1998 Jun;144 ( Pt 6):1537-47 [9639924.001]
  • [Cites] Mol Microbiol. 1998 Jul;29(2):431-47 [9720863.001]
  • [Cites] Mol Microbiol. 1998 Jul;29(2):449-63 [9720864.001]
  • [Cites] J Bacteriol. 1999 Apr;181(8):2655-8 [10198037.001]
  • [Cites] J Biol Chem. 2004 Dec 31;279(53):55202-10 [15502156.001]
  • [Cites] J Bacteriol. 2005 Jan;187(2):498-506 [15629921.001]
  • [Cites] Plant Cell Physiol. 2004 Dec;45(12):1768-78 [15653795.001]
  • [Cites] J Bacteriol. 2005 Feb;187(4):1254-65 [15687189.001]
  • [Cites] J Bacteriol. 2005 Oct;187(19):6683-90 [16166530.001]
  • (PMID = 19482921.001).
  • [ISSN] 1098-5530
  • [Journal-full-title] Journal of bacteriology
  • [ISO-abbreviation] J. Bacteriol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Bacterial Proteins; 0 / PII Nitrogen Regulatory Proteins; 57657-57-5 / PIID regulatory protein, Bacteria
  • [Other-IDs] NLM/ PMC2715732
  •  go-up   go-down


46. Palomeras Vilches A, Picas Jufresa A, Buñuel Alvarez JC, Gassen C: [Descriptive study of a polymyalgia rheumatica case series in a Primary Care Centre]. Aten Primaria; 2010 Jan;42(1):57-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Descriptive study of a polymyalgia rheumatica case series in a Primary Care Centre].
  • [Transliterated title] Estudio descriptivo de una serie de casos de polimialgia reumática controlados en un centro de atención primaria.

  • MedlinePlus Health Information. consumer health - Polymyalgia Rheumatica.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19467733.001).
  • [ISSN] 0212-6567
  • [Journal-full-title] Atencion primaria
  • [ISO-abbreviation] Aten Primaria
  • [Language] SPA
  • [Publication-type] Letter
  • [Publication-country] Spain
  •  go-up   go-down


47. Marin K, Stirnberg M, Eisenhut M, Krämer R, Hagemann M: Osmotic stress in Synechocystis sp. PCC 6803: low tolerance towards nonionic osmotic stress results from lacking activation of glucosylglycerol accumulation. Microbiology; 2006 Jul;152(Pt 7):2023-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Osmotic stress in Synechocystis sp. PCC 6803: low tolerance towards nonionic osmotic stress results from lacking activation of glucosylglycerol accumulation.
  • PCC 6803 was challenged by salt (NaCl), and the osmolytes sorbitol and maltose.
  • The physiological response towards each of the three compounds was found to be different.
  • After salt addition, the cell volume remained unchanged, and the accumulation of the osmoprotective compound glucosylglycerol (GG) was observed after activation of the key enzyme GgpS at the biochemical and gene (ggpS) expression level.
  • Consequently, a successful response of Synechocystis cells to an osmotic challenge is indicative of the de novo synthesis of GG upon salt-dependent activation of the GgpS enzyme or the uptake of external solutes.

  • Hazardous Substances Data Bank. SODIUM CHLORIDE .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16804177.001).
  • [ISSN] 1350-0872
  • [Journal-full-title] Microbiology (Reading, England)
  • [ISO-abbreviation] Microbiology (Reading, Engl.)
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Bacterial Proteins; 0 / Glucosides; 0 / glucosylglycerol; 451W47IQ8X / Sodium Chloride; 69-79-4 / Maltose; EC 2.4.1.- / Glucosyltransferases; EC 2.4.1.- / glucosylglycerol-phosphate synthase
  •  go-up   go-down


48. Imashimizu M, Yoshimura H, Katoh H, Ehira S, Ohmori M: NaCl enhances cellular cAMP and upregulates genes related to heterocyst development in the cyanobacterium, Anabaena sp. strain PCC 7120. FEMS Microbiol Lett; 2005 Nov 1;252(1):97-103
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] NaCl enhances cellular cAMP and upregulates genes related to heterocyst development in the cyanobacterium, Anabaena sp. strain PCC 7120.
  • PCC 7120, by the addition of 200 mM NaCl to the culture medium.
  • DNA microarray analysis showed that expression of a gene cluster containing all5347 and alr5351 (hglE) was upregulated by NaCl in the wild-type strain but not in the cyaC mutant.
  • [MeSH-minor] Base Sequence. Culture Media. Gene Expression Profiling. Molecular Sequence Data. Oligonucleotide Array Sequence Analysis. Signal Transduction

  • Hazardous Substances Data Bank. SODIUM CHLORIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16182471.001).
  • [ISSN] 0378-1097
  • [Journal-full-title] FEMS microbiology letters
  • [ISO-abbreviation] FEMS Microbiol. Lett.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Bacterial Proteins; 0 / Culture Media; 451W47IQ8X / Sodium Chloride; E0399OZS9N / Cyclic AMP
  •  go-up   go-down


49. Powers JF, Tischler AS, Mohammed M, Naeem R: Microarray-based comparative genomic hybridization of pheochromocytoma cell lines from neurofibromatosis knockout mice reveals genetic alterations similar to those in human pheochromocytomas. Cancer Genet Cytogenet; 2005 May;159(1):27-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Microarray-based comparative genomic hybridization of pheochromocytoma cell lines from neurofibromatosis knockout mice reveals genetic alterations similar to those in human pheochromocytomas.
  • Somatic genetic aberrations have been identified in both sporadic pheochromocytomas and those associated with familial tumor syndromes; however, individual variations between human tumors and the absence of in vitro human pheochromocytoma models hinder efforts to understand the roles of those aberrations in tumorigenesis.
  • Pheochromocytomas occur frequently in neurofibromatosis knockout mice and we have recently developed cell lines from those tumors.
  • The availability of multiple tumors from genetically identical animals provides a powerful tool for understanding the pathobiology of pheochromocytomas.
  • For the present investigation, we performed a genomic scanning analysis of four mouse pheochromocytoma cell lines by standard cytogenetics and microarray-based comparative genomic hybridization in order to identify genetic common denominators.
  • Mouse chromosome 4 is homologous to human chromosome 1p, which is the most frequent deletion in human pheochromocytomas.
  • These comparisons suggest that genetic mechanisms in the genesis of pheochromocytomas may be similar across species.
  • [MeSH-major] Adrenal Gland Neoplasms / genetics. Chromosome Deletion. Chromosomes, Human, Pair 1 / genetics. Chromosomes, Human, Pair 3 / genetics. Neurofibromatoses / genetics. Pheochromocytoma / genetics


50. Prasad BR, Nikolskaya N, Connolly D, Smith TJ, Byrne SJ, Gérard VA, Gun'ko YK, Rochev Y: Long-term exposure of CdTe quantum dots on PC12 cellular activity and the determination of optimum non-toxic concentrations for biological use. J Nanobiotechnology; 2010;8:7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Long-term exposure of CdTe quantum dots on PC12 cellular activity and the determination of optimum non-toxic concentrations for biological use.
  • The cellular interaction, uptake and resultant toxic influence of CdTe QDs (gelatinised and non-gelatinised Thioglycolic acid (TGA) capped) have been investigated with pheochromocytoma 12 (PC12) cells.
  • In conjunction to their analysis by confocal microscopy, the QD - cell interplay was explored as the QD concentrations were varied over extended (up to 72 hours) co-incubation times.
  • Cell morphology was analysed as the QD concentrations were varied over co-incubations up to 72 hours.
  • The QDs were found to be excellent fluorophores, illuminating the cytoplasm of the cells and no deleterious effects were witnessed at concentrations of ~10-9 M.
  • Three assays were utilised to probe how individual cell functions (viability, DNA quantification and proliferation) were affected by the presence of the QDs at various concentrations and incubation times.
  • Cell response was found to not only be concentration dependant but also influenced by the surface environment of the QDs.
  • We have found that PC12 cells are highly susceptible to an increased concentration range of the QDs, while the gelatine coating acts as a barrier towards enhanced toxicity at higher QD concentrations.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] ACS Nano. 2008 Jun;2(6):1153-66 [19206333.001]
  • [Cites] J Am Chem Soc. 2002 May 1;124(17):4586-94 [11971705.001]
  • [Cites] Toxicol Appl Pharmacol. 2009 Jan 15;234(2):222-35 [18983864.001]
  • [Cites] Small. 2008 Nov;4(11):2006-15 [18949793.001]
  • [Cites] Talanta. 2005 Sep 15;67(3):462-71 [18970190.001]
  • [Cites] Environ Health Perspect. 2008 Jul;116(7):915-22 [18629314.001]
  • [Cites] Nano Lett. 2007 Nov;7(11):3452-61 [17949046.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Aug 21;104(34):13666-71 [17698956.001]
  • [Cites] Small. 2007 Jul;3(7):1152-6 [17534993.001]
  • [Cites] Langmuir. 2007 Feb 13;23(4):1974-80 [17279683.001]
  • [Cites] Small. 2006 Dec;2(12):1412-7 [17192996.001]
  • [Cites] Toxicol Lett. 2006 Dec 15;167(3):191-200 [17049762.001]
  • [Cites] Nano Lett. 2006 Sep;6(9):2049-59 [16968024.001]
  • [Cites] Nano Lett. 2006 Jul;6(7):1491-5 [16834436.001]
  • [Cites] J Neurosci. 2006 Feb 15;26(7):1893-5 [16481420.001]
  • [Cites] Science. 2006 Feb 3;311(5761):622-7 [16456071.001]
  • [Cites] Chem Biol. 2005 Nov;12(11):1227-34 [16298302.001]
  • [Cites] Nat Methods. 2004 Oct;1(1):73-8 [16138413.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 May 24;102(21):7583-8 [15897449.001]
  • [Cites] J Mol Med (Berl). 2005 May;83(5):377-85 [15688234.001]
  • [Cites] Nano Lett. 2005 Apr;5(4):645-8 [15826102.001]
  • [Cites] Nano Lett. 2005 Apr;5(4):603-7 [15826094.001]
  • [Cites] Nano Lett. 2005 Feb;5(2):331-8 [15794621.001]
  • [Cites] Chem Soc Rev. 2005 Apr;34(4):299-312 [15778764.001]
  • [Cites] Science. 1998 Sep 25;281(5385):2013-6 [9748157.001]
  • [Cites] Toxicol Appl Pharmacol. 1999 Jan 1;154(1):59-66 [9882592.001]
  • [Cites] Science. 1998 Sep 25;281(5385):2016-8 [9748158.001]
  • [Cites] Microbiol Immunol. 2004;48(9):669-75 [15383704.001]
  • [Cites] J Am Chem Soc. 2004 May 19;126(19):6115-23 [15137777.001]
  • [Cites] Science. 2003 May 30;300(5624):1434-6 [12775841.001]
  • [Cites] Br J Pharmacol. 2003 Mar;138(5):901-11 [12642392.001]
  • [Cites] Science. 2002 Nov 29;298(5599):1759-62 [12459582.001]
  • [Cites] Trends Pharmacol Sci. 2002 Jul;23(7):331-7 [12119154.001]
  • [Cites] J Am Chem Soc. 2002 Jun 5;124(22):6378-82 [12033868.001]
  • [Cites] ACS Nano. 2008 May;2(5):928-38 [19206490.001]
  • (PMID = 20338051.001).
  • [ISSN] 1477-3155
  • [Journal-full-title] Journal of nanobiotechnology
  • [ISO-abbreviation] J Nanobiotechnology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2856518
  •  go-up   go-down


51. Gupta VK: Systemic hypertension, headache, and ocular hemodynamics: a new hypothesis. MedGenMed; 2006;8(3):63
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The association between systemic hypertension and headache remains controversial and its pathophysiologic basis is uncertain.
  • Hypertensive crises, including those associated with pheochromocytoma, are not accompanied by attacks of angle-closure glaucoma.

  • MedlinePlus Health Information. consumer health - Headache.
  • MedlinePlus Health Information. consumer health - High Blood Pressure.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Headache. 2000 Mar;40(3):241-7 [10759928.001]
  • [Cites] Med Hypotheses. 2004;62(1):45-8 [14729003.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 2002 Apr;72(4):431 [11909898.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 2002 Apr;72(4):463-6 [11909904.001]
  • [Cites] Stroke. 2002 Jun;33(6):1480-6 [12052978.001]
  • [Cites] Cephalalgia. 2002 May;22(4):313-6 [12100095.001]
  • [Cites] Eye (Lond). 2003 Jan;17(1):84-8 [12579176.001]
  • [Cites] Cephalalgia. 2004;24 Suppl 1:9-160 [14979299.001]
  • [Cites] J Glaucoma. 2004 Aug;13(4):319-26 [15226661.001]
  • [Cites] Rev Cardiovasc Med. 2004 Summer;5(3):148-55 [15346098.001]
  • [Cites] JAMA. 1966 Sep 5;197(10):754-8 [5953366.001]
  • [Cites] Br Med J. 1971 Jan 16;1(5741):142-3 [5539420.001]
  • [Cites] N Engl J Med. 1972 Sep 28;287(13):631-3 [5076458.001]
  • [Cites] Physiol Rev. 1975 Jul;55(3):383-417 [1153528.001]
  • [Cites] Arch Neurol. 1976 Apr;33(4):281-8 [1259642.001]
  • [Cites] Br Heart J. 1977 Jan;39(1):7-12 [831740.001]
  • [Cites] Acta Ophthalmol (Copenh). 1977 Feb;55(1):35-51 [576545.001]
  • [Cites] Aust N Z J Med. 1976 Oct;6(5):492-7 [140651.001]
  • [Cites] Headache. 1979 Jan;19(1):31-6 [759403.001]
  • [Cites] Br J Clin Pharmacol. 1984;18 Suppl 2:189S-195S [6532482.001]
  • [Cites] Exp Eye Res. 1986 Nov;43(5):759-69 [3803461.001]
  • [Cites] J R Coll Gen Pract. 1987 Aug;37(301):346-9 [2834550.001]
  • [Cites] J Hum Hypertens. 1989 Feb;3(1):41-4 [2542548.001]
  • [Cites] Headache. 1991 Jul;31(7):439-45 [1774158.001]
  • [Cites] Arch Ophthalmol. 1992 May;110(5):596-7 [1580826.001]
  • [Cites] Lancet. 1994 Aug 20;344(8921):519-21 [7914618.001]
  • [Cites] Exp Eye Res. 1995 Mar;60(3):267-78 [7789407.001]
  • [Cites] Hypertension. 1996 Sep;28(3):494-504 [8794839.001]
  • [Cites] Cephalalgia. 1997 Aug;17(5):561-9 [9251870.001]
  • [Cites] Hypertension. 1998 May;31(5):1146-50 [9576127.001]
  • [Cites] Ophthalmic Physiol Opt. 1997 Nov;17(6):456-65 [9666918.001]
  • [Cites] J Intern Med. 1998 Oct;244(4):325-32 [9797496.001]
  • [Cites] Br J Ophthalmol. 2005 Mar;89(3):284-7 [15722304.001]
  • [Cites] Headache. 2005 May;45(5):612-4 [15953285.001]
  • [Cites] Ophthalmology. 2005 Aug;112(8):1337-42 [16024084.001]
  • [Cites] Acta Neurol Scand. 2005 Oct;112(4):259-64 [16146497.001]
  • [Cites] Hypertension. 2006 Feb;47(2):149-54 [16380533.001]
  • [Cites] JAMA. 2006 Jun 28;295(24):2859-66 [16804152.001]
  • [Cites] Arch Intern Med. 2001 Jan 22;161(2):252-5 [11176740.001]
  • [Cites] Arch Ophthalmol. 2003 Jun;121(6):856-62 [12796259.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2003 Oct;44(10):4439-42 [14507890.001]
  • [Cites] J Hum Hypertens. 2003 Nov;17(11):787-90 [14578919.001]
  • [Cites] Can J Neurol Sci. 2003 Aug;30(3):210-4 [12945943.001]
  • (PMID = 17406187.001).
  • [ISSN] 1531-0132
  • [Journal-full-title] MedGenMed : Medscape general medicine
  • [ISO-abbreviation] MedGenMed
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 48
  • [Other-IDs] NLM/ PMC1781314
  •  go-up   go-down


52. Basile U, Cavallaro G, Polistena A, Giustini S, Orlando G, Cotesta D, Petramala L, Letizia C, Calvieri S, De Toma G: Gastrointestinal and retroperitoneal manifestations of type 1 neurofibromatosis. J Gastrointest Surg; 2010 Jan;14(1):186-94
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Type 1 neurofibromatosis (NF1) is a genetic disease characterized by neoplastic and not neoplastic disorders, involving tissues of neuroectodermal or mesenchymal origin.
  • DATA SOURCES: Abdominal manifestations of NF1 comprehend five categories of tumors: neurogenic with neurofibromas, malignant peripheral nerve sheath tumors and ganglioneuromas, neuroendocrine with pheochromocytomas and carcinoids, non-neurogenic gastrointestinal stromal tumors, i.e., GISTs, and embryonal tumors and miscellaneous.
  • CONCLUSIONS: Early diagnosis of these abdominal manifestations is very important given the risk of malignancy, organic complications such as in the case of pheochromocytomas or hemorrhagic-obstructive complications such as in the case of the tumors of the gastrointestinal tract (GISTs and neurofibromas).
  • The importance of an annual clinical evaluation on the part of a multidisciplinary pool of clinicians in highly specialized centers allows early detection of complications and of neoplastic transformation.
  • [MeSH-major] Neurofibromatosis 1 / diagnosis
  • [MeSH-minor] Abdominal Neoplasms / diagnosis. Carcinoma, Embryonal / diagnosis. Carcinoma, Neuroendocrine / diagnosis. Ganglioneuroma / diagnosis. Gastrointestinal Stromal Tumors / diagnosis. Humans. Nerve Sheath Neoplasms / diagnosis. Neurofibroma / diagnosis. Retroperitoneal Neoplasms / diagnosis

  • Genetic Alliance. consumer health - Neurofibromatosis.
  • Genetic Alliance. consumer health - Neurofibromatosis type 1.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Reprod Biomed Online. 2002 May-Jun;4(3):218-22 [12709270.001]
  • [Cites] Neurology. 2004 Nov 23;63(10):1944-6 [15557519.001]
  • [Cites] Brain. 1988 Dec;111 ( Pt 6):1355-81 [3145091.001]
  • [Cites] Magn Reson Imaging. 1991;9(3):463-5 [1908933.001]
  • [Cites] Am J Hum Genet. 2003 May;72(5):1288-92 [12660952.001]
  • [Cites] Cell. 1990 Jul 13;62(1):187-92 [1694727.001]
  • [Cites] AJR Am J Roentgenol. 2004 Dec;183(6):1629-36 [15547202.001]
  • [Cites] World J Gastroenterol. 2007 Jun 28;13(24):3384-7 [17659681.001]
  • [Cites] Am J Surg Pathol. 1994 Mar;18(3):250-7 [7906923.001]
  • [Cites] World J Gastroenterol. 2007 May 14;13(18):2629-32 [17552016.001]
  • [Cites] Cancer Res. 2003 Feb 15;63(4):752-5 [12591720.001]
  • [Cites] Mod Pathol. 2001 Nov;14(11):1169-74 [11706080.001]
  • [Cites] J Med Genet. 2002 May;39(5):311-4 [12011145.001]
  • [Cites] Neurology. 1997 Apr;48(4):1121-7 [9109916.001]
  • [Cites] Radiology. 1995 Jun;195(3):721-4 [7754001.001]
  • [Cites] Neurology. 2001 Jun 12;56(11):1433-43 [11409413.001]
  • [Cites] Int J Urol. 2007 Jan;14(1):73-4 [17199864.001]
  • [Cites] Science. 2003 Jan 31;299(5607):708-10 [12522257.001]
  • [Cites] Neurology. 1998 Jun;50(6):1755-60 [9633723.001]
  • [Cites] Can Med Assoc J. 1978 Aug 26;119(4):352-3 [99222.001]
  • [Cites] Arch Intern Med. 1963 Sep;112:357-62 [14045280.001]
  • [Cites] Osteoporos Int. 2005 Aug;16(8):928-36 [15551055.001]
  • [Cites] J Comput Assist Tomogr. 2005 May-Jun;29(3):418-9 [15891517.001]
  • [Cites] JAMA. 1997 Jul 2;278(1):51-7 [9207339.001]
  • [Cites] J Med Genet. 2007 Jan;44(1):e61 [17209131.001]
  • [Cites] Cancer Res. 2002 Mar 1;62(5):1573-7 [11894862.001]
  • [Cites] Ann Neurol. 1997 Feb;41(2):143-9 [9029062.001]
  • [Cites] Am J Surg Pathol. 2003 May;27(5):625-41 [12717247.001]
  • [Cites] Nature. 2002 Jan 31;415(6871):526-30 [11793011.001]
  • [Cites] Am J Surg Pathol. 2006 Jan;30(1):90-6 [16330947.001]
  • [Cites] Arch Neurol. 1988 May;45(5):575-8 [3128965.001]
  • [Cites] J Pediatr Orthop. 1986 Jan-Feb;6(1):72-88 [3079778.001]
  • [Cites] AJR Am J Roentgenol. 1994 Sep;163(3):617-20 [8079855.001]
  • [Cites] Pediatr Dermatol. 1990 Dec;7(4):293-5 [2127842.001]
  • [Cites] N Engl J Med. 1991 May 2;324(18):1264-6 [1901624.001]
  • [Cites] J Pathol. 2004 Jan;202(1):80-5 [14694524.001]
  • [Cites] J Clin Ultrasound. 1983 Oct;11(8):460-2 [6417179.001]
  • [Cites] Pediatr Radiol. 1997 Feb;27(2):124-9 [9028843.001]
  • [Cites] Am J Surg Pathol. 1989 Oct;13(10):828-37 [2476943.001]
  • [Cites] J Urol. 1999 Nov;162(5):1582-6 [10524872.001]
  • [Cites] Genet Med. 2002 May-Jun;4(3):105-11 [12180143.001]
  • [Cites] Pathology. 2001 Aug;33(3):390-5 [11523947.001]
  • [Cites] AJR Am J Roentgenol. 1988 Aug;151(2):381-8 [3134807.001]
  • [Cites] Radiographics. 2005 Mar-Apr;25(2):455-80 [15798063.001]
  • [Cites] Cell. 1990 Aug 10;62(3):599-608 [2116237.001]
  • [Cites] Am J Surg Pathol. 1993 Aug;17(8):837-41 [8338194.001]
  • [Cites] Am J Surg Pathol. 1986 May;10(5):348-57 [2422964.001]
  • [Cites] Hum Mutat. 2000;15(6):541-55 [10862084.001]
  • [Cites] Cancer. 1986 May 15;57(10):2006-21 [3082508.001]
  • [Cites] J Comput Assist Tomogr. 2008 Jan-Feb;32(1):4-8 [18303281.001]
  • [Cites] J Med Genet. 1989 Nov;26(11):704-11 [2511318.001]
  • [Cites] Am J Med Genet. 1997 Nov 28;73(1):80-6 [9375928.001]
  • [Cites] Science. 1990 Jul 13;249(4965):181-6 [2134734.001]
  • [Cites] Cancer. 1963 Aug;16:1003-14 [14050004.001]
  • [Cites] Clin Imaging. 1994 Apr-Jun;18(2):142-5 [8033007.001]
  • [Cites] Neurology. 2002 May 28;58(10):1461-70 [12041525.001]
  • [Cites] J Clin Gastroenterol. 1984 Dec;6(6):529-34 [6439777.001]
  • [Cites] Surgery. 1983 Dec;94(6):938-40 [6648808.001]
  • (PMID = 19495890.001).
  • [ISSN] 1873-4626
  • [Journal-full-title] Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
  • [ISO-abbreviation] J. Gastrointest. Surg.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 62
  •  go-up   go-down


53. García-Rubio I, Alonso PJ, Medina M, Martínez JI: Hyperfine correlation spectroscopy and electron spin echo envelope modulation spectroscopy study of the two coexisting forms of the hemeprotein cytochrome c6 from Anabaena Pcc7119. Biophys J; 2009 Jan;96(1):141-52
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Oxidized cytochrome c(6) from Anabaena PCC 7119 was studied by electron spin echo envelope modulation spectroscopy.
  • Combining the experimental information here presented and previous continuous wave-electron paramagnetic resonance and electron nuclear double resonance results, some details on the electronic structure of the heme center in the protein are obtained.
  • These results are discussed on the basis of a molecular model that considers one unpaired electron localized mainly in the iron d orbitals and propagation of the spin density within the heme center via spin polarization of the nitrogen sigma-orbitals.
  • The coexistence of two heme forms at physiological pH values in this c-type cytochrome is also discussed taking into account the experimental evidence.
  • [MeSH-minor] Algorithms. Anabaena. Bacterial Proteins / chemistry. Electromagnetic Fields. Electron Spin Resonance Spectroscopy / methods. Electrons. Heme / chemistry. Hydrogen-Ion Concentration. Iron Compounds / chemistry. Models, Chemical. Models, Molecular. Nitrogen Compounds / chemistry. Spectrum Analysis / methods

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. IRON COMPOUNDS .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Inorg Chem. 2003 Jul 28;42(15):4526-44 [12870942.001]
  • [Cites] Biophys J. 2006 Sep 15;91(6):2250-63 [16798796.001]
  • [Cites] Biochim Biophys Acta. 1973 Sep 21;322(1):38-44 [4355311.001]
  • [Cites] Biochim Biophys Acta. 1976 May 20;434(1):290-5 [181067.001]
  • [Cites] J Biol Chem. 1977 Jan 25;252(2):574-82 [13072.001]
  • [Cites] Biochim Biophys Acta. 1977 Mar 28;491(1):137-48 [191085.001]
  • [Cites] Biochem Biophys Res Commun. 1980 Feb 27;92(4):1362-9 [6245651.001]
  • [Cites] Biochem J. 1987 Aug 15;246(1):43-54 [2823795.001]
  • [Cites] Biochemistry. 1989 Oct 3;28(20):8033-9 [2557894.001]
  • [Cites] Biochemistry. 1992 Jan 14;31(1):189-99 [1310029.001]
  • [Cites] Biochemistry. 1993 Aug 24;32(33):8446-56 [8395204.001]
  • [Cites] Eur J Biochem. 1993 Aug 15;216(1):329-41 [8396033.001]
  • [Cites] Eur J Biochem. 1995 Feb 1;227(3):829-37 [7867644.001]
  • [Cites] Biophys J. 2005 Oct;89(4):2628-39 [16040738.001]
  • [Cites] J Biol Inorg Chem. 2006 Jun;11(4):467-75 [16596390.001]
  • [Cites] J Am Chem Soc. 2003 Dec 24;125(51):15846-54 [14677976.001]
  • (PMID = 18835911.001).
  • [ISSN] 1542-0086
  • [Journal-full-title] Biophysical journal
  • [ISO-abbreviation] Biophys. J.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Bacterial Proteins; 0 / Cytochromes c6; 0 / Iron Compounds; 0 / Nitrogen Compounds; 42VZT0U6YR / Heme
  • [Other-IDs] NLM/ PMC2710011
  •  go-up   go-down


54. Nau P, Demyttenaere S, Muscarella P, Narula V, Hazey JW, Ellison EC, Melvin WS: Pheochromocytoma does not increase risk in laparoscopic adrenalectomy. Surg Endosc; 2010 Nov;24(11):2760-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pheochromocytoma does not increase risk in laparoscopic adrenalectomy.
  • BACKGROUND: Laparoscopic adrenalectomy (LA) has become the standard approach to an adrenal mass.
  • The use of LA for pheochromocytoma (PHE) has been questioned due to concerns of increased morbidity and negative hemodynamic sequelae.
  • This study aimed to compare the outcomes of LA for PHE with the results of LA for other adrenal pathologies.
  • Time in the intensive care unit (1.1 vs 0.1 days; p < 0.001) and time until oral intake (1.5 vs 1.0 days; p = 0.02) also were increased in the PHE population.
  • CONCLUSIONS: Concerns of increased morbidity related to a laparoscopic approach for patients with a diagnosis of PHE are unfounded.
  • [MeSH-major] Adrenal Gland Neoplasms / surgery. Adrenalectomy. Laparoscopy. Pheochromocytoma / surgery


55. Battchikova N, Zhang P, Rudd S, Ogawa T, Aro EM: Identification of NdhL and Ssl1690 (NdhO) in NDH-1L and NDH-1M complexes of Synechocystis sp. PCC 6803. J Biol Chem; 2005 Jan 28;280(4):2587-95
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Identification of NdhL and Ssl1690 (NdhO) in NDH-1L and NDH-1M complexes of Synechocystis sp. PCC 6803.
  • PCC 6803, NDH-1L and NDH-1M, were studied by two-dimensional blue-native/SDS-PAGE followed by electrospray tandem mass spectrometry.
  • In addition, NdhL and a novel subunit, Ssl1690 (designated NdhO), were shown to be components of this complex.
  • All subunits mentioned above were present in the NDH-1M complex except NdhD1 and NdhF1.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15548534.001).
  • [ISSN] 0021-9258
  • [Journal-full-title] The Journal of biological chemistry
  • [ISO-abbreviation] J. Biol. Chem.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Peptides; 0 / Protein Subunits; EC 1.6.99.1 / NADPH Dehydrogenase
  •  go-up   go-down


56. Summerfield TC, Winter RT, Eaton-Rye JJ: Investigation of a requirement for the PsbP-like protein in Synechocystis sp. PCC 6803. Photosynth Res; 2005 Jun;84(1-3):263-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Investigation of a requirement for the PsbP-like protein in Synechocystis sp. PCC 6803.
  • The sll1418 gene encodes a PsbP-like protein in Synechocystis sp. PCC 6803.
  • Also the wild-type and DeltaPsbP strains exhibited similar oxygen evolution and assembly of Photosystem II (PS II) centers.
  • Moreover, the absence of PsbP did not affect the ability of alkaline pH to restore photoautotrophic growth in the DeltaPsbO:DeltaPsbU strain.
  • PCC 6803 [Kimura et al. (2002) Plant Cell Physiol 43: 932-938].
  • These results are consistent with the conclusion that PsbP is associated with approximately 3 of PS II centers, and may play a regulatory role in PS II [Thornton et al. (2004) Plant Cell 16: 2164-2175].
  • [MeSH-minor] Amino Acid Sequence. Gene Deletion. Gene Expression Regulation, Bacterial. Hot Temperature. Molecular Sequence Data. Photosystem II Protein Complex / chemistry. Photosystem II Protein Complex / metabolism. Sequence Homology, Amino Acid

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):98-103 [12518057.001]
  • [Cites] Biochemistry. 1998 Feb 10;37(6):1551-8 [9484225.001]
  • [Cites] Biochemistry. 1993 Feb 23;32(7):1825-32 [8382523.001]
  • [Cites] Biochemistry. 2002 Jun 25;41(25):8004-12 [12069591.001]
  • [Cites] J Biol Chem. 1991 Jul 15;266(20):13370-6 [1712783.001]
  • [Cites] Plant Physiol. 1999 May;120(1):301-8 [10318707.001]
  • [Cites] Plant Mol Biol. 1989 Dec;13(6):693-700 [2518835.001]
  • [Cites] Methods Mol Biol. 2004;274:309-24 [15187289.001]
  • [Cites] Plant Cell Physiol. 2002 Oct;43(10):1244-9 [12407205.001]
  • [Cites] Biochemistry. 1998 Oct 13;37(41):14437-49 [9772170.001]
  • [Cites] Trends Plant Sci. 2004 Jan;9(1):18-25 [14729215.001]
  • [Cites] Plant Cell. 2004 Aug;16(8):2164-75 [15258264.001]
  • [Cites] Nucleic Acids Res. 1997 Dec 15;25(24):4876-82 [9396791.001]
  • [Cites] J Biol Chem. 1995 Mar 24;270(12):6901-7 [7896839.001]
  • [Cites] Plant Cell Physiol. 2002 Aug;43(8):932-8 [12198196.001]
  • [Cites] Science. 2004 Mar 19;303(5665):1831-8 [14764885.001]
  • [Cites] FEBS Lett. 2003 May 22;543(1-3):148-53 [12753923.001]
  • [Cites] Eur J Biochem. 2004 Mar;271(5):962-71 [15009208.001]
  • [Cites] Biochim Biophys Acta. 2001 Mar 9;1546(1):196-204 [11257522.001]
  • [Cites] Biochemistry. 2005 Jan 18;44(2):805-15 [15641809.001]
  • [Cites] J Biol Chem. 1997 Jul 11;272(28):17821-6 [9211937.001]
  • [Cites] Biochim Biophys Acta. 1996 Nov 12;1277(1-2):35-60 [8950371.001]
  • (PMID = 16049784.001).
  • [ISSN] 0166-8595
  • [Journal-full-title] Photosynthesis research
  • [ISO-abbreviation] Photosyn. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Bacterial Proteins; 0 / Photosystem II Protein Complex
  •  go-up   go-down


57. Nagano-Saito A, Liu J, Doyon J, Dagher A: Dopamine modulates default mode network deactivation in elderly individuals during the Tower of London task. Neurosci Lett; 2009 Jul 10;458(1):1-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Task-induced deactivation is frequently reported in the ventro-medial prefrontal cortex (vmPFC) and posterior cingulate cortex (PCC), regions considered to belong to the default mode network.
  • To investigate the effect of dopamine on task-induced deactivation, we used positron emission tomography to measure cerebral blood flow during performance of the Tower of London task before and after administration of the dopamine receptor agonist apomorphine in six healthy volunteers (49-66 years old) and six Parkinson disease patients (52-69 years old).
  • Although task-induced deactivation was observed in the vmPFC and PCC in both groups and in both conditions, an inverse correlation between activation and problem complexity was observed in the vmPFC only in the apomorphine condition.
  • [MeSH-minor] Aged. Analysis of Variance. Apomorphine. Brain Mapping. Dopamine Agonists. Female. HIV Infections / pathology. HIV Infections / radionuclide imaging. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Nerve Net / blood supply. Parkinson Disease / pathology. Parkinson Disease / radionuclide imaging. Positron-Emission Tomography / methods

  • Hazardous Substances Data Bank. DOPAMINE .
  • Hazardous Substances Data Bank. APOMORPHINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19442867.001).
  • [ISSN] 1872-7972
  • [Journal-full-title] Neuroscience letters
  • [ISO-abbreviation] Neurosci. Lett.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Dopamine Agonists; N21FAR7B4S / Apomorphine; VTD58H1Z2X / Dopamine
  •  go-up   go-down


58. Gockel I, Vetter G, Heintz A, Junginger T: Endoscopic adrenalectomy for pheochromocytoma: difference between the transperitoneal and retroperitoneal approaches in terms of the operative course. Surg Endosc; 2005 Aug;19(8):1086-92
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endoscopic adrenalectomy for pheochromocytoma: difference between the transperitoneal and retroperitoneal approaches in terms of the operative course.
  • BACKGROUND: Due to the intraoperative catecholamine secretion with hemodynamic changes, a larger tumor size and marked neovascularization, as compared with other adrenal pathologies, endoscopic adrenalectomy for pheochromocytoma represents a particular challenge involving a more difficult and morbid procedure.
  • The aim of this study was to identify the optimal surgical approach for endoscopic adrenalectomy in patients with pheochromocytoma.
  • METHODS: Over a period of 10 years (February 1994 to June 2004), 38 consecutive patients underwent endoscopic adrenalectomy for pheochromocytoma.
  • CONCLUSION: After adequate preparation, endoscopic adrenalectomy may be performed in patients with pheochromocytoma via both the retroperitoneal and the transperitoneal approaches.
  • [MeSH-major] Adrenal Gland Neoplasms / surgery. Adrenalectomy / methods. Endoscopy / methods. Pheochromocytoma / surgery


59. Park J, Campese V: Clinical characteristics of resistant hypertension: the importance of compliance and the role of diagnostic evaluation in delineating pathogenesis. J Clin Hypertens (Greenwich); 2007 Jan;9(1 Suppl 1):7-12
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Routine laboratory work will reveal chronic kidney disease, which is the most common associated factor in resistant hypertension.
  • Secondary or identifiable causes of resistant hypertension include primary aldosteronism, renovascular disease, and pheochromocytoma.

  • MedlinePlus Health Information. consumer health - High Blood Pressure.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17215649.001).
  • [ISSN] 1524-6175
  • [Journal-full-title] Journal of clinical hypertension (Greenwich, Conn.)
  • [ISO-abbreviation] J Clin Hypertens (Greenwich)
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antihypertensive Agents
  • [Number-of-references] 37
  •  go-up   go-down


60. Andreou AZ, Vanko M, Bezakova L, Feussner I: Properties of a mini 9R-lipoxygenase from Nostoc sp. PCC 7120 and its mutant forms. Phytochemistry; 2008 Jun;69(9):1832-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Properties of a mini 9R-lipoxygenase from Nostoc sp. PCC 7120 and its mutant forms.
  • Lipoxygenases (LOXs) consist of a class of enzymes that catalyze the regio- and stereospecific dioxygenation of polyunsaturated fatty acids.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18439634.001).
  • [ISSN] 0031-9422
  • [Journal-full-title] Phytochemistry
  • [ISO-abbreviation] Phytochemistry
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] EC 1.13.11.12 / Lipoxygenase
  •  go-up   go-down


61. Walker T, Bail DH, Schmid E, Haeberle L, Kuehne H, Ziemer G: Challenging the advanced: cardiac surgery without awareness of a pheochromocytoma. Thorac Cardiovasc Surg; 2006 Oct;54(7):498-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Challenging the advanced: cardiac surgery without awareness of a pheochromocytoma.
  • We report the case of a 75-year-old male patient who underwent bypass surgery.
  • Postoperatively, laboratory findings and diagnostic imaging confirmed the diagnosis made intraoperatively of a pheochromocytoma.
  • Any surgery without awareness of the possibility of a pheochromocytoma will dramatically increase intraoperative and postoperative morbidity and mortality, especially in cardiac surgery.
  • [MeSH-major] Cardiopulmonary Bypass. Coronary Artery Bypass. Coronary Stenosis / complications. Coronary Stenosis / surgery. Hypertension / etiology. Intraoperative Complications. Pheochromocytoma / complications


62. Guest JF, Watson HG, Limaye S: Modeling the cost-effectiveness of prothrombin complex concentrate compared with fresh frozen plasma in emergency warfarin reversal in the United kingdom. Clin Ther; 2010 Dec;32(14):2478-93
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Modeling the cost-effectiveness of prothrombin complex concentrate compared with fresh frozen plasma in emergency warfarin reversal in the United kingdom.
  • Indications for its long-term use include recurrent venous thrombosis, prosthetic heart valves, stroke prevention in atrial fibrillation, valvular heart disease, and prosthetic heart valve replacement.
  • OBJECTIVE: The aim of this study was to estimate the cost-effectiveness of using prothrombin complex concentrate (PCC) compared with fresh frozen plasma (FFP) for emergency warfarin reversal in patients with a life-threatening intracranial, gastrointestinal, or retroperitoneal hemorrhage.
  • Estimates of health care resource use pertaining to managing warfarin-treated patients after a life-threatening hemorrhage were provided by 11 consultant physicians with experience in warfarin reversal.
  • These published clinical outcomes and clinician-derived health care resource use estimates were used to construct a decision model depicting the treatment patterns and associated resource use attributable to current management of a hypothetical cohort of adults undergoing emergency warfarin reversal as a result of an intracranial, gastrointestinal, or retroperitoneal hemorrhage in the United Kingdom.
  • The model only considered direct health care costs borne by the secondary care sector of the National Health Service, and not those borne in the community (with the exception of the cost of stroke rehabilitation) and estimated the cost effectiveness of using PCC compared with FFP to reverse the anticoagulant effects of warfarin, from the perspective of the National Health Service, at 2007-2008 prices.
  • The cost per life-year gained with PCC was estimated to range from £1000 to £2000, depending on hemorrhage type (ie, intracranial, gastrointestinal, or retroperitoneal).
  • The cost per quality-adjusted life-year gained with PCC was estimated at £3000 or less depending on hemorrhage type.
  • CONCLUSION: PCC appeared to be a more cost-effective treatment than FFP for the emergency reversal of warfarin, from the perspective of the UK National Health Service, in this model analysis.
  • [MeSH-major] Anticoagulants / adverse effects. Blood Coagulation Factors / economics. Emergency Medical Services / economics. Models, Economic. Plasma. Warfarin / adverse effects

  • Genetic Alliance. consumer health - Prothrombin.
  • MedlinePlus Health Information. consumer health - Blood Thinners.
  • MedlinePlus Health Information. consumer health - Emergency Medical Services.
  • Hazardous Substances Data Bank. WARFARIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier HS Journals, Inc. All rights reserved.
  • (PMID = 21353116.001).
  • [ISSN] 1879-114X
  • [Journal-full-title] Clinical therapeutics
  • [ISO-abbreviation] Clin Ther
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anticoagulants; 0 / Blood Coagulation Factors; 37224-63-8 / prothrombin complex concentrates; 5Q7ZVV76EI / Warfarin
  •  go-up   go-down


63. BOSANSKA L, PETRAK O, ZELINKA T, MRAZ M, WIDIMSKY J Jr, HALUZIK M: The effect of pheochromocytoma treatment on subclinical inflammation and endocrine function of adipose tissue. Physiol Res; 2009;58(3):319-25
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The effect of pheochromocytoma treatment on subclinical inflammation and endocrine function of adipose tissue.
  • The aim of our study was to evaluate the influence of surgical removal of pheochromocytoma on the endocrine function of adipose tissue and subclinical inflammation as measured by circulating C-reactive protein (CRP) levels.
  • Eighteen patients with newly diagnosed pheochromocytoma were included into study.
  • Anthropometric measures, biochemical parameters, serum CRP, leptin, adiponectin and resistin levels were measured at the time of diagnosis and six months after surgical removal of pheochromocytoma.
  • Surgical removal of pheochromocytoma significantly increased body weight, decreased both systolic and diastolic blood pressure, fasting blood glucose and glycated hemoglobin levels.
  • Serum CRP levels were decreased by 50 % six months after surgical removal of pheochromocytoma (0.49+/-0.12 vs. 0.23+/-0.05 mg/l, p<0.05) despite a significant increase in body weight.
  • We conclude that increased body weight in patients after surgical removal of pheochromocytoma is accompanied by an attenuation of subclinical inflammation probably due to catecholamine normalization.

  • Genetic Alliance. consumer health - Pheochromocytoma.
  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - Pheochromocytoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18637714.001).
  • [ISSN] 0862-8408
  • [Journal-full-title] Physiological research
  • [ISO-abbreviation] Physiol Res
  • [Language] ENG
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Czech Republic
  • [Chemical-registry-number] 0 / ADIPOQ protein, human; 0 / Adiponectin; 0 / Biomarkers; 0 / Leptin; 0 / RETN protein, human; 0 / Resistin; 9007-41-4 / C-Reactive Protein
  •  go-up   go-down


64. Bento A, Vasconcelos J, Jara A: [Pheocromocytoma with negative MIBG]. Rev Port Cardiol; 2010 Jun;29(6):1059-64
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Feocromocitoma com MIBG negative.
  • Pheochomocytomas are catecholamine-releasing tumors derived from chromaffin cells.
  • [MeSH-major] Adrenal Gland Neoplasms / diagnosis. Pheochromocytoma / diagnosis

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - Pheochromocytoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20967963.001).
  • [ISSN] 0870-2551
  • [Journal-full-title] Revista portuguesa de cardiologia : orgão oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology
  • [ISO-abbreviation] Rev Port Cardiol
  • [Language] por
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Portugal
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 35MRW7B4AD / 3-Iodobenzylguanidine
  •  go-up   go-down


65. Summerfield TC, Sherman LA: Global transcriptional response of the alkali-tolerant cyanobacterium Synechocystis sp. strain PCC 6803 to a pH 10 environment. Appl Environ Microbiol; 2008 Sep;74(17):5276-84
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Global transcriptional response of the alkali-tolerant cyanobacterium Synechocystis sp. strain PCC 6803 to a pH 10 environment.
  • Many cyanobacterial strains are able to grow at a pH range from neutral to pH 10 or 11.
  • Such alkaline conditions favor cyanobacterial growth (e.g., bloom formation), and cyanobacteria must have developed strategies to adjust to changes in CO2 concentration and ion availability.
  • Synechocystis sp. strain PCC 6803 exhibits similar photoautotrophic growth characteristics at pH 10 and pH 7.5, and we examined global gene expression following transfer from pH 7.5 to pH 10 to determine cellular adaptations at an elevated pH.
  • The strategies used to develop homeostasis at alkaline pH had elements similar to those of many bacteria, as well as components unique to phototrophic microbes.
  • In addition, upregulated genes encoded transporters with the potential to contribute to osmotic, pH, and ion homeostasis (e.g., a water channel protein, a large-conductance mechanosensitive channel, a putative anion efflux transporter, a hexose/proton symporter, and ABC transporters of unidentified substrates).
  • The pH transition altered the CO2/HCO3(-) ratio within the cell, and the upregulation of three inducible bicarbonate transporters (BCT1, SbtA, and NDH-1S) likely reflected a response to this perturbed ratio.
  • Interestingly, the transition to pH 10 resulted in increased abundance of transcripts of photosystem II genes encoding extrinsic and low-molecular-weight polypeptides, although there was little change in photosystem I gene transcripts.
  • [MeSH-minor] Gene Expression Profiling. Gene Expression Regulation, Bacterial. Genes, Bacterial. Hydrogen-Ion Concentration. Oligonucleotide Array Sequence Analysis. Photosynthesis / genetics. Photosystem I Protein Complex / genetics. RNA, Bacterial / genetics

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Microbiol. 2002 Feb;43(4):843-53 [12085767.001]
  • [Cites] J Bacteriol. 1999 Apr;181(8):2394-402 [10198001.001]
  • [Cites] Gene. 2002 Sep 4;297(1-2):11-9 [12384281.001]
  • [Cites] Microbiology. 2003 May;149(Pt 5):1147-53 [12724376.001]
  • [Cites] Plant Cell. 2004 Dec;16(12):3326-40 [15548742.001]
  • [Cites] J Biol Chem. 2004 Dec 17;279(51):53078-86 [15471853.001]
  • [Cites] Biochemistry. 2005 Jan 18;44(2):805-15 [15641809.001]
  • [Cites] Microbiology. 2005 Feb;151(Pt 2):447-55 [15699194.001]
  • [Cites] J Bacteriol. 2005 Apr;187(7):2368-76 [15774880.001]
  • [Cites] Microbiology. 2005 May;151(Pt 5):1671-82 [15870474.001]
  • [Cites] J Biol Chem. 2005 Jun 3;280(22):21531-8 [15805106.001]
  • [Cites] Plant Cell. 2005 Oct;17(10):2768-81 [16155179.001]
  • [Cites] Biochim Biophys Acta. 2005 Nov 30;1717(2):67-88 [16277975.001]
  • [Cites] J Bacteriol. 2006 Apr;188(7):2355-63 [16547021.001]
  • [Cites] Biochem J. 2006 Jun 1;396(2):215-8 [16573521.001]
  • [Cites] Plant Cell Physiol. 2006 Jun;47(6):799-804 [16621843.001]
  • [Cites] FEBS J. 2006 Oct;273(19):4516-27 [16972939.001]
  • [Cites] Arch Microbiol. 2006 Oct;186(4):273-86 [16868740.001]
  • [Cites] Plant J. 2007 Jan;49(2):313-24 [17181779.001]
  • [Cites] Arch Microbiol. 2007 Apr;187(4):265-79 [17160677.001]
  • [Cites] FEMS Microbiol Ecol. 2007 Mar;59(3):638-50 [17381519.001]
  • [Cites] Crit Rev Microbiol. 2007;33(3):183-209 [17653987.001]
  • [Cites] J Bacteriol. 2007 Nov;189(21):7829-40 [17720783.001]
  • [Cites] Int J Biochem Cell Biol. 2008;40(2):164-9 [17350877.001]
  • [Cites] Photosynth Res. 2007 Nov-Dec;94(2-3):265-74 [17990072.001]
  • [Cites] J Bacteriol. 2000 Mar;182(5):1191-9 [10671437.001]
  • [Cites] Mol Microbiol. 2000 Aug;37(4):828-38 [10972805.001]
  • [Cites] J Biol Chem. 2000 Oct 13;275(41):31630-4 [10906128.001]
  • [Cites] J Bacteriol. 2001 Feb;183(4):1376-84 [11157951.001]
  • [Cites] J Biol Chem. 2001 Jun 29;276(26):23450-5 [11297562.001]
  • [Cites] Mol Microbiol. 2002 Jun;44(6):1493-506 [12067339.001]
  • [Cites] Plant Cell Physiol. 2008 Jan;49(1):11-8 [18003670.001]
  • [Cites] Physiol Plant. 2007 Sep;131(1):22-32 [18251921.001]
  • [Cites] FEBS Lett. 2003 May 22;543(1-3):148-53 [12753923.001]
  • [Cites] BMC Genomics. 2003 Jun 12;4(1):23 [12803655.001]
  • [Cites] Plant Physiol. 2003 Aug;132(4):1825-39 [12913140.001]
  • [Cites] FEMS Microbiol Lett. 2003 Oct 24;227(2):255-62 [14592717.001]
  • [Cites] J Biol Chem. 2004 Feb 13;279(7):5739-51 [14612435.001]
  • [Cites] Biochim Biophys Acta. 2004 Feb 15;1608(2-3):75-96 [14871485.001]
  • [Cites] Extremophiles. 2004 Apr;8(2):109-15 [15064977.001]
  • [Cites] J Bacteriol. 2004 Jun;186(11):3331-45 [15150218.001]
  • [Cites] Science. 1973 Jan 26;179(4071):382-4 [4630211.001]
  • [Cites] J Bacteriol. 1986 May;166(2):693-6 [3084453.001]
  • [Cites] Methods Enzymol. 1988;167:677-85 [2853286.001]
  • [Cites] Biotechniques. 1990 Mar;8(3):250-1 [1691916.001]
  • [Cites] DNA Res. 1996 Jun 30;3(3):109-36 [8905231.001]
  • [Cites] J Bacteriol. 1997 Jul;179(13):4319-27 [9209050.001]
  • [Cites] Plant Mol Biol. 1998 May;37(2):205-15 [9617794.001]
  • [Cites] Mol Microbiol. 1998 May;28(4):813-21 [9643548.001]
  • [Cites] J Bacteriol. 1998 Dec;180(24):6642-8 [9852009.001]
  • [Cites] J Bacteriol. 2002 Aug;184(15):4246-58 [12107143.001]
  • (PMID = 18606800.001).
  • [ISSN] 1098-5336
  • [Journal-full-title] Applied and environmental microbiology
  • [ISO-abbreviation] Appl. Environ. Microbiol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Photosystem I Protein Complex; 0 / RNA, Bacterial
  • [Other-IDs] NLM/ PMC2546634
  •  go-up   go-down


66. Biswas A, Vasquez YM, Dragomani TM, Kronfel ML, Williams SR, Alvey RM, Bryant DA, Schluchter WM: Biosynthesis of cyanobacterial phycobiliproteins in Escherichia coli: chromophorylation efficiency and specificity of all bilin lyases from Synechococcus sp. strain PCC 7002. Appl Environ Microbiol; 2010 May;76(9):2729-39
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Biosynthesis of cyanobacterial phycobiliproteins in Escherichia coli: chromophorylation efficiency and specificity of all bilin lyases from Synechococcus sp. strain PCC 7002.
  • A multiplasmid coexpression system was used to recreate the biosynthetic pathway for phycobiliproteins from the cyanobacterium Synechococcus sp. strain PCC 7002 in Escherichia coli.
  • This system efficiently produced chromophorylated allophycocyanin (ApcA/ApcB) and alpha-phycocyanin with holoprotein yields ranging from 3 to 12 mg liter(-1) of culture.
  • The N-terminal, allophycocyanin-like domain of ApcE (L(CM)(99)) was produced in soluble form and was shown to have intrinsic bilin lyase activity.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biol Chem. 1987 Dec 25;262(36):17350-5 [2447072.001]
  • [Cites] Biochim Biophys Acta. 2009 Sep;1787(9):1122-8 [19397890.001]
  • [Cites] Biochemistry. 2000 Nov 7;39(44):13487-95 [11063585.001]
  • [Cites] Plant Cell. 2001 Apr;13(4):965-78 [11283349.001]
  • [Cites] Biochim Biophys Acta. 2001 Jun 1;1505(2-3):248-57 [11334789.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10560-5 [11553806.001]
  • [Cites] Biochemistry. 2001 Oct 16;40(41):12444-56 [11591166.001]
  • [Cites] Trends Plant Sci. 2002 Aug;7(8):357-66 [12167331.001]
  • [Cites] J Bacteriol. 2002 Sep;184(17):4666-71 [12169589.001]
  • [Cites] J Biol Chem. 2003 Mar 14;278(11):9219-26 [12514179.001]
  • [Cites] Biochim Biophys Acta. 2004 Jul 9;1657(2-3):131-45 [15238270.001]
  • [Cites] FEBS Lett. 2004 Aug 27;573(1-3):1-5 [15327965.001]
  • [Cites] FEBS Lett. 1974 Nov 15;48(2):209-13 [4215676.001]
  • [Cites] Arch Microbiol. 1975 Jun 20;104(1):15-22 [808186.001]
  • [Cites] Biochem J. 1979 Apr 1;179(1):1-6 [475748.001]
  • [Cites] Biochem J. 1979 Sep 1;181(3):577-83 [117797.001]
  • [Cites] Arch Biochem Biophys. 1981 Apr 15;208(1):42-8 [7259188.001]
  • [Cites] J Biol Chem. 1981 Dec 10;256(23):12600-6 [6795210.001]
  • [Cites] J Mol Biol. 1986 Apr 20;188(4):651-76 [3090271.001]
  • [Cites] Anal Biochem. 1986 Jul;156(1):194-201 [3526971.001]
  • [Cites] J Biol Chem. 1986 Dec 5;261(34):15891-4 [3782095.001]
  • [Cites] Biol Chem Hoppe Seyler. 1987 Apr;368(4):353-67 [3111493.001]
  • [Cites] J Biol Chem. 1988 Dec 5;263(34):18343-9 [3142876.001]
  • [Cites] J Biol Chem. 1988 Dec 5;263(34):18350-7 [3192538.001]
  • [Cites] J Biol Chem. 1989 Jan 5;264(1):1-4 [2491842.001]
  • [Cites] Methods Enzymol. 1988;167:291-303 [3148835.001]
  • [Cites] Biochim Biophys Acta. 1989 Oct 26;977(1):40-51 [2508754.001]
  • [Cites] J Biol Chem. 1989 Oct 25;264(30):17860-7 [2808356.001]
  • [Cites] J Mol Biol. 1990 Aug 5;214(3):787-96 [2117667.001]
  • [Cites] J Biol Chem. 1991 Apr 15;266(11):7239-47 [1901865.001]
  • [Cites] J Biol Chem. 1992 Aug 15;267(23):16138-45 [1644801.001]
  • [Cites] J Biol Chem. 1992 Aug 15;267(23):16146-54 [1644802.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):7017-21 [1495995.001]
  • [Cites] J Biol Chem. 1994 Mar 25;269(12):8686-94 [8132596.001]
  • [Cites] Eur J Biochem. 1994 Apr 1;221(1):563-80 [8168545.001]
  • [Cites] Biochim Biophys Acta. 1994 Jul 29;1186(3):153-62 [8043589.001]
  • [Cites] Plant Mol Biol. 1994 Oct;26(1):313-26 [7524727.001]
  • [Cites] J Biol Chem. 1994 Nov 18;269(46):28988-96 [7961862.001]
  • [Cites] J Mol Biol. 1995 Jun 2;249(2):424-40 [7783202.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):8989-94 [8799141.001]
  • [Cites] J Bacteriol. 1997 Feb;179(4):998-1006 [9023176.001]
  • [Cites] Plant Mol Biol. 1998 Jun;37(3):577-80 [9617824.001]
  • [Cites] Plant J. 1998 Jul;15(1):99-107 [9744099.001]
  • [Cites] Eur J Biochem. 1998 Oct 1;257(1):154-9 [9799114.001]
  • [Cites] Biochim Biophys Acta. 2005 Jan 7;1706(1-2):81-7 [15620367.001]
  • [Cites] J Biol Chem. 2006 Mar 31;281(13):8573-81 [16452471.001]
  • [Cites] Biochemistry. 2006 Jun 13;45(23):7092-9 [16752899.001]
  • [Cites] J Biol Chem. 2006 Jun 30;281(26):17768-78 [16644722.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Sep 4;104(36):14300-5 [17726096.001]
  • [Cites] J Biol Chem. 2007 Nov 23;282(47):34093-103 [17895251.001]
  • [Cites] Photosynth Res. 2008 Feb-Mar;95(2-3):163-8 [17912606.001]
  • [Cites] Genome Biol. 2007;8(12):R259 [18062815.001]
  • [Cites] J Biol Chem. 2008 Mar 21;283(12):7513-22 [18199753.001]
  • [Cites] J Biol Chem. 2008 Mar 21;283(12):7503-12 [18199754.001]
  • [Cites] Mol Microbiol. 2008 Apr;68(2):263-76 [18284595.001]
  • [Cites] Biotechnol Lett. 2008 Jun;30(6):1001-4 [18224279.001]
  • [Cites] BMC Plant Biol. 2008;8:56 [18485196.001]
  • [Cites] Biochemistry. 2008 Jul 8;47(27):7304-16 [18549244.001]
  • [Cites] J Biol Chem. 2008 Jul 11;283(28):19293-300 [18482977.001]
  • [Cites] J Bacteriol. 2008 Jul;190(14):4808-17 [18469097.001]
  • [Cites] Biotechnol Appl Biochem. 2009 Feb;52(Pt 2):135-40 [18547168.001]
  • [Cites] J Biosci Bioeng. 2009 Mar;107(3):246-9 [19269586.001]
  • [Cites] J Biol Chem. 2009 Apr 3;284(14):9290-8 [19182270.001]
  • [Cites] FEBS Lett. 2000 Mar 3;469(1):9-13 [10708746.001]
  • (PMID = 20228104.001).
  • [ISSN] 1098-5336
  • [Journal-full-title] Applied and environmental microbiology
  • [ISO-abbreviation] Appl. Environ. Microbiol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Bacterial Proteins; 0 / Phycobilins; 0 / Phycobiliproteins; 0 / allophycocyanin; 11016-15-2 / Phycocyanin; 20298-86-6 / phycocyanobilin; EC 1.- / Oxidoreductases; EC 1.- / phycocyanobilin ferredoxin oxidoreductase, Synechocystis; EC 4.- / Lyases
  • [Other-IDs] NLM/ PMC2863458
  •  go-up   go-down


67. Komorowski J, Jurczynska J, Stepien T, Kolomecki K, Kuzdak K, Stepien H: Serum concentrations of TNF α and its soluble receptors in patients with adrenal tumors treated by surgery. Int J Mol Sci; 2010;11(6):2281-90
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Serum concentrations of TNF α and its soluble receptors in patients with adrenal tumors treated by surgery.
  • The peripheral blood levels of TNF alpha and its soluble receptors were studied in 39 patients with malignant and benign adrenal tumors treated by adrenalectomy.
  • The concentrations of TNF alpha were significantly elevated in patients with malignant tumors of the adrenal cortex and in patients with Conn's syndrome compared to control.
  • In patients with non-functioning adenomas and pheochromocytomas, TNF alpha levels were similar to those detected in the control.
  • In subjects with myelolipomas, the serum concentration of TNF alpha was lower compared to the control.
  • After adrenalectomy, the levels of TNF alpha were decreased in patients with malignant tumors and in patients with Conn's syndrome, nonfunctioniong adenomas and pheochromocytomas compared to the concentration before surgery.
  • The serum concentrations of soluble receptors of TNF alpha did not differ among different patient groups and compared to the control.
  • After adrenalectomy, the blood concentrations of TNF alpha R1 and TNF alpha R2 were decreased in patients with Conn's syndrome.
  • However, to confirm practicality of the evaluation of TNF alpha and its soluble receptors in differential diagnosis in patients with adrenal tumors, a larger study group is needed.
  • [MeSH-major] Adrenal Gland Neoplasms / blood. Adrenal Gland Neoplasms / surgery. Receptors, Tumor Necrosis Factor / blood. Tumor Necrosis Factor-alpha / blood
  • [MeSH-minor] Adrenalectomy. Adult. Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged. Receptors, Tumor Necrosis Factor, Type I / blood. Receptors, Tumor Necrosis Factor, Type II / blood

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Gen Comp Endocrinol. 2000 May;118(2):249-61 [10890565.001]
  • [Cites] Immunol Today. 2000 Mar;21(3):110-3 [10689296.001]
  • [Cites] Br J Pharmacol. 2002 Feb;135(4):855-75 [11861313.001]
  • [Cites] Cell Signal. 2002 Jun;14(6):477-92 [11897488.001]
  • [Cites] Biochem Biophys Res Commun. 1987 Mar 30;143(3):997-1004 [2436621.001]
  • [Cites] Nature. 1987 Oct 15-21;329(6140):630-2 [2443857.001]
  • [Cites] Science. 1990 May 25;248(4958):1019-23 [2160731.001]
  • [Cites] Leukemia. 1991 Jan;5(1):32-5 [1999955.001]
  • [Cites] Immunol Today. 1991 May;12(5):141-2 [1652255.001]
  • [Cites] Cytokine. 1990 Jul;2(4):231-7 [1966549.001]
  • [Cites] J Exp Med. 1992 Feb 1;175(2):323-9 [1310100.001]
  • [Cites] J Reprod Immunol. 1992 Aug;22(2):105-16 [1323674.001]
  • [Cites] Hepatology. 1992 Sep;16(3):749-55 [1324217.001]
  • [Cites] Clin Exp Immunol. 1992 Sep;89(3):351-5 [1325303.001]
  • [Cites] Tidsskr Nor Laegeforen. 1992 Nov 20;112(28):3545-7 [1334285.001]
  • [Cites] Oncology. 1994 Mar-Apr;51(2):142-53 [8196898.001]
  • [Cites] J Clin Endocrinol Metab. 1994 Nov;79(5):1492-7 [7962348.001]
  • [Cites] Annu Rev Immunol. 1995;13:307-38 [7612226.001]
  • [Cites] Melanoma Res. 1995 Aug;5(4):235-42 [7496158.001]
  • [Cites] J Clin Endocrinol Metab. 1996 Feb;81(2):807-13 [8636308.001]
  • [Cites] J Exp Med. 1996 Oct 1;184(4):1397-411 [8879212.001]
  • [Cites] Endocr Res. 1996 Nov;22(4):867-73 [8969952.001]
  • [Cites] J Drug Target. 1998;5(6):403-13 [9783674.001]
  • [Cites] Clin Cancer Res. 1997 Dec;3(12 Pt 1):2451-8 [9815646.001]
  • [Cites] Curr Opin Immunol. 1999 Jun;11(3):340-5 [10465590.001]
  • [Cites] Endokrynol Pol. 2006 Nov-Dec;57(6):633-40 [17253437.001]
  • [Cites] Clin Cancer Res. 2007 Apr 15;13(8):2422-8 [17438101.001]
  • [Cites] Front Biosci. 2008;13:2774-83 [17981752.001]
  • [Cites] J Immunol. 2008 Oct 1;181(7):4461-70 [18802049.001]
  • [Cites] Biochem Biophys Res Commun. 2008 Nov 28;376(4):748-52 [18814840.001]
  • [Cites] Neoplasma. 2009;56(1):56-62 [19152246.001]
  • [Cites] Endokrynol Pol. 2009 Jan-Feb;60(1):9-13 [19224499.001]
  • [Cites] Infect Immun. 2001 Nov;69(11):6881-6 [11598062.001]
  • (PMID = 20640152.001).
  • [ISSN] 1422-0067
  • [Journal-full-title] International journal of molecular sciences
  • [ISO-abbreviation] Int J Mol Sci
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Receptors, Tumor Necrosis Factor; 0 / Receptors, Tumor Necrosis Factor, Type I; 0 / Receptors, Tumor Necrosis Factor, Type II; 0 / Tumor Necrosis Factor-alpha
  • [Other-IDs] NLM/ PMC2904916
  • [Keywords] NOTNLM ; TNF α / TNF α R1 / TNF α R2 / adrenal tumors / adrenalectomy
  • [General-notes] NLM/ Original DateCompleted: 20110714
  •  go-up   go-down


68. Davidson DF: Elevated urinary dopamine in adults and children. Ann Clin Biochem; 2005 May;42(Pt 3):200-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Information on the significance of an elevated urinary dopamine is limited and can lead to misinterpretation of the cause of such a finding.
  • METHODS: The urine catecholamine and metabolite results of specimens (analysed by HPLC-ECD) from 5933 adults and 467 children were examined retrospectively over a 57-month period.
  • Those with elevated dopamine were identified and the explanation for this finding was sought.
  • RESULTS: In adults, the conditions associated with an elevated dopamine were: urine over-collection; drug effects (including those due to intravenous dopamine, L-dopa, methyldopa, clozapine, antidepressants and metoclopramide); clinical effects (including those due to phaeochromocytoma, carcinoid tumour and pregnancy).
  • In children, high urine dopamine was found in cases of neuroblastoma, Costello syndrome, leukaemia, phaeochromocytoma, Menkes disease and rhabdomyosarcoma of the bladder.
  • It was most commonly associated with: over-collection, probable drug effects and neural crest tumours.
  • [MeSH-minor] Adrenal Gland Neoplasms / urine. Adult. Antidepressive Agents / therapeutic use. Catecholamines / urine. Child. Dihydroxyphenylalanine / therapeutic use. Female. Humans. Leukemia / urine. Male. Neuroblastoma / urine. Pheochromocytoma / urine. Pregnancy. Reference Values. Retrospective Studies. Specimen Handling / methods

  • Hazardous Substances Data Bank. DOPAMINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15949155.001).
  • [ISSN] 0004-5632
  • [Journal-full-title] Annals of clinical biochemistry
  • [ISO-abbreviation] Ann. Clin. Biochem.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antidepressive Agents; 0 / Catecholamines; 63-84-3 / Dihydroxyphenylalanine; VTD58H1Z2X / Dopamine
  •  go-up   go-down


69. Miller C, Elkas JC: Conservative management of extra-adrenal pheochromocytoma during pregnancy. Obstet Gynecol; 2005 Oct;106(4):868
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Conservative management of extra-adrenal pheochromocytoma during pregnancy.
  • [MeSH-major] Adrenal Gland Neoplasms / therapy. Pheochromocytoma / therapy. Pregnancy Complications, Neoplastic / therapy


70. Fung MM, Viveros OH, O'Connor DT: Diseases of the adrenal medulla. Acta Physiol (Oxf); 2008 Feb;192(2):325-35
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diseases of the adrenal medulla.
  • The adrenal glands are vital in the organism's response to environmental stress.
  • It co-releases catecholamines (primarily adrenaline and to some extent noradrenaline) as well as peptides by the all-or-none process of exocytosis from chromaffin granules, to aid in blood pressure and blood flow regulation, with regulated increments during the activation of the sympathetic nervous system.
  • The co-released peptides function to regulate catecholamine release, blood vessel contraction and innate immune responses.
  • Pathology within the adrenal medulla and the autonomic nervous system is primarily because of neoplasms.
  • The most common tumour, called phaeochromocytoma when located in the adrenal medulla, originates from chromaffin cells and excretes catecholamines, but may be referred to as secreting paragangliomas when found in extra-adrenal chromaffin cells.
  • We will also briefly discuss the catecholamine deficiency state.

  • Genetic Alliance. consumer health - Adrenal Diseases.
  • MedlinePlus Health Information. consumer health - Adrenal Gland Disorders.
  • MedlinePlus Health Information. consumer health - Autonomic Nervous System Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Lab Med. 2004 Mar;24(1):85-103 [15157558.001]
  • [Cites] J Clin Endocrinol Metab. 2003 Sep;88(9):4083-7 [12970267.001]
  • [Cites] JAMA. 1983 Jan 21;249(3):383-5 [6848829.001]
  • [Cites] J Clin Endocrinol Metab. 1983 Mar;56(3):582-5 [6822655.001]
  • [Cites] Regul Pept. 1983 May;6(2):111-9 [6878752.001]
  • [Cites] J Hypertens. 1988 Mar;6(3):187-98 [3361117.001]
  • [Cites] Kidney Int. 1990 Mar;37(3):955-64 [2313983.001]
  • [Cites] J Clin Invest. 1990 May;85(5):1555-9 [2332506.001]
  • [Cites] J Clin Endocrinol Metab. 2006 Mar;91(3):827-36 [16317055.001]
  • [Cites] N Engl J Med. 1981 Sep 10;305(11):623-6 [7266587.001]
  • [Cites] N Engl J Med. 2003 Mar 20;348(12):1134-49 [12646671.001]
  • [Cites] J Clin Endocrinol Metab. 2003 Feb;88(2):553-8 [12574179.001]
  • [Cites] Circulation. 2002 May 28;105(21):2518-23 [12034659.001]
  • [Cites] N Engl J Med. 2002 May 9;346(19):1459-66 [12000816.001]
  • [Cites] JAMA. 2002 Mar 20;287(11):1427-34 [11903030.001]
  • [Cites] Am J Med Genet. 2002 Mar 1;108(2):140-7 [11857564.001]
  • [Cites] J Clin Endocrinol Metab. 2001 Nov;86(11):5210-6 [11701678.001]
  • [Cites] Cancer. 2001 May 15;91(10):1905-13 [11346873.001]
  • [Cites] Hypertension. 2000 Dec;36(6):1045-52 [11116123.001]
  • [Cites] J Clin Endocrinol Metab. 2007 Apr;92(4):1217-25 [17284633.001]
  • [Cites] Ann N Y Acad Sci. 2006 Aug;1073:149-55 [17102081.001]
  • [Cites] Clin Endocrinol (Oxf). 2006 Dec;65(6):699-705 [17121518.001]
  • [Cites] Endocrinol Metab Clin North Am. 2006 Dec;35(4):699-724, viii [17127142.001]
  • [Cites] Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):92-102 [17237836.001]
  • [Cites] J Clin Endocrinol Metab. 2007 Apr;92(4):1245-8 [17227803.001]
  • [Cites] Medicine (Baltimore). 1991 Jan;70(1):33-45 [1988765.001]
  • [Cites] Am J Hypertens. 1995 Jun;8(6):651-5 [7662252.001]
  • [Cites] Cancer Cell. 2005 Aug;8(2):91-3 [16098460.001]
  • [Cites] JAMA. 2005 Oct 26;294(16):2057-63 [16249420.001]
  • [Cites] Am J Surg Pathol. 2006 Feb;30(2):268-73 [16434904.001]
  • [Cites] J Hypertens. 2006 Dec;24(12):2331-9 [17082709.001]
  • [Cites] Am J Med. 1990 Jun;88(6):607-13 [2189303.001]
  • (PMID = 18021328.001).
  • [ISSN] 1748-1716
  • [Journal-full-title] Acta physiologica (Oxford, England)
  • [ISO-abbreviation] Acta Physiol (Oxf)
  • [Language] ENG
  • [Grant] United States / NHLBI NIH HHS / HL / HL058120-090004; United States / NIDDK NIH HHS / DK / DK060702-05; United States / NHLBI NIH HHS / HL / HL058120-099006; United States / NIDDK NIH HHS / DK / R01 DK060702-05; United States / NHLBI NIH HHS / HL / HL058120-09; United States / NHLBI NIH HHS / HL / P01 HL058120-09; United States / NHLBI NIH HHS / HL / P01 HL058120-099006; United States / NIDDK NIH HHS / DK / R01 DK060702; United States / NHLBI NIH HHS / HL / P01 HL058120; United States / NHLBI NIH HHS / HL / P01 HL058120-090004
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Catecholamines
  • [Number-of-references] 33
  • [Other-IDs] NLM/ NIHMS57919; NLM/ PMC2576282
  •  go-up   go-down


71. Ferrier N, Bitar G, Marcaggi X, Amat G: [The "tako-tsubo" syndrome: report of two cases]. Ann Cardiol Angeiol (Paris); 2007 Apr;56(2):97-103
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [The "tako-tsubo" syndrome: report of two cases].
  • [Transliterated title] Le syndrome de "tako-tsubo": à propos de deux cas.
  • The "tako-tsubo" syndrome, initially described by Japanese authors is an apical akinesis of the left ventricule without significant coronary artery disease, with a moderate elevation of troponine I.
  • They were refered for suspected acute coronary syndrome including on admission chest pain and ST segment elevation.
  • In the two cases, we didn't find arguments for myocarditis, recanalized thrombosis, coronary spasm, pheochromocytomas, but a risk factor is inboth: emotional stress.
  • Maybe the diagnosis could be easier with the submillimeter cardiac computed tomography.
  • [MeSH-major] Cardiomyopathies / diagnosis. Ventricular Dysfunction, Left / diagnosis

  • MedlinePlus Health Information. consumer health - Cardiomyopathy.
  • Hazardous Substances Data Bank. ACETYLSALICYLIC ACID .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17484095.001).
  • [ISSN] 0003-3928
  • [Journal-full-title] Annales de cardiologie et d'angéiologie
  • [ISO-abbreviation] Ann Cardiol Angeiol (Paris)
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Adrenergic beta-Antagonists; 0 / Hydroxymethylglutaryl-CoA Reductase Inhibitors; 0 / Platelet Aggregation Inhibitors; R16CO5Y76E / Aspirin
  •  go-up   go-down


72. Ito Y, Shimazawa M, Akao Y, Nakajima Y, Seki N, Nozawa Y, Hara H: Lig-8, a bioactive lignophenol derivative from bamboo lignin, protects against neuronal damage in vitro and in vivo. J Pharmacol Sci; 2006 Oct;102(2):196-204
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In pheochromocytoma (PC12) cell cultures, lig-8 (1 to 30 microM) concentration-dependently inhibited OGD- and tunicamycin (2 microg/ml)-induced cell deaths (significant at >/=3 microM and >/=1 microM, respectively).
  • In human neuroblastoma (SH-SY5Y) cell culture, the PSI-induced apoptotic cell death and fusion protein accumulation (revealing reduced proteasome activity) was inhibited by lig-8 (30 microM).
  • [MeSH-minor] Animals. Cell Culture Techniques. Dose-Response Relationship, Drug. Green Fluorescent Proteins / analysis. Humans. Male. Mice. Mice, Inbred Strains. PC12 Cells. Proteasome Inhibitors. Rats. Retinal Ganglion Cells / drug effects. Retinal Ganglion Cells / pathology. Tunicamycin / pharmacology

  • MedlinePlus Health Information. consumer health - Retinal Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17031070.001).
  • [ISSN] 1347-8613
  • [Journal-full-title] Journal of pharmacological sciences
  • [ISO-abbreviation] J. Pharmacol. Sci.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Lig-8 compound; 0 / Neuroprotective Agents; 0 / Proteasome Inhibitors; 11089-65-9 / Tunicamycin; 147336-22-9 / Green Fluorescent Proteins; 9005-53-2 / Lignin
  •  go-up   go-down


73. Ionescu D, Voss B, Oren A, Hess WR, Muro-Pastor AM: Heterocyst-specific transcription of NsiR1, a non-coding RNA encoded in a tandem array of direct repeats in cyanobacteria. J Mol Biol; 2010 Apr 30;398(2):177-88
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the context of a genome-wide search for potential non-coding RNAs, we identified an array of 12 tandem repeats that is transcribed in large amounts when cells enter conditions that trigger cell differentiation and switch to nitrogen fixation.
  • PCC 7120, it is about 60 nt in length, has a very distinct predicted secondary structure, and is expressed very early and transiently after nitrogen step-down.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2010 Elsevier Ltd. All rights reserved.
  • (PMID = 20227418.001).
  • [ISSN] 1089-8638
  • [Journal-full-title] Journal of molecular biology
  • [ISO-abbreviation] J. Mol. Biol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / RNA, Bacterial; 0 / RNA, Untranslated; 0 / Rho Factor; 147336-22-9 / Green Fluorescent Proteins
  •  go-up   go-down


74. Rodea-Palomares I, González-García C, Leganés F, Fernández-Piñas F: Effect of pH, EDTA, and anions on heavy metal toxicity toward a bioluminescent cyanobacterial bioreporter. Arch Environ Contam Toxicol; 2009 Oct;57(3):477-87
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effect of pH, EDTA, and anions on heavy metal toxicity toward a bioluminescent cyanobacterial bioreporter.
  • The bioavailability and therefore toxicity of a metal depends on the chemical species present in a particular environment.
  • We evaluated the effect of a series of factors that could potentially modify metal speciation on the toxicity of Hg, Cu, Zn, and Cd toward a recombinant strain of the freshwater cyanobacterium Anabaena sp.
  • PCC 7120 with cloned lux operon of luminescent terrestrial bacterium Photorhabdus luminescens.
  • The tested factors were pH, EDTA (as organic ligand), and anions PO(4)(3-), CO(3)(2-), and Cl(-).
  • In general, metal toxicity significantly correlated to the predicted metal free-ion concentration, although Zn-EDTA complexes and certain Hg chloro-complexes could also exhibit some toxicity to cyanobacteria.
  • The combination of toxicity studies that take into account a range of factors that might modulate metal toxicity with chemical modeling to predict changes in metal speciation might be useful for interpreting complex toxicity data.
  • Finally, this cyanobacterial bioreporter, due to its ecological relevance as a primary producer, could be used as a tool for toxicity assessment in freshwater environments.
  • [MeSH-minor] Anions / pharmacology. Biological Availability. Carbonates / pharmacology. Chlorides / pharmacology. Dose-Response Relationship, Drug. Edetic Acid / pharmacology. Hydrogen-Ion Concentration. Luciferases, Bacterial / genetics. Luminescent Measurements. Models, Chemical. Phosphates / pharmacology. Photorhabdus / enzymology. Photorhabdus / genetics

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. Disodium EDTA .
  • Hazardous Substances Data Bank. ETHYLENEDIAMINE TETRAACETIC ACID .
  • Hazardous Substances Data Bank. DISODIUM CALCIUM EDTA .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19169738.001).
  • [ISSN] 1432-0703
  • [Journal-full-title] Archives of environmental contamination and toxicology
  • [ISO-abbreviation] Arch. Environ. Contam. Toxicol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anions; 0 / Carbonates; 0 / Chlorides; 0 / Metals, Heavy; 0 / Phosphates; 0 / Water Pollutants, Chemical; 9G34HU7RV0 / Edetic Acid; EC 1.14.14.3 / Luciferases, Bacterial
  •  go-up   go-down


75. Buscombe JR, Cwikla JB, Caplin ME, Hilson AJ: Long-term efficacy of low activity meta-[131I]iodobenzylguanidine therapy in patients with disseminated neuroendocrine tumours depends on initial response. Nucl Med Commun; 2005 Nov;26(11):969-76
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In many centres financial or radiation protection constraints mean that lower activities of 131I-MIBG have to be used at each administration, therefore instead of giving a single administration of a higher activity 131I-MIBG a series of multiple lower activity administrations are used.
  • Most of patients had carcinoid (17), two had phaeochromocytoma, two gastrinoma and two an undifferentiated NET, one had malignant paraganglioma and one had medullary cell carcinoma of the thyroid.
  • Response to therapy was determined by changes in the size of the tumour on computed tomography and/or magnetic resonance imaging using the response evaluation criteria in solid tumours (RECIST).
  • The median time from the last treatment to progression of disease and death (if applicable) was also calculated.
  • At 18 months after the patient's last treatment, only seven patients (28%) had no progression of their disease.
  • In those with progression of disease at 6 months, at the 6-month assessment point, there had been four deaths (16%), at 12 months, there were three additional cancer deaths and finally at 18 months, there were a further five deaths.
  • In those patients who died the mean time interval between disease progression and death was 4.6 months (range 0-12 months).
  • In these patients with progressive and extensive disease this technique provided prolonged progression-free and overall survival with minimal side effects especially if an initial response to treatment was seen.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16208174.001).
  • [ISSN] 0143-3636
  • [Journal-full-title] Nuclear medicine communications
  • [ISO-abbreviation] Nucl Med Commun
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 35MRW7B4AD / 3-Iodobenzylguanidine
  •  go-up   go-down


76. Ceyhan GO, Demir IE, Altintas B, Rauch U, Thiel G, Müller MW, Giese NA, Friess H, Schäfer KH: Neural invasion in pancreatic cancer: a mutual tropism between neurons and cancer cells. Biochem Biophys Res Commun; 2008 Sep 26;374(3):442-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Neural invasion by pancreatic cancer cells (PCC) worsens the prognosis and frequently limits curative resection.
  • We established a novel in-vitro model in which T3M4-PCCs were co-cultured with either isolated myenteric plexus cells (MP) or dorsal root ganglia (DRG) of newborn rats within a three-dimensional extracellular matrix gel.
  • The close vicinity of MP or DRG to T3M4-PCCs induced early morphologic changes on T3M4-PCCs at the migration front prior to the migration process with elongated and neurite-targeting PCCs, compared to round and non-grouping at the non-migrating front.
  • T3M4-PCCs built cancer-cell clusters around the DRG or MP, a process which was accelerated by increasing number of T3M4-PCCs or neurons.
  • These findings indicate that neuro-cancer interactions start prior to PCC migration and induce evident changes in cancer and nerve biology.
  • These findings can be reproduced within the introduced 3D in-vitro migration assay which allows investigation in the early pathogenesis of neural PCC invasion.
  • [MeSH-minor] Animals. Cell Line, Tumor. Coculture Techniques. Ganglia, Spinal / pathology. Glial Cell Line-Derived Neurotrophic Factor. Humans. Myenteric Plexus / pathology. Neoplasm Invasiveness. Nerve Growth Factor / pharmacology. Rats. Rats, Sprague-Dawley. Tropism

  • Genetic Alliance. consumer health - Pancreatic cancer.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18640096.001).
  • [ISSN] 1090-2104
  • [Journal-full-title] Biochemical and biophysical research communications
  • [ISO-abbreviation] Biochem. Biophys. Res. Commun.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Glial Cell Line-Derived Neurotrophic Factor; 9061-61-4 / Nerve Growth Factor
  •  go-up   go-down


77. Ni S, Benning MM, Smola MJ, Feldmann EA, Kennedy MA: Crystal structure of Npun_R1517, a putative negative regulator of heterocyst differentiation from Nostoc punctiforme PCC 73102. Proteins; 2009 Feb 15;74(3):794-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Crystal structure of Npun_R1517, a putative negative regulator of heterocyst differentiation from Nostoc punctiforme PCC 73102.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19089958.001).
  • [ISSN] 1097-0134
  • [Journal-full-title] Proteins
  • [ISO-abbreviation] Proteins
  • [Language] eng
  • [Databank-accession-numbers] PDB/ 3E56
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Bacterial Proteins
  •  go-up   go-down


78. Pacak K: Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab; 2007 Nov;92(11):4069-79
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Preoperative management of the pheochromocytoma patient.
  • Pheochromocytomas are rare neuroendocrine tumors with a highly variable clinical presentation, but they most commonly present as spells of headaches, sweating, palpitations, and hypertension.
  • Patients with pheochromocytoma may develop complicated and potentially lethal cardiovascular and other complications, especially in the setting of diagnostic or interventional procedures (e.g. upon induction of anesthesia or during surgery).
  • Because this warrants prompt diagnosis and treatment, the physician should be aware of the clinical manifestations and complications of catecholamine excess and be able to provide proper preoperative management to minimize catecholamine-related pre-, intra-, and postoperative adverse events.
  • The following clinical scenario and discussion aim to enhance the knowledge of the physician regarding the behavior of pheochromocytoma and to outline current approaches to comprehensive preoperative management of patients suffering from this tumor.
  • [MeSH-major] Adrenal Gland Neoplasms / surgery. Pheochromocytoma / surgery. Preoperative Care

  • Genetic Alliance. consumer health - Pheochromocytoma.
  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - Pheochromocytoma.
  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17989126.001).
  • [ISSN] 0021-972X
  • [Journal-full-title] The Journal of clinical endocrinology and metabolism
  • [ISO-abbreviation] J. Clin. Endocrinol. Metab.
  • [Language] eng
  • [Grant] United States / Intramural NIH HHS / /
  • [Publication-type] Case Reports; Journal Article; Research Support, N.I.H., Intramural; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Catecholamines; 0 / Receptors, Adrenergic
  • [Number-of-references] 86
  •  go-up   go-down


79. Vanuga P, Pura M, Kreze A Jr: [Genetic background of tumors originating from adrenomedullar and extraadrenal chromaffin tissue--update]. Vnitr Lek; 2010 Dec;56(12):1296-302
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Genetic background of tumors originating from adrenomedullar and extraadrenal chromaffin tissue--update].
  • It is anticipated that an inherited/familial forms of pheochromocytomas cause approximately 20% of all pheochromocytomas.
  • Therefore, the classic "rule of 10" axioma used to remember the key features of disorder is invalid.
  • Various mutations in several genes have been identified, which underly syndromes with paragangliomas and/or pheochromocytomas.
  • The more candidate genes, the less numbers of patients with apparently sporadic forms of the disorder.
  • This review has summarized the current knowledge of the genetic background of tumors orginating from adrenomedullar and extra-adrenal chromaffin tissue.
  • [MeSH-major] Adrenal Gland Neoplasms / genetics. Multiple Endocrine Neoplasia / genetics. Paraganglioma / genetics
  • [MeSH-minor] Adrenal Medulla. Humans. Pheochromocytoma / genetics

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21261119.001).
  • [ISSN] 0042-773X
  • [Journal-full-title] Vnitr̆ní lékar̆ství
  • [ISO-abbreviation] Vnitr Lek
  • [Language] slo
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Czech Republic
  •  go-up   go-down


80. Kurian D, Phadwal K, Mäenpää P: Proteomic characterization of acid stress response in Synechocystis sp. PCC 6803. Proteomics; 2006 Jun;6(12):3614-24
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Proteomic characterization of acid stress response in Synechocystis sp. PCC 6803.
  • A comparative proteomic analysis using 2-DE coupled with MALDI-MS and LC-MS/MS was performed in Synechocystis sp.
  • PCC 6803 to identify protein candidates involved in acid stress response in cyanobacteria.
  • Comparison of soluble proteins from the cytoplasmic fraction of cells grown on media set at pH 7.5 and 5.5 using 2-DE identified four proteins, which showed significant changes in the abundance.
  • Compared to the cytoplasmic proteome, the periplasmic proteome showed remarkable changes as a function of external pH.
  • Protein expression profiling at different external pH, i.e., 9.0, 7.5, 6.0 and 5.5, allowed classifying the periplasmic proteins depending on their preferential expression patterns towards acidity or alkalinity.
  • Among the acid- and base-induced proteins, oxalate decarboxylase and carbonic anhydrase were already known for their role in pH homeostasis.
  • Several unknown proteins from the periplasm, that showed significant changes in response to pH, provide ideal targets for further studies in understanding pH stress response in cyanobacteria.
  • [MeSH-minor] Computational Biology. Cytoplasm / chemistry. Electrophoresis, Gel, Two-Dimensional. Hydrogen-Ion Concentration. Peptide Fragments / chemistry. Peptide Mapping. Silver Staining. Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16691555.001).
  • [ISSN] 1615-9853
  • [Journal-full-title] Proteomics
  • [ISO-abbreviation] Proteomics
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Bacterial Proteins; 0 / Peptide Fragments; 0 / Proteome
  •  go-up   go-down


81. Nicolaisen K, Hahn A, Valdebenito M, Moslavac S, Samborski A, Maldener I, Wilken C, Valladares A, Flores E, Hantke K, Schleiff E: The interplay between siderophore secretion and coupled iron and copper transport in the heterocyst-forming cyanobacterium Anabaena sp. PCC 7120. Biochim Biophys Acta; 2010 Nov;1798(11):2131-40
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The interplay between siderophore secretion and coupled iron and copper transport in the heterocyst-forming cyanobacterium Anabaena sp. PCC 7120.
  • PCC 7120 were identified.
  • Inactivation of schE resulted in an enhanced sensitivity to high metal concentrations and decreased secretion of hydroxamate-type siderophores.
  • Our results unravel a link between iron and copper homeostasis in Anabaena sp. PCC 7120.

  • MedlinePlus Health Information. consumer health - Iron.
  • Hazardous Substances Data Bank. IRON, ELEMENTAL .
  • Hazardous Substances Data Bank. COPPER, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier B.V. All rights reserved.
  • (PMID = 20647000.001).
  • [ISSN] 0006-3002
  • [Journal-full-title] Biochimica et biophysica acta
  • [ISO-abbreviation] Biochim. Biophys. Acta
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Bacterial Proteins; 0 / Siderophores; 789U1901C5 / Copper; E1UOL152H7 / Iron
  •  go-up   go-down


82. Muramatsu M, Sonoike K, Hihara Y: Mechanism of downregulation of photosystem I content under high-light conditions in the cyanobacterium Synechocystis sp. PCC 6803. Microbiology; 2009 Mar;155(Pt 3):989-96
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mechanism of downregulation of photosystem I content under high-light conditions in the cyanobacterium Synechocystis sp. PCC 6803.
  • PCC 6803, the levels of PSI content, chlorophyll and transcripts of the psaAB genes encoding reaction-centre subunits of PSI could not be maintained low during HL incubation, although the causal relationship among these phenotypes remains unknown.
  • [MeSH-major] Bacterial Proteins / metabolism. Light. Photosystem I Protein Complex / metabolism. Synechocystis / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19246769.001).
  • [ISSN] 1350-0872
  • [Journal-full-title] Microbiology (Reading, England)
  • [ISO-abbreviation] Microbiology (Reading, Engl.)
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Bacterial Proteins; 0 / Photosystem I Protein Complex; 1406-65-1 / Chlorophyll; 88755TAZ87 / Aminolevulinic Acid
  •  go-up   go-down


83. Maldonado MJ, Nieto JC, Díez-Cuenca M, Piñero DP: Posterior corneal curvature changes after undersurface ablation of the flap and in-the-bed LASIK retreatment. Ophthalmology; 2006 Jul;113(7):1125-33
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To analyze LASIK retreatment-induced changes in the posterior corneal curvature (PCC) with undersurface ablation of the flap (UAF) and in-the-bed techniques.
  • MAIN OUTCOME MEASURES: Micropachymetry, Orbscan II scanning-slit PCC data, and visual acuity (VA).
  • Eyes undergoing UAF had no significant change in PCC, whereas eyes undergoing conventional retreatment had an increase in the posterior corneal power within the central 3-mm zone (P = 0.008) 3 months after retreatment.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16713626.001).
  • [ISSN] 1549-4713
  • [Journal-full-title] Ophthalmology
  • [ISO-abbreviation] Ophthalmology
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


84. Thouënnon E, Elkahloun AG, Guillemot J, Gimenez-Roqueplo AP, Bertherat J, Pierre A, Ghzili H, Grumolato L, Muresan M, Klein M, Lefebvre H, Ouafik L, Vaudry H, Plouin PF, Yon L, Anouar Y: Identification of potential gene markers and insights into the pathophysiology of pheochromocytoma malignancy. J Clin Endocrinol Metab; 2007 Dec;92(12):4865-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Identification of potential gene markers and insights into the pathophysiology of pheochromocytoma malignancy.
  • CONTEXT: Pheochromocytomas are catecholamine-producing tumors that are generally benign but that can also present as or develop into malignancy.
  • Occurrence of malignant pheochromocytomas can only be asserted by imaging of metastatic lesions.
  • OBJECTIVES: We conducted a gene expression profiling of benign and malignant tumors to identify a gene signature that would allow us to discriminate benign from malignant pheochromocytomas and to gain a better understanding of tumorigenic pathways associated with malignancy.
  • DESIGN: A total of 36 patients with pheochromocytoma was studied retrospectively.
  • RESULTS: We identified and validated a set of predictor genes that could accurately distinguish the two tumor subtypes through unsupervised clustering.
  • Most of the differentially expressed genes were down-regulated in malignant tumors, and several of these genes encoded neuroendocrine factors involved in prominent characteristics of chromaffin cell biology.
  • In particular, the expression of two key processing enzymes of trophic peptides, peptidylglycine alpha-amidating monooxygenase and glutaminyl-peptide cyclotransferase, was reduced in malignant pheochromocytomas.
  • CONCLUSION: The gene expression profiling of benign and malignant pheochromocytomas clearly identified a set of genes that could be used as a prognostic multi-marker and revealed that the expression of several genes encoding neuroendocrine proteins was reduced in malignant compared with benign tumors.
  • [MeSH-major] Adrenal Gland Neoplasms / genetics. Adrenal Gland Neoplasms / pathology. Pheochromocytoma / genetics. Pheochromocytoma / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Child, Preschool. Female. Genetic Markers. Humans. Infant. Male. Middle Aged. Oligonucleotide Array Sequence Analysis. RNA, Neoplasm / biosynthesis. RNA, Neoplasm / genetics. Reproducibility of Results. Reverse Transcriptase Polymerase Chain Reaction

  • Genetic Alliance. consumer health - Pheochromocytoma.
  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - Pheochromocytoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17878247.001).
  • [ISSN] 0021-972X
  • [Journal-full-title] The Journal of clinical endocrinology and metabolism
  • [ISO-abbreviation] J. Clin. Endocrinol. Metab.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Genetic Markers; 0 / RNA, Neoplasm
  •  go-up   go-down


85. Krifka S, Stangl M, Wiesbauer S, Hiller KA, Schmalz G, Federlin M: Influence of different cusp coverage methods for the extension of ceramic inlays on marginal integrity and enamel crack formation in vitro. Clin Oral Investig; 2009 Sep;13(3):333-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • No information is available to date about cusp design of thin (1.0 mm) non-functional cusps and its influence upon (1) marginal integrity of ceramic inlays (CI) and partial ceramic crowns (PCC) and (2) crack formation of dental tissues.
  • CI and PCC preparations were performed on extracted human molars.
  • PCC with horizontal reduction of non-functional cusps showed statistically significant less microleakage than PCC without such a cusp coverage.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Adhes Dent. 2008 Aug;10(4):307-14 [18792702.001]
  • [Cites] Clin Oral Investig. 2007 Mar;11(1):35-43 [17031673.001]
  • [Cites] J Prosthet Dent. 2001 Aug;86(2):168-72 [11514804.001]
  • [Cites] Dent Mater. 2008 Jan;24(1):39-44 [17467049.001]
  • [Cites] Eur J Oral Sci. 2001 Aug;109(4):222-9 [11531067.001]
  • [Cites] Oper Dent. 2004 Sep-Oct;29(5):560-70 [15470879.001]
  • [Cites] Clin Oral Investig. 2008 Mar;12(1):53-9 [17690921.001]
  • [Cites] Clin Oral Investig. 2006 Dec;10(4):317-23 [16896837.001]
  • [Cites] J Prosthet Dent. 1976 Aug;36(2):171-5 [789864.001]
  • [Cites] Am J Dent. 1998 Aug;11(4):181-4 [10388373.001]
  • [Cites] J Dent Res. 1978 Apr;57(4):571-82 [280571.001]
  • [Cites] Biomaterials. 2008 Dec;29(36):4847-54 [18804277.001]
  • [Cites] Clin Oral Investig. 2003 Jun;7(2):80-5 [12743836.001]
  • [Cites] Clin Oral Investig. 2008 Dec;12(4):331-6 [18536945.001]
  • [Cites] Clin Oral Investig. 2005 Mar;9(1):8-17 [15309565.001]
  • [Cites] Am J Dent. 2007 Feb;20(1):21-6 [17380803.001]
  • [Cites] Quintessence Int. 2004 Apr;35(4):281-6 [15119713.001]
  • [Cites] Aust Dent J. 1998 Apr;43(2):110-6 [9612985.001]
  • [Cites] Oper Dent. 2008 Sep-Oct;33(5):516-25 [18833858.001]
  • [Cites] J Mater Sci Mater Med. 2000 Mar;11(3):133-40 [15348042.001]
  • [Cites] Quintessence Int Dent Dig. 1983 Apr;14(4):437-47 [6574554.001]
  • [Cites] J Dent. 1992 Jun;20(3):131-9 [1624616.001]
  • [Cites] Am J Dent. 2001 Aug;14(4):216-20 [11699740.001]
  • [Cites] J Adhes Dent. 2007;9 Suppl 1:107-16 [18341237.001]
  • [Cites] Quintessence Int. 1994 Apr;25(4):269-75 [8058900.001]
  • [Cites] Clin Oral Investig. 2007 Dec;11(4):345-52 [17973129.001]
  • [Cites] Dent Mater. 2005 Mar;21(3):262-71 [15705433.001]
  • [Cites] Oper Dent. 2006 Mar-Apr;31(2):204-11 [16827023.001]
  • [Cites] J Adhes Dent. 2003 Spring;5(1):63-70 [12729085.001]
  • [Cites] Clin Oral Investig. 2008 Jun;12(2):151-6 [18040728.001]
  • [Cites] Quintessence Int. 2003 Jun;34(6):409-17 [12859085.001]
  • [Cites] J Prosthet Dent. 2003 Jun;89(6):551-7 [12815348.001]
  • [Cites] J Dent. 2006 Mar;34(3):221-9 [16112335.001]
  • [Cites] J Adhes Dent. 2001 Spring;3(1):45-64 [11317384.001]
  • [Cites] J Adhes Dent. 2008 Feb;10(1):41-8 [18389735.001]
  • [Cites] J Dent. 1976 Sep;4(5):199-206 [787027.001]
  • [Cites] Schweiz Monatsschr Zahnmed. 1990;100(12):1445-9 [2277977.001]
  • [Cites] J Esthet Restor Dent. 2003;15(7):391-401; discussion 401 [15000906.001]
  • (PMID = 19137332.001).
  • [ISSN] 1436-3771
  • [Journal-full-title] Clinical oral investigations
  • [ISO-abbreviation] Clin Oral Investig
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Vita Mark II; 12001-21-7 / Dental Porcelain
  •  go-up   go-down


86. Dühring U, Ossenbühl F, Wilde A: Late assembly steps and dynamics of the cyanobacterial photosystem I. J Biol Chem; 2007 Apr 13;282(15):10915-21
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PCC 6803 proteins in combination with blue native polyacrylamide gel electrophoresis.
  • We show that in addition to a complete photosystem I monomer, containing all 11 subunits, we detected a PsaK-less monomer and a short-lived PsaL/PsaK-less complex.
  • PCC 6803 that accumulates also less trimers.
  • The PsaK-less photosystem I monomer may represent an intermediate complex that is important for the exchange of the two PsaK variants during high light acclimation.
  • [MeSH-major] Photosystem I Protein Complex / metabolism. Synechocystis / enzymology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17303568.001).
  • [ISSN] 0021-9258
  • [Journal-full-title] The Journal of biological chemistry
  • [ISO-abbreviation] J. Biol. Chem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Photosystem I Protein Complex; 0 / Protein Subunits
  •  go-up   go-down


87. Bogos B, Ughy B, Domonkos I, Laczkó-Dobos H, Komenda J, Abasova L, Cser K, Vass I, Sallai A, Wada H, Gombos Z: Phosphatidylglycerol depletion affects photosystem II activity in Synechococcus sp. PCC 7942 cells. Photosynth Res; 2010 Jan;103(1):19-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Phosphatidylglycerol depletion affects photosystem II activity in Synechococcus sp. PCC 7942 cells.
  • PCC 7942 mutant produced by inactivating its cdsA gene presumably encoding cytidine 5'-diphosphate-diacylglycerol synthase, a key enzyme in PG synthesis.
  • PCC 7942/DeltacdsA cells grew photoautotrophically.
  • [(35)S]methionine labeling confirmed that PG depletion did not block the de novo synthesis of PSII proteins but slowed down the assembly of the newly synthesized D1 protein into PSII core complexes.
  • [MeSH-major] Phosphatidylglycerols / physiology. Photosystem II Protein Complex / metabolism. Synechococcus / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur J Biochem. 2004 Sep;271(17):3523-32 [15317587.001]
  • [Cites] Nat Struct Mol Biol. 2009 Mar;16(3):334-42 [19219048.001]
  • [Cites] Plant Physiol. 2000 Oct;124(2):795-804 [11027727.001]
  • [Cites] Eur J Biochem. 2004 Feb;271(4):685-93 [14764084.001]
  • [Cites] Biochim Biophys Acta. 2008 Sep;1777(9):1184-94 [18585998.001]
  • [Cites] Prog Lipid Res. 2008 Nov;47(6):422-35 [18590767.001]
  • [Cites] Plant J. 2003 Dec;36(6):762-70 [14675442.001]
  • [Cites] Nature. 2001 Jun 21;411(6840):909-17 [11418848.001]
  • [Cites] Biochem Biophys Res Commun. 2008 May 2;369(2):660-5 [18295600.001]
  • [Cites] Nature. 2001 Feb 8;409(6821):739-43 [11217865.001]
  • [Cites] Nucleic Acids Res. 1997 Mar 15;25(6):1203-10 [9092630.001]
  • [Cites] J Bacteriol. 2000 Jan;182(2):543-5 [10629209.001]
  • [Cites] Plant Physiol. 2007 Jul;144(3):1336-46 [17513482.001]
  • [Cites] J Plant Res. 2004 Dec;117(6):495-505 [15538651.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10655-60 [10984546.001]
  • [Cites] J Biol Chem. 2004 Nov 19;279(47):48620-9 [15347679.001]
  • [Cites] Plant Physiol. 2004 Apr;134(4):1471-8 [15064373.001]
  • [Cites] Anal Biochem. 1991 Dec;199(2):223-31 [1812789.001]
  • [Cites] Nature. 2005 Dec 15;438(7070):1040-4 [16355230.001]
  • [Cites] Biochemistry. 1997 Sep 30;36(39):11769-76 [9305967.001]
  • [Cites] Plant Cell Physiol. 2002 Jul;43(7):751-8 [12154137.001]
  • [Cites] Biochemistry. 2002 Mar 19;41(11):3796-802 [11888298.001]
  • [Cites] Can J Biochem Physiol. 1959 Aug;37(8):911-7 [13671378.001]
  • [Cites] Arch Microbiol. 1975;102(1):23-8 [804297.001]
  • [Cites] J Bacteriol. 1984 Apr;158(1):36-42 [6425267.001]
  • [Cites] Biochemistry. 1995 Jul 25;34(29):9625-31 [7626631.001]
  • [Cites] J Biol Chem. 1996 Mar 29;271(13):7501-7 [8631780.001]
  • [Cites] J Biol Chem. 2009 Jun 5;284(23):15598-606 [19351885.001]
  • [Cites] DNA Res. 1996 Jun 30;3(3):109-36 [8905231.001]
  • [Cites] Plant Cell Physiol. 2002 Dec;43(12 ):1456-64 [12514242.001]
  • [Cites] Eur J Biochem. 1995 Jun 15;230(3):987-93 [7601163.001]
  • [Cites] Plant Physiol. 2002 Jun;129(2):594-604 [12068104.001]
  • [Cites] Gene. 1995 Sep 22;163(1):41-6 [7557476.001]
  • [Cites] Plant Physiol. 2003 Nov;133(3):1376-84 [14551333.001]
  • [Cites] J Biol Chem. 2000 Mar 3;275(9):6509-14 [10692455.001]
  • [Cites] Anal Biochem. 1998 Dec 15;265(2):381-4 [9882418.001]
  • [Cites] Eur J Biochem. 1987 Jun 1;165(2):461-5 [3109903.001]
  • (PMID = 19763873.001).
  • [ISSN] 1573-5079
  • [Journal-full-title] Photosynthesis research
  • [ISO-abbreviation] Photosyn. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Bacterial Proteins; 0 / Fatty Acids; 0 / Phosphatidylglycerols; 0 / Photosystem II Protein Complex; 0 / Protein Subunits
  •  go-up   go-down


88. Rakhimberdieva MG, Bolychevtseva YV, Elanskaya IV, Karapetyan NV: Protein-protein interactions in carotenoid triggered quenching of phycobilisome fluorescence in Synechocystis sp. PCC 6803. FEBS Lett; 2007 May 29;581(13):2429-33
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Protein-protein interactions in carotenoid triggered quenching of phycobilisome fluorescence in Synechocystis sp. PCC 6803.
  • Non-Arrhenius behavior of the light-on quenching rate suggests that carotenoid-absorbed light triggers a process that bears a strong resemblance to soluble protein folding, showing temperature-dependent enthalpy of activated complex formation.
  • [MeSH-minor] Bacterial Proteins / metabolism. Glycerol / pharmacology. Light. Osmotic Pressure. Photosystem II Protein Complex / genetics. Spectrometry, Fluorescence. Temperature. Thermodynamics

  • Hazardous Substances Data Bank. GLYCERIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17485085.001).
  • [ISSN] 0014-5793
  • [Journal-full-title] FEBS letters
  • [ISO-abbreviation] FEBS Lett.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Bacterial Proteins; 0 / Photosystem II Protein Complex; 0 / Phycobilisomes; 36-88-4 / Carotenoids; PDC6A3C0OX / Glycerol
  •  go-up   go-down


89. Fujimori T, Higuchi M, Sato H, Aiba H, Muramatsu M, Hihara Y, Sonoike K: The mutant of sll1961, which encodes a putative transcriptional regulator, has a defect in regulation of photosystem stoichiometry in the cyanobacterium Synechocystis sp. PCC 6803. Plant Physiol; 2005 Sep;139(1):408-16
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The mutant of sll1961, which encodes a putative transcriptional regulator, has a defect in regulation of photosystem stoichiometry in the cyanobacterium Synechocystis sp. PCC 6803.
  • In acclimation to changing light environments, photosynthetic organisms modulate the ratio of two photosynthetic reaction centers (photosystem I [PSI] and photosystem II).
  • Measurements of chlorophyll fluorescence and analysis of the reaction center subunits of PSI through western blotting in this mutant revealed that the content of PSI could not be suppressed under high-light condition.
  • [MeSH-major] Bacterial Proteins / physiology. Genes, Bacterial / genetics. Photosystem I Protein Complex / biosynthesis. Synechocystis / genetics. Synechocystis / metabolism. Transcription Factors / genetics. Transcription Factors / physiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] FEBS Lett. 2000 Aug 11;479(1-2):72-7 [10940391.001]
  • [Cites] Oncogene. 1999 Jun 3;18(22):3316-23 [10362352.001]
  • [Cites] Plant Cell Physiol. 2001 Apr;42(4):379-84 [11333308.001]
  • [Cites] Biochem J. 2001 Jul 1;357(Pt 1):211-6 [11415451.001]
  • [Cites] Plant Mol Biol. 2001 Jul;46(4):459-68 [11485202.001]
  • [Cites] Biochim Biophys Acta. 2001 Oct 30;1507(1-3):5-31 [11687205.001]
  • [Cites] J Biol Chem. 2002 Jun 7;277(23):20343-54 [11914373.001]
  • [Cites] Curr Opin Struct Biol. 2002 Aug;12(4):523-30 [12163077.001]
  • [Cites] Annu Rev Plant Biol. 2002;53:551-80 [12221988.001]
  • [Cites] Planta. 2003 Jan;216(3):446-53 [12520336.001]
  • [Cites] J Bacteriol. 2003 Jul;185(13):3878-87 [12813082.001]
  • [Cites] Plant Cell. 2003 Jul;15(7):1578-90 [12837948.001]
  • [Cites] J Bacteriol. 2003 Nov;185(22):6615-23 [14594835.001]
  • [Cites] J Bacteriol. 2004 Feb;186(4):956-67 [14761990.001]
  • [Cites] FEBS Lett. 2004 Sep 10;574(1-3):101-5 [15358547.001]
  • [Cites] Biochem Biophys Res Commun. 1972 Dec 18;49(6):1617-23 [4404797.001]
  • [Cites] Plant Cell. 1995 May;7(5):649-58 [7780311.001]
  • [Cites] Plant Physiol. 1998 Aug;117(4):1205-16 [9701577.001]
  • [Cites] Methods Enzymol. 1998;297:124-39 [9750206.001]
  • [Cites] Plant Cell. 2001 Apr;13(4):793-806 [11283337.001]
  • (PMID = 16113218.001).
  • [ISSN] 0032-0889
  • [Journal-full-title] Plant physiology
  • [ISO-abbreviation] Plant Physiol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Bacterial Proteins; 0 / Photosystem I Protein Complex; 0 / Transcription Factors; 1406-65-1 / Chlorophyll
  • [Other-IDs] NLM/ PMC1203389
  •  go-up   go-down


90. Squizzato A, Gerdes VE, Ageno W, Büller HR: The coagulation system in endocrine disorders: a narrative review. Intern Emerg Med; 2007 Jun;2(2):76-83
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Also unprovoked bleeding or thrombotic events have been associated with endocrine disease.
  • In the published literature a clear bleeding diathesis has only been associated with overt hypothyroidism, mainly mediated by an acquired von Willebrand syndrome.
  • Also effects of pheochromocytoma, hyperprolactinaemia and hyperaldosteronism on the coagulation system have been described.
  • [MeSH-minor] Addison Disease / complications. Cushing Syndrome / complications. Human Growth Hormone / blood. Humans. Hyperthyroidism / complications. Hypothyroidism / complications

  • MedlinePlus Health Information. consumer health - Bleeding Disorders.
  • MedlinePlus Health Information. consumer health - Endocrine Diseases.
  • MedlinePlus Health Information. consumer health - Steroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Thromb Haemost. 2004 Sep;92(3):662-5 [15457603.001]
  • [Cites] Scand J Haematol. 1976 Feb;16(2):154-60 [1257701.001]
  • [Cites] Wiad Lek. 1989 Mar 1;42(5):273-7 [2815743.001]
  • [Cites] Cerebrovasc Dis. 1998 Jul-Aug;8(4):240-3 [9684065.001]
  • [Cites] Exp Clin Endocrinol Diabetes. 2000;108(7):486-92 [11083070.001]
  • [Cites] Lancet. 1998 Oct 31;352(9138):1455-61 [9808008.001]
  • [Cites] Lancet. 1999 Apr 3;353(9159):1167-73 [10209995.001]
  • [Cites] Lancet. 2001 Mar 10;357(9258):783-91 [11253984.001]
  • [Cites] Lancet. 1947 Mar 29;1(6448):402-5 [20289886.001]
  • [Cites] Endocr J. 2004 Jun;51(3):387-8 [15256787.001]
  • [Cites] J Clin Invest. 1995 Mar;95(3):995-1001 [7884001.001]
  • [Cites] Maturitas. 1996 Jul;24(3):147-55 [8844628.001]
  • [Cites] J Clin Endocrinol Metab. 2002 Aug;87(8):3662-6 [12161492.001]
  • [Cites] Acta Haematol. 1982;68(1):39-42 [6812355.001]
  • [Cites] Sports Med. 2004;34(8):513-54 [15248788.001]
  • [Cites] J Endocrinol Invest. 2000 Mar;23(3):145-50 [10803470.001]
  • [Cites] Lancet. 1990 Aug 4;336(8710):285-8 [1973979.001]
  • [Cites] Blood. 1982 Nov;60(5):1169-72 [7126870.001]
  • [Cites] J Am Coll Cardiol. 2005 Apr 19;45(8):1243-8 [15837256.001]
  • [Cites] J Endocrinol Invest. 2002 Apr;25(4):345-50 [12030606.001]
  • [Cites] Haemophilia. 2002 Mar;8(2):142-4 [11952850.001]
  • [Cites] J Pediatr. 1968 Sep;73(3):320-8 [5667414.001]
  • [Cites] Exp Clin Endocrinol Diabetes. 1997;105(6):331-5 [9439928.001]
  • [Cites] J Endocrinol Invest. 1988 Nov;11(10):723-5 [2466071.001]
  • [Cites] J Endocrinol Invest. 1997 Apr;20(4):211-4 [9211128.001]
  • [Cites] J Rheumatol. 1989 Mar;16(3):378-80 [2498514.001]
  • [Cites] J Clin Endocrinol Metab. 2001 Feb;86(2):732-7 [11158038.001]
  • [Cites] Acta Med Scand. 1976;199(1-2):95-8 [1251777.001]
  • [Cites] J Lab Clin Med. 1983 Sep;102(3):444-9 [6411844.001]
  • [Cites] Thromb Haemost. 2005 Feb;93(2):392-3 [15711766.001]
  • [Cites] Thromb Haemost. 1996 Sep;76(3):422-8 [8883281.001]
  • [Cites] J Thromb Haemost. 2003 Jul;1(7):1371-80 [12871270.001]
  • [Cites] Kidney Int. 1997 Jan;51(1):164-72 [8995730.001]
  • [Cites] J Vasc Surg. 2005 Sep;42(3):570-2 [16171610.001]
  • [Cites] Blood Coagul Fibrinolysis. 1992 Dec;3(6):789-93 [1489900.001]
  • [Cites] Nephrol Dial Transplant. 2000 May;15(5):717-8 [10809818.001]
  • [Cites] Lancet. 1987 May 2;1(8540):1007-9 [2883346.001]
  • [Cites] Eur J Haematol. 2000 Dec;65(6):357-69 [11168493.001]
  • [Cites] Nature. 1962 Sep 22;195:1214-5 [14038141.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 2005 Aug;76(8):1182-3 [16024907.001]
  • [Cites] J Endocrinol Invest. 2004 Dec;27(11):1065-71 [15754740.001]
  • [Cites] Q J Med. 1986 Jan;58(225):43-51 [3704105.001]
  • [Cites] Clin Appl Thromb Hemost. 2001 Apr;7(2):113-5 [11292187.001]
  • [Cites] J Clin Endocrinol Metab. 2001 Dec;86(12):5912-9 [11739463.001]
  • [Cites] Blood Coagul Fibrinolysis. 1990 Aug;1(3):299-306 [2103314.001]
  • [Cites] Thromb Res. 2006;118(2):247-52 [16005496.001]
  • [Cites] J Am Med Assoc. 1951 Nov 3;147(10):924-6 [14873595.001]
  • [Cites] Hypertension. 1998 Dec;32(6):965-71 [9856958.001]
  • [Cites] J Clin Endocrinol Metab. 2005 Nov;90(11):6064-71 [16091487.001]
  • [Cites] Thromb Haemost. 1985 Aug 30;54(2):518-20 [4082087.001]
  • [Cites] Thromb Haemost. 1998 Jan;79(1):99-103 [9459332.001]
  • [Cites] J Clin Endocrinol Metab. 2005 Jun;90(6):3202-8 [15769980.001]
  • [Cites] Hematol Oncol Clin North Am. 1987 Jun;1(2):261-79 [3308823.001]
  • [Cites] J Physiol. 1961 Apr;156:217-24 [13717715.001]
  • [Cites] Clin Endocrinol (Oxf). 2000 Jan;52(1):123-6 [10651763.001]
  • [Cites] N Engl J Med. 1998 Dec 17;339(25):1828-34 [9854120.001]
  • [Cites] Scand J Haematol. 1970;7(3):212-6 [5447966.001]
  • [Cites] Horm Metab Res. 2003 Apr;35(4):228-35 [12778366.001]
  • [Cites] N Engl J Med. 1999 Oct 14;341(16):1206-16 [10519899.001]
  • [Cites] Endocr J. 2005 Dec;52(6):709-14 [16410662.001]
  • [Cites] Haematologica. 2004 Nov;89(11):1341-6 [15531456.001]
  • [Cites] Postgrad Med J. 1990 Apr;66(774):280-4 [2201013.001]
  • [Cites] Thromb Haemost. 1992 Jul 6;68(1):69-73 [1514175.001]
  • [Cites] Endocrinology. 2004 Jun;145(6):2804-14 [14977860.001]
  • [Cites] Eur J Clin Invest. 2001 Feb;31(2):131-7 [11168451.001]
  • [Cites] Eur J Endocrinol. 1997 Jan;136(1):1-7 [9037116.001]
  • [Cites] Lupus. 2003;12(7):569-72 [12892401.001]
  • [Cites] Int J Clin Pract. 2003 Mar;57(2):78-81 [12661786.001]
  • [Cites] Exp Clin Endocrinol Diabetes. 2000;108(4):294-8 [10961361.001]
  • [Cites] J Thromb Haemost. 2004 Aug;2(8):1316-20 [15304037.001]
  • [Cites] N Engl J Med. 2005 Apr 28;352(17 ):1791-8 [15858188.001]
  • [Cites] Am J Med. 1987 Oct;83(4):773-6 [3674065.001]
  • [Cites] Clin Endocrinol (Oxf). 1997 Jan;46(1):69-74 [9059560.001]
  • [Cites] N Engl J Med. 1965 Nov 11;273(20):1057-61 [5834816.001]
  • [Cites] Stroke. 2005 Oct;36(10):2302-10 [16179578.001]
  • (PMID = 17657422.001).
  • [ISSN] 1828-0447
  • [Journal-full-title] Internal and emergency medicine
  • [ISO-abbreviation] Intern Emerg Med
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Glucocorticoids; 12629-01-5 / Human Growth Hormone
  • [Number-of-references] 77
  •  go-up   go-down


91. Homma K, Hayashi K, Wakino S, Irie R, Mukai M, Kumagai H, Shibata H, Saruta T: Primary malignant hepatic pheochromocytoma with negative adrenal scintigraphy. Hypertens Res; 2006 Jul;29(7):551-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary malignant hepatic pheochromocytoma with negative adrenal scintigraphy.
  • A computed tomography scan revealed no adrenal tumor but a large liver mass (5 x 5 cm), and magnetic resonance imaging showed a high signal intensity lesion on the T2-weighted image.
  • Twenty-four hour urinary excretion of catecholamine metabolites was markedly increased, although a 123I-metaiodobenzyl guanidine (MIBG) scintigram failed to show accumulation in the hepatic mass, and no difference was noted between the catecholamine concentration in the tumor-drainage vein and that obtained from the vein draining from the non-tumor area.
  • Liver biopsy did show features compatible with pheochromocytoma (i.e., chromogranin A-positive cells).
  • Transcatheter arterial embolization of the liver tumor was conducted and resulted in a marked (50%) decrease in the 24-h urine normetanephrine excretion.
  • Thus, we experienced a case of primary malignant hepatic pheochromocytoma with negative 123I-MIBG scanning.
  • [MeSH-major] Adrenal Glands / radionuclide imaging. Liver Neoplasms / radionuclide imaging. Pheochromocytoma / radionuclide imaging

  • Genetic Alliance. consumer health - Pheochromocytoma.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Pheochromocytoma.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17044668.001).
  • [ISSN] 0916-9636
  • [Journal-full-title] Hypertension research : official journal of the Japanese Society of Hypertension
  • [ISO-abbreviation] Hypertens. Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Catecholamines; 0 / Radiopharmaceuticals; 35MRW7B4AD / 3-Iodobenzylguanidine
  •  go-up   go-down


92. Willenberg HS, Zschucke D, Bornstein SR: [Adrenal gland tumors]. Internist (Berl); 2007 Sep;48(9):971-86
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Adrenal gland tumors].
  • Adrenal masses are one of the most common tumors in humans.
  • They are a very heterogenous group of diseases and include benign and malignant adrenocortical lesions, metastases, pheochromocytomas and other entities.
  • Adrenal masses originating from steroidogenic or chromaffin cells may be silent or the source of subclinical or overt hormone excess, such as primary aldosteronism, hypercortisolism or symptomatic catecholamine excess.
  • On the other hand, adrenal hyperplasia may be the result of excess ACTH secretion in steroid biosynthesis disorders with deficient glucocorticoid secretion, in glucocorticoid resistance, in Cushing's disease, or ectopic ACTH syndrome.
  • Algorithms for endocrine testing, imaging studies and their combination are available for defining the tumor entity and for the characterization of the hormone excess syndromes.
  • Recent developments in molecular biology have provided tools for testing for hereditary tumor syndromes associated with adrenal tumorigenesis and to establish strategies for further treatment and follow-up.
  • [MeSH-major] Adrenal Gland Neoplasms / diagnosis. Adrenal Gland Neoplasms / therapy
  • [MeSH-minor] Diagnosis, Differential. Humans

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Internist (Berl). 2006 Sep;47(9):953-9 [16823578.001]
  • [Cites] Arch Surg. 1994 Mar;129(3):291-6 [8129606.001]
  • [Cites] J Clin Endocrinol Metab. 2006 Nov;91(11):4501-4 [16895957.001]
  • [Cites] Endocr Relat Cancer. 2005 Sep;12(3):667-80 [16172199.001]
  • [Cites] Am J Surg. 1964 Jan;107:159-72 [14099489.001]
  • [Cites] J Clin Endocrinol Metab. 2000 May;85(5):1863-7 [10843166.001]
  • [Cites] Pathologe. 2003 Jul;24(4):272-9 [14513274.001]
  • [Cites] Surgery. 1995 Dec;118(6):1090-8 [7491528.001]
  • [Cites] N Engl J Med. 1998 Jul 2;339(1):27-31 [9647876.001]
  • [Cites] Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):92-102 [17237836.001]
  • [Cites] J Cancer Res Clin Oncol. 2001;127(3):143-55 [11260859.001]
  • [Cites] Am J Surg Pathol. 1989 Mar;13(3):202-6 [2919718.001]
  • [Cites] J Urol. 1978 Dec;120(6):660-5 [731800.001]
  • [Cites] Lancet. 2005 Jun 18-24;365(9477):2125-36 [15964450.001]
  • [Cites] J Clin Endocrinol Metab. 2000 Feb;85(2):637-44 [10690869.001]
  • [Cites] Endocr Rev. 1995 Aug;16(4):460-84 [8521790.001]
  • [Cites] Dtsch Med Wochenschr. 2007 Feb 2;132(5):207-17; quiz 219-20 [17252364.001]
  • [Cites] Internist (Berl). 2002 Feb;43(2):186-95 [11963756.001]
  • [Cites] Lancet. 2006 May 13;367(9522):1605-17 [16698415.001]
  • [Cites] Radiologe. 2003 Apr;43(4):284-92 [12721644.001]
  • [Cites] Mayo Clin Proc. 1981 Jun;56(6):354-60 [6453259.001]
  • [Cites] N Engl J Med. 2002 May 9;346(19):1459-66 [12000816.001]
  • [Cites] Endocr Rev. 2004 Apr;25(2):309-40 [15082524.001]
  • [Cites] Ann Intern Med. 1999 May 4;130(9):759-71 [10357696.001]
  • [Cites] Med Klin (Munich). 2006 Jan 15;101(1):65-8 [16418816.001]
  • (PMID = 17684715.001).
  • [ISSN] 0020-9554
  • [Journal-full-title] Der Internist
  • [ISO-abbreviation] Internist (Berl)
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 28
  •  go-up   go-down


93. Piga R, Micheletto R, Kawakami Y: Acoustical nanometre-scale vibrations of live cells detected by a near-field optical setup. Opt Express; 2007 Apr 30;15(9):5589-94
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Here we show intriguing data of cell membrane nanometer-scale dynamics associated to different phenomena of the cell's life, such as cell cycle and cell death, on rat pheochromocytoma line PC12.
  • Working in culture medium with alive and unperturbed samples, we could detect nanometer-sized movements; Fourier components revealed a clear distinct behavior associated to regulation of neurite outgrowth and changes on morphology after necrotic stimulus.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19532815.001).
  • [ISSN] 1094-4087
  • [Journal-full-title] Optics express
  • [ISO-abbreviation] Opt Express
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


94. Mann SJ: Severe paroxysmal hypertension (pseudopheochromocytoma). Curr Hypertens Rep; 2008 Feb;10(1):12-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Paroxysmal hypertension always engenders a search for a catecholamine-secreting pheochromocytoma.
  • Yet 98% of people with paroxysmal hypertension do not have this tumor.
  • This review presents an approach to understanding and successfully treating this disorder.
  • A specific personality profile associated with this disorder suggests a psychological basis, attributable to repressed emotion related to prior emotional trauma or a repressive (nonemotional) coping style.
  • [MeSH-major] Emotions. Hypertension / drug therapy. Hypertension / psychology. Stress Disorders, Post-Traumatic / diagnosis
  • [MeSH-minor] Adrenal Gland Neoplasms / complications. Adrenal Gland Neoplasms / diagnosis. Anti-Anxiety Agents / therapeutic use. Antidepressive Agents / therapeutic use. Antihypertensive Agents / therapeutic use. Blood Pressure Monitoring, Ambulatory. Diagnosis, Differential. Humans. Panic Disorder / complications. Pheochromocytoma / complications. Pheochromocytoma / diagnosis. Psychotherapy. Sympathetic Nervous System / physiopathology

  • MedlinePlus Health Information. consumer health - High Blood Pressure.
  • MedlinePlus Health Information. consumer health - Post-Traumatic Stress Disorder.
  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Psychoneuroendocrinology. 1987;12(1):13-20 [3588809.001]
  • [Cites] Ann Intern Med. 2001 Feb 20;134(4):315-29 [11182843.001]
  • [Cites] Hypertension. 1987 Mar;9(3):309-14 [3818023.001]
  • [Cites] Clin Pharmacokinet. 1994 May;26(5):335-46 [7914479.001]
  • [Cites] Psychosom Med. 1988 Jul-Aug;50(4):434-8 [3045849.001]
  • [Cites] Arch Intern Med. 1997 May 12;157(9):945-8 [9140264.001]
  • [Cites] J Hypertens. 1987 Jun;5(3):277-83 [3611776.001]
  • [Cites] Arch Intern Med. 1986 Jul;146(7):1315-20 [3718127.001]
  • [Cites] N Engl J Med. 1981 Sep 10;305(11):623-6 [7266587.001]
  • [Cites] Am J Hypertens. 2003 Oct;16(10):881-8 [14553971.001]
  • [Cites] Ann N Y Acad Sci. 2006 Aug;1073:332-47 [17102103.001]
  • [Cites] Medicine (Baltimore). 1991 Jan;70(1):46-66 [1988766.001]
  • [Cites] Br J Clin Pharmacol. 1979;8(Suppl 2):157S-161S [526397.001]
  • [Cites] Arch Intern Med. 1999 Apr 12;159(7):670-4 [10218745.001]
  • [Cites] Psychosomatics. 1996 Sep-Oct;37(5):444-50 [8824124.001]
  • [Cites] Arch Intern Med. 1990 Jul;150(7):1528-33 [2369252.001]
  • [Cites] Arch Intern Med. 1969 Jan;123(1):1-7 [5761734.001]
  • [Cites] Am J Hypertens. 2001 Jun;14(6 Pt 1):553-8 [11411735.001]
  • (PMID = 18367021.001).
  • [ISSN] 1534-3111
  • [Journal-full-title] Current hypertension reports
  • [ISO-abbreviation] Curr. Hypertens. Rep.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Anxiety Agents; 0 / Antidepressive Agents; 0 / Antihypertensive Agents
  • [Number-of-references] 20
  •  go-up   go-down


95. Chen JC, Lee WH, Chen PC, Tseng CP, Huang EY: Rat NPFF(1) receptor-mediated signaling: functional comparison of neuropeptide FF (NPFF), FMRFamide and PFR(Tic)amide. Peptides; 2006 May;27(5):1005-14
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We established a pheochromocytoma PC-12 cell line clone stably expressing rat NPFF1 receptors.

  • Hazardous Substances Data Bank. AMPHETAMINE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16490283.001).
  • [ISSN] 0196-9781
  • [Journal-full-title] Peptides
  • [ISO-abbreviation] Peptides
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Dopamine and cAMP-Regulated Phosphoprotein 32; 0 / Neuropeptides; 0 / Oligopeptides; 0 / PFR(Tic)amide; 0 / Receptors, Neuropeptide; 0 / Tetrahydroisoquinolines; 0 / neuropeptide FF receptor; 1F7A44V6OU / Colforsin; 64190-70-1 / FMRFamide; 99566-27-5 / phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide; CK833KGX7E / Amphetamine; EC 2.7.11.24 / Mitogen-Activated Protein Kinase 1; EC 2.7.11.24 / Mitogen-Activated Protein Kinase 3; EC 2.7.11.24 / p38 Mitogen-Activated Protein Kinases; EC 4.6.1.1 / Adenylyl Cyclases
  •  go-up   go-down


96. Maric D, Ruetzler C, Barker JL, Hallenbeck JM: Development of an ischemic tolerance model in a PC12 cell line. J Cereb Blood Flow Metab; 2005 Feb;25(2):154-162
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Although ischemic tolerance has been described in a variety of primary cell culture systems, no similar in vitro models have been reported with any cell line.
  • A model of ischemic preconditioning in the rat pheochromocytoma PC12 cell line is described here.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Blood. 1994 Sep 1;84(5):1415-20 [8068938.001]
  • [Cites] Neurosci Res. 1995 Oct;23(3):289-96 [8545077.001]
  • [Cites] Cytometry. 1996 Oct 1;25(2):173-81 [8891447.001]
  • [Cites] Neurobiology (Bp). 1996;4(1-2):1-11 [9116683.001]
  • [Cites] J Neurosci Res. 1997 Jun 15;48(6):563-70 [9210526.001]
  • [Cites] FEBS Lett. 1997 Sep 1;414(1):117-21 [9305743.001]
  • [Cites] J Neurochem. 1998 Jan;70(1):120-9 [9422354.001]
  • [Cites] Neuroreport. 1998 May 11;9(7):1273-6 [9631411.001]
  • [Cites] J Neurosci. 1999 Mar 1;19(5):1657-62 [10024352.001]
  • [Cites] Brain Res. 1999 May 8;827(1-2):143-51 [10320703.001]
  • [Cites] Am J Physiol. 1999 May;276(5 Pt 1):C1171-83 [10329967.001]
  • [Cites] Stroke. 1999 Sep;30(9):1851-4 [10471435.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):436-41 [10618436.001]
  • [Cites] Am J Physiol Cell Physiol. 2000 Jan;278(1):C144-53 [10644522.001]
  • [Cites] J Neurosci. 2000 Oct 1;20(19):7183-92 [11007874.001]
  • [Cites] Methods Cell Biol. 2001;66:417-36 [11396014.001]
  • [Cites] Mol Neurobiol. 2001 Feb;23(1):21-51 [11642542.001]
  • [Cites] Neuron. 2001 Dec 6;32(5):767-70 [11738023.001]
  • [Cites] Trends Biotechnol. 2002 Mar;20(3):110-5 [11841862.001]
  • [Cites] Brain Res. 2002 Feb 22;928(1-2):69-75 [11844473.001]
  • [Cites] Nat Cell Biol. 2002 Mar;4(3):240-5 [11854752.001]
  • [Cites] J Cereb Blood Flow Metab. 2002 May;22(5):520-5 [11973424.001]
  • [Cites] Cell Signal. 2002 Aug;14(8):649-54 [12020764.001]
  • [Cites] Science. 2002 May 31;296(5573):1648-9 [12040181.001]
  • [Cites] Cell Mol Neurobiol. 2001 Dec;21(6):771-81 [12043847.001]
  • [Cites] J Mol Neurosci. 2002 Jun;18(3):189-201 [12059037.001]
  • [Cites] J Neurosci. 2002 Aug 1;22(15):6401-7 [12151519.001]
  • [Cites] Ann N Y Acad Sci. 2002 Oct;971:366-70 [12438154.001]
  • [Cites] Ann N Y Acad Sci. 2002 Oct;971:379-88 [12438156.001]
  • [Cites] J Cereb Blood Flow Metab. 2002 Nov;22(11):1283-96 [12439285.001]
  • [Cites] Neuron. 2002 Nov 14;36(4):559-62 [12441046.001]
  • [Cites] J Neurosci. 2002 Dec 1;22(23):10291-301 [12451129.001]
  • [Cites] Ann N Y Acad Sci. 2002 Nov;973:463-7 [12485912.001]
  • [Cites] J Neurosci. 2002 Dec 15;22(24):10690-8 [12486162.001]
  • [Cites] Drug Discov Today. 2002 Feb 1;7(3):197-205 [11815236.001]
  • [Cites] Drug Discov Today. 2003 Feb 15;8(4):168-74 [12581711.001]
  • [Cites] Drug Discov Today. 2003 Feb 15;8(4):175-83 [12581712.001]
  • [Cites] EXS. 2003;(93):71-85 [12613172.001]
  • [Cites] Trends Neurosci. 2003 May;26(5):248-54 [12744841.001]
  • [Cites] Curr Mol Med. 2003 Jun;3(4):313-24 [12776987.001]
  • [Cites] Aging Cell. 2003 Oct;2(5):245-56 [14570232.001]
  • [Cites] Proc Natl Acad Sci U S A. 1976 Jul;73(7):2424-8 [1065897.001]
  • [Cites] Cytometry. 1992;13(8):795-808 [1333943.001]
  • [Cites] J Neurobiol. 1994 Mar;25(3):294-303 [7910846.001]
  • (PMID = 15647748.001).
  • [ISSN] 0271-678X
  • [Journal-full-title] Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
  • [ISO-abbreviation] J. Cereb. Blood Flow Metab.
  • [Language] eng
  • [Grant] United States / Intramural NIH HHS / / Z99 NS999999
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Annexin A5; 0 / Benzimidazoles; EC 3.4.22.- / Casp3 protein, rat; EC 3.4.22.- / Caspase 3; EC 3.4.22.- / Caspases; P976261J69 / bisbenzimide ethoxide trihydrochloride
  • [Other-IDs] NLM/ NIHMS8292; NLM/ PMC1378216
  •  go-up   go-down


97. Yang W, Liu P, Liu Y, Wang Q, Tong Y, Ji J: Proteomic analysis of rat pheochromocytoma PC12 cells. Proteomics; 2006 May;6(10):2982-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Proteomic analysis of rat pheochromocytoma PC12 cells.
  • Here we report the construction of a large-scale 2-D protein database for PC12 cells.
  • The proteins extracted from PC12 cells were separated by 2-DE and identified by MALDI-TOF/TOF MS.
  • [MeSH-minor] Animals. Electrophoresis, Gel, Two-Dimensional. PC12 Cells. Pheochromocytoma. Rats. Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

  • [Email] Email this result item
    Email the results to the following email address: